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The focus of this thesis is on physical activity in patients participating in cardiac reha-
bilitation (CR) following coronary heart disease (CHD). Both the effects of standard CR 
and CR extended with behavioural interventions is investigated. Secondary outcomes 
include sedentary behaviour, fatigue and participation in society. This chapter gives 
background information on the patient population, on CR, and on the primary and 
secondary outcomes. Additionally, the theoretical background of the investigated be-
havioural interventions is described. The chapter concludes with the aims and outline 
of this thesis.
CORONARy HeARt diseAse
CHD is the most common type of cardiovascular disease and is caused by the growth 
of plaque inside the coronary arteries (atherosclerosis), resulting in a reduced flow of 
oxygen-rich blood.1 Acute coronary syndrome (ACS) is a subcategory of CHD and in-
cludes myocardial infarction and unstable angina pectoris. The most common treatment 
of patients with CHD is the prescription of cardio-protective medication (such as aspirin 
and statins) or invasive treatment such as a percutaneous coronary intervention (PCI) 
or coronary artery bypass graft surgery (CABG).1 During a PCI, catheterization is used to 
open the blocked artery, often combined with the placement of a stent. During CABG, 
a bypass is created to circumvent the blocked coronary arteries. The average length of 
hospitalization after a myocardial infarction is currently circa 5 days.2,3  
In 2015, over 700.000 people with CHD were living in the Netherlands, a country with 
circa 17 million inhabitants. The incidence of new cases was over 70.000 patients with 
myocardial infarction and almost 40.000 patients with angina pectoris.1,4 Improvements 
in medical treatment have increased survival rates.1,3,4 However, in the Netherlands still 
9000 people died caused by CHD in 20151,4 and cardiovascular diseases remain the 
number one cause of death in Europe, accounting for 45% of deaths.3 With a yearly cost 
of 2.1 milliard euros in the Netherlands, the economic impact of CHD is high.1
CARdiAC ReHABilitAtiON
In the first year after CHD, the risk of suffering a recurrent cardiovascular event is 20%.5,6 
Risk factors for the development of (recurrent) cardiovascular problems include high 
cholesterol, hypertension, diabetes, obesity and unhealthy lifestyle habits such as smok-
ing, unhealthy diet and no regular physical activity.7 Adherence to a healthy lifestyle is 
estimated to result in a 20 to 35% mortality risk reduction in patients with CHD, which 
General introduction
9
1is comparable to the effects of cardio-protective drugs.
8 Despite the ample evidence 
of the benefits of a healthy lifestyle, results of the EUROASPIRE study still show a high 
prevalence of unhealthy lifestyles and suboptimal control of risk factors among a large 
group of European patients with CHD.9,10 
CR has been recognized as essential for secondary prevention in patients after CHD.11-13 
CR has evolved from exercise-only programs to more comprehensive programs includ-
ing psychological and educational interventions. Currently, CR in the Netherlands lasts 
6-12 weeks and, in line with both the European and American guidelines, focuses on the 
adoption of a healthy lifestyle and the optimization of aerobic capacity, cardiovascular 
risk factors and psychosocial status.11-13 The programs are led by a multidisciplinary team 
consisting of physical therapists, cardiologists, rehabilitation physicians, social workers, 
psychologists, psychiatrists, and dieticians.13 Meta-analyses and systematic reviews 
have shown substantial benefits of CR on risk factors such as lipid profile, blood pressure 
and smoking rate, but also on quality of life, aerobic capacity, mortality, and hospital 
readmissions.14-17 Economic evaluations also indicated that CR is a cost-effective inter-
vention.16,18 Notwithstanding these benefits, long-term maintenance of results seems 
less optimal. After completion of CR a deterioration of benefits is often reported.19-21 The 
standard 3-month CR period is possibly insufficient to incorporate lifestyle changes into 
daily life.
PHysiCAl ACtivity ANd sedeNtARy BeHAviOuR 
Physical activity can be defined as bodily movements produced by skeletal muscles 
that increase energy expenditure.22 In patients with CHD, regular physical activity is 
associated with a substantially lower risk of recurrent cardiovascular events and a 25% 
mortality risk reduction.8,23 In addition, physical activity positively influences blood 
pressure, lipid profile, body mass index and diabetes.24,25 Despite the extensive benefits 
of having an active lifestyle, only 40% of European patients with CHD report regular 
physical activity.10 Since physical activity is an important tool for large-scale cardio-
vascular disease prevention with effects comparable to cardio-protective medication, 
promoting physical activity should be given high priority.8,26 Although Dutch, European 
and American guidelines recommend implementing physical activity counselling into 
CR11-13, structural counselling programs are often lacking and only general advice on 
the benefits of physical activity is given. A clear overview of the literature with regard 
to the effects of current standard CR on physical activity is lacking, but it has been sug-
gested that current CR is insufficient for changes in physical activity and more structural 
counselling programs using behavioural techniques might be needed.27,28 
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Physical activity and sedentary behaviour are different concepts, but often confused 
with one another.29 Sedentary behaviour can be defined as a behaviour (during waking 
hours) that requires very low energy expenditure, mainly sitting or lying.29 Someone can 
have an active lifestyle (e.g. frequently exercising during leisure time) and simultaneous-
ly have a sedentary lifestyle (e.g. accumulating long sedentary periods at work). Recent 
studies in general populations have shown that sedentary behaviour is, independent of 
physical activity, related to health outcomes such as diabetes, cardiovascular disease, 
and mortality.30-34 Taking regular active breaks during sedentary time might counteract 
the detrimental effects of prolonged sedentary periods.35,36 Current CR programs gen-
erally do not address sedentary behaviour. Studies investigating the consequences of 
sedentary behaviour in patients participating in CR are scarce. A first study showed that 
sedentary time is long among CR graduates and associated with a higher body mass 
index and lower aerobic capacity.30 
FAtigue ANd PARtiCiPAtiON iN sOCiety
Perceived fatigue after myocardial infarction was reported to be high and is described 
as one of the most disturbing symptoms.37 It is unknown whether CR is effective in 
improving fatigue. Since fatigue is known to be associated with depression and aero-
bic capacity38 and CR is known to positively influence these outcomes 14,15,39, it can be 
hypothesized that CR might also lead to improvements in fatigue. In addition, previous 
studies have found an association between physical activity and fatigue and between 
sedentary behaviour and fatigue.40 Interventions that aim to improve physical activity 
and sedentary behaviour during CR might therefore also positively impact fatigue. 
Another understudied CR outcome is participation in society. The CR guidelines recom-
mend optimizing participation in society with regard to domestic, occupational, and 
recreational activities.13 With regard to occupational activities, previous studies have 
shown that 80% of patients with ACS have returned to work within 1 year.41 Research 
on participation in domestic and recreational activities, such as going out and house-
keeping is scarce. CR could have a direct or indirect effect on participation in society. 
Improvements in aerobic capacity, often seen during CR14,15, could influence physical 
strain of daily activities, which in turn could improve participation in society.42 In line 
with our hypothesis for fatigue, participation in society could also be improved by CR 
interventions that aim to increase physical activity.43
Both fatigue and participation in society deserve more attention as an outcome of CR 
since they are known to affect quality of life.44,45 
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BeHAviOuRAl iNteRveNtiONs
There are several theoretical models explaining (changes in) health behaviour, such as 
the social cognitive theory, the theory of planned behaviour, the health belief model 
and the transtheoretical model of change.46,47 Although there are clear differences 
between these theories, there is also overlap between the models in for instance the 
determinants of health behaviour.46 The social cognitive theory describes self-efficacy, 
knowledge, outcome expectations, goals and perceived facilitators as important deter-
minants of health behaviour.46 These determinants overlap with determinants described 
by for instance the theory of planned behaviour (e.g. self-efficacy, outcome expecta-
tion and goals), the health belief model (e.g. outcomes expectations and perceived 
facilitators) and the transtheoretical model of change (e.g. self-efficacy).46,48 It has been 
hypothesized that behaviour change techniques (such as self-monitoring and goal set-
ting) can influence these determinants, leading to changes in health behaviour which, in 
turn, could lead to changes in health.49,50 Therefore, an important step when designing 
a behavioural intervention is to select appropriate (evidenced-based) behaviour change 
techniques.49,51 In this thesis, we did not favour a certain theoretical model or aim to 
investigate the working mechanism of separate behaviour change techniques. Rather, 
we were interested in the synergistic effects of combining evidence-based behaviour 
change techniques (grounded in multiple theoretical models) in a pragmatic behavioural 
intervention. Results of reviews and meta-analyses have shown that giving information 
on consequences of behaviour, self-monitoring, goal setting, planning, receiving feed-
back, identifying barriers and developing plans for relapse prevention are promising 
techniques to change health behaviour in cardiac patients.27,28,52-54 Combining these 
techniques seems more successful than using a single strategy.28,52 In addition, reviews 
and meta-analyses have shown that motivational interviewing is an effective counsel-
ling method to guide people with behaviour changes.55-57 Motivational interviewing is 
defined as a directive counselling style for eliciting behaviour change by helping people 
to explore and resolve ambivalence.58 
Previous studies have shown promising results after adding behavioural interventions 
aiming at further improvements in lifestyle (such as sufficient physical activity) to CR.59-62 
However, the impact of these studies are limited. Most protocols were designed to 
evaluate short-term effectiveness; knowledge about long-term maintenance is scarce. 
Additionally, the behavioural interventions were often not integrated into existing CR 
programs. For successful implementation into daily clinical practice, pragmatic trials 
that use existing infrastructure are needed. Lastly, previous studies largely rely on self-
reported measures for changes in physical activity that are known to have poor validity 
and reliability.63
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OutliNe OF tHis tHesis
Objectives
The main objective of this thesis was to evaluate the added value of (pragmatic) 
behavioural lifestyle interventions integrated into standard CR on physical activity in 
patients with ACS. Secondary, the intervention effects on sedentary behaviour, cardio-
vascular health, aerobic capacity, perceived level of fatigue and participation in society 
were studied. Furthermore, the effects of standard CR with regard to the understudied 
outcomes physical activity, sedentary behaviour, fatigue and participation in society 
were described. To study the effects of standard CR, data collected in the Capri Monitor 
longitudinal cohort was used. To study the additional effects of two novel behavioural 
lifestyle interventions, data collected in the OPTICARE randomized controlled trial was 
used.
Capri monitor 
Capri Monitor is a longitudinal cohort study of patients who participate in multidisci-
plinary standard CR at Capri (CR centre located in Rotterdam and The Hague in the Neth-
erlands). The Capri program is in line with the Dutch guidelines and lasts around 6-12 
weeks.13 In this period patients participate twice a week in a 1.5-hour exercise program 
consisting of gymnastic exercise to increase muscle strength, running/brisk walking, 
sports activities and relaxation exercises. Additionally, patients can participate in edu-
cational sessions on healthy diet, cardiovascular risk factors and psychosocial problems. 
Upon indication and motivation, patients can also participate in a stress management 
program, a dietary program, a smoking cessation program and/or an individualized 
psychologic program. An extensive measurement protocol was performed at the start 
of rehabilitation, at the completion of CR and at 1-year follow-up. For this thesis, patients 
that were referred to CR after CHD were selected and data on fatigue, participation in 
society, and aerobic capacity was used.
OPtiCARe
In the OPTICARE randomized controlled trial the additional effects of two novel behav-
ioural lifestyle interventions (CR+F intervention using face-to-face group counselling 
and CR+T intervention using individual telephonic counselling) added to standard CR 
after an ACS were investigated (See Figure 1.1).
The CR+F intervention was developed by Capri by an expert group consisting of physi-
cal therapists, social workers, psychologists, dieticians and researchers. The content 
of this intervention was based on the following evidence-based behavioural change 
techniques: information about health behaviour, self-monitoring, goal setting, feed-
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back, barrier identification and relapse prevention. The CR+F intervention consisted 
of 3 months of standard CR with the addition of three face-to-face physical activity 
group counselling sessions led by physical therapists trained in motivational interview-
ing. During the sessions, information was given on the health consequences of both 
physical activity and sedentary behaviour. Patients used a pedometer for continuous 
objective feedback on physical activity and to set goals. A booklet with assignments 
focusing on for instance goal setting, barrier identification and relapse prevention was 
used during the sessions. The initial CR program was followed by 9 months of aftercare 
with three group sessions, each comprising a 1-hour exercise program and 1 hour of 
healthy lifestyle counselling. The exercise program served as self-monitoring of aerobic 
capacity and also intended to stimulate interaction between patients in the group. The 
counselling sessions in the aftercare program focused on the permanent adoption of a 
healthy lifestyle (i.e., healthy diet and optimal physical activity), but also on psychosocial 
problems. During the sessions, information on consequences of health behaviours was 
repeated and there was a focus on relapse prevention. During these sessions, patients 
were coached alternatingly by a dietician, a social worker and a physical therapist. All 
coaches were trained in motivational interviewing. Finally, the cholesterol and blood 
pressure levels were monitored and medication was adjusted when needed. The target 
level was: LDL ≤1.8 mmol/l and systolic blood pressure (SBP) <140 mmHg.
The CR+T intervention consisted of 3 months of standard CR, followed by 9 months of 
aftercare with five to six healthy lifestyle, telephonic counselling sessions. This inter-
vention was based on an existing behavioural program that already had been proven 
effective in Australia.64 Similar behaviour change techniques as described above were 
used in this intervention. During the phone calls information was given on risk factors 
CR-only 
CR+F 
Face-to-Face 
CR+T 
Telephone 
standard CR 
3 group sessions  
including fitness training and 
lifestyle counselling 
5-6 telephonic lifestyle 
counselling sessions 
standard CR 
3 physical activity 
counselling  
sessions 
standard CR 
Follow up 
T0                              3 Months                                                  12 Months                           18 Months 
Follow up 
Follow up 
Figure 1.1 Design of the OPTICARE study
CR+F= cardiac rehabilitation plus face-to-face group counselling; CR+T= cardiac rehabilitation plus individual 
telephonic counselling; CR-only= standard cardiac rehabilitation; m=months.
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(e.g. cholesterol, blood pressure) and health behaviours (e.g. diet, physical activity). 
Patients were stimulated to self-monitor their own risk factors (for instance measuring 
cholesterol at their doctor’s offi  ce) and to set goals. During follow-up calls, progress 
was discussed. At the end of every phone call, patients received a written overview of 
the topics that were discussed and the agreements made. The coaching was off ered 
by the Medical Service Center of the health insurance company “Zilveren Kruis”, which 
consisted of specialized nurses who were trained in motivational interviewing.
The OPTICARE aimed to evaluate eff ects from a cardiology viewpoint on cardiovascular 
risk factors (the focus of a separate thesis) and from a rehabilitation medicine viewpoint 
on physical activity (current thesis). Measurements were performed at randomization, 
after standard CR, at the end of after-care, and 6 months later (see Figure 1.1).
short overview of this thesis
Figure 1.2 shows a schematic overview of the content of this thesis.
* Cardiovascular Risk Profile 
(Blood pressure, Lipids, Smoking)
*Anxiety and depression
*Health related quality of life
(Chapter 8)
 
*Sedentary behaviour
(Chapter 7)
*Aerobic capacity
*Fatigue
*Participation in society
(Chapter 9)
 
Direct intervention effectir ct i t r ti  ff ct 
 
Indirect (mediating) effectI ir ct ( i ti ) ff ct
 
+ Behavioural intervention 
(CR+F/ CR+T) 
 
Aerobic 
capacity
 
 Participation in society
(Chapter 5)
 
Health-related quality of life
 
*Physical activity
*Sedentary Behaviour
(Chapter 2+3)
InterventionI t r ti
 
Outcometc
 
xx
 
XX
 
 
 Depression 
 
Standard cardiac 
rehabilitation
Fatigue
(Chapter 4)
Part 1: Capri Monitor
Part 2: OPTICARE
Physical activity
(Chapter 7) 
xx Primary Outcomeri r  tc
Figure 1.2 Outline of the thesis
CR+F = cardiac rehabilitation plus face-to-face group counselling; CR+T = cardiac rehabilitation plus individual 
telephonic counselling.
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1In Part i the focus is on short- and long-term outcomes of current standard CR after CHD. 
The literature regarding the effects of CR on physical activity is systematically summa-
rized in Chapter 2. Changes during and after CR in objectively measured physical activ-
ity and sedentary behaviour are described in Chapter 3; in fatigue and its association 
with aerobic capacity and depression in Chapter 4; and in participation in society and 
its association with health-related quality of life in Chapter 5.  
In Part ii the outcomes of the OPTICARE trial are described in patients with ACS. 
Chapter 6 provides insights into the rationale and design of the OPTICARE trial. Chapter 
7 describes the primary results of the interventions on physical activity and sedentary 
behaviour. Chapter 8 focuses on the results with regard to cardiovascular health, de-
pression and anxiety, and health-related quality of life. In Chapter 9 secondary effects of 
the interventions on aerobic capacity, fatigue and participation in society are described 
and whether these effects are mediated by physical activity and sedentary behaviour. 
In the concluding Chapter 10, the main findings of the different chapters are integrated 
and interpreted. Methodological considerations, clinical implications and directions for 
future research are discussed.
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ABstRACt
Background: Optimal physical activity levels have health benefits for patients 
with an acute coronary syndrome (ACS) and are an important goal of cardiac 
rehabilitation (CR). 
Purpose: To systematically review literature regarding short-term (<6 months 
after completion of CR) and long-term effects (≥6 months after completion) of 
standard CR on physical activity levels in patients with ACS.
data sources: PubMed, EMBASE, CINAHL and PEDro were systematically 
searched for relevant randomized controlled trials (RCTs) from 1990 until 2012. 
study selection: Randomized controlled trials (RCTs) investigating CR for pa-
tients with ACS reporting physical activity level were reviewed. 
data extraction: Two reviewers independently selected articles, extracted data, 
and assessed methodological quality. Result were summarized with a best-
evidence synthesis. Results were categorized as: 1) center-based/home-based CR 
vs no intervention, 2) comparison of different durations of CR, and 3) comparison 
of 2 types of CR.
data synthesis: A total of 26 RCTs were included. Compared with no interven-
tion, there was, at most, conflicting evidence for center-based CR and moderate 
evidence for home-based CR for short-term effectiveness. Limited evidence and 
no evidence were found for long-term maintenance for center-based and home-
based CR, respectively. When directly compared with center-based CR, moderate 
evidence showed that home-based CR has better long-term effects. There was 
no clear evidence that increasing training volume, extending duration of CR or 
adding an extra intervention to CR is more effective. 
limitations: Because of the variety of CR interventions and the variety of out-
come measures in the included RCTs, pooling of data was not possible. Therefore, 
a best-evidence synthesis was used.
Conclusions: It would appear that center-based CR is not sufficient to improve 
and maintain physical activity habits. Home-based programs might be more suc-
cessful, but the literature on these programs is limited. More research on finding 
successful interventions to improve activity habits is needed. 
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iNtROduCtiON
New drug therapies and revascularization techniques developed since the 1980s have 
dramatically changed the care of patients with cardiovascular conditions. Although car-
diovascular disease is still the leading cause of death worldwide,1 since the introduction 
of these treatments, survival rates have increased, hospitalization has shortened, and 
cardiac function has been better preserved.2,3 Healthy lifestyle management is crucial 
for successful secondary prevention for this growing number of surviving patients.2,4 
Cardiac rehabilitation (CR), including lifestyle education, has become increasingly im-
portant.  
An important goal of CR is to improve daily physical activity levels. Regular physical 
activity reduces cardiac mortality by 20-30% in patients with myocardial infarction.5 
Besides improving cardiac mortality, having an active lifestyle also has positive effects 
on the most important cardiovascular risk factors such as lipid profile, blood pressure 
and body composition.6,7
The core of current standard CR consists of exercise programs led by physical thera-
pists, complemented with educational or psychosocial interventions. Previous reviews 
reported that besides reducing cardiovascular risk factors and improving quality of life, 
standard CR does improve physical fitness.8,9 However, improved fitness (what a person 
can do) does not automatically result in a more active lifestyle (what a person really does 
in daily life).10
A review published in 1998 suggested that CR is not sufficient to change physical ac-
tivity habits in the long term.11 However, medical practice has changed greatly since 
this review was written. The introduction of new drug therapies and revascularization 
techniques has shortened the time available in hospital for lifestyle education, putting 
more emphasize on CR.2,3 Moreover, a shift was seen from exercise-only CR to compre-
hensive programs including lifestyle education. It is unclear whether current standard 
CR programs are sufficient to improve and maintain physical activity levels. Therefore, 
the purpose of this study was to systematically review the recent scientific literature 
regarding the effect of current standard CR on levels of daily physical activity after an 
acute coronary syndrome (ACS). To establish whether any improvements are maintained 
over time, we focused not only on the effects achieved immediately after CR but also on 
the effects in the long term.
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metHOds
data sources and searches
We systematically searched PubMed, EMBASE, CINAHL, and PEDro for relevant random-
ized controlled trials (RCTs). The search was limited to RCTs published between 1990 
and December 2012. RCTs published before 1990 were excluded because there have 
been major changes in medical practice since the development of new drugs and revas-
cularization techniques in the 1980s. The search strings consisted of keywords related 
to ‘heart disease’, ‘cardiac rehabilitation’ and ‘randomized controlled trials’, and can be 
found in detail in Appendix 2A. 
study selection
Randomized controlled trials fulfilling the following criteria were included: 
1) The study population consisted of patients who had recently (<1 year) either survived 
ACS, or undergone coronary artery bypass grafting (CABG) or percutaneous coronary 
intervention (PCI). ACS usually occurs as a result of one of three problems: ST-elevation 
myocardial infarction, non-ST-elevation myocardial infarction, or unstable angina. In the 
Netherlands these patients are usually treated with primary or elective PCI or CABG.
2) The intervention investigated was a CR program that lasted for at least 4 weeks. 
We defined CR as a structured exercise program combined with psychosocial and 
educational interventions undertaken in a center-based or home-based setting. As the 
exercise program forms the core of CR, interventions were categorized based on the 
location where the exercise program was performed. Thus, interventions containing a 
center-based exercise program were classified into the category center-based CR and in-
terventions containing a home-based exercise program into the category home-based 
CR. Exercise-only interventions were excluded because this type of intervention is no 
longer considered as standard CR.2,6,12 
3) An outcome measure for physical activity was reported. Physical activity was defined 
as any bodily movement produced by skeletal muscles and resulting in energy expen-
diture.13
4) Minimal follow-up was completion of the CR intervention. 
5) The article was written in English, Dutch, French or German.
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Two reviewers (N.H., R.D.) independently selected relevant articles based on the 
inclusion criteria. Before reading the full text, a first selection was based on titles and 
abstracts. If an article was not available, we tried to obtain it by contacting the author. 
Disagreement between the 2 reviewers was discussed. If needed, a third reviewer (B.H.) 
resolved disagreements.
data extraction and quality assessment
Data on outcome measures for level of daily physical activity, study population, sample 
size, CR intervention, and control intervention were extracted by one reviewer (N.H.) 
using a standardized form, and were checked by a second reviewer (R.D.). Data on out-
come measures for physical activity were divided into short-term and long-term effects. 
Short-term effects were defined as effects measured less than 6 months after comple-
tion of CR; long-term effects were defined as effects measured 6 months or longer after 
completion of CR. In case multiple measurements within the short term or long term 
were reported in a single RCT, the measurement closest to completion of CR was used 
for analysis of short-term effectiveness and the measurement closest to 1 year after 
completion of CR was used for analysis of long-term effectiveness. If data on the same 
RCT and population were reported in multiple publications, we extracted and presented 
them as originating from a single RCT. Disagreement was resolved by discussion or by 
the third reviewer (B.H.).
Two reviewers (N.H., R.D.) independently assessed the methodological quality of in-
cluded RCTs using the list published by Furlan et al.14 This list consists of 12 items that 
are scored as yes (+), no (-) or unsure (+/-). A study was considered of ‘high quality’ if at 
least 6 questions (≥50%) were scored as yes. Disagreement was resolved by discussion 
or by resorting to a third reviewer (B.H.).
data synthesis and analysis
Due to the heterogeneity of CR interventions and the outcome measures for physical ac-
tivity, pooling of data was not possible. Therefore, we used a best-evidence synthesis.15 
This method allows methodological quality and outcomes of the RCTs to be taken into 
account. Strength of evidence for the effectiveness of CR to improve physical activity in 
the short term (<6 months after completion of CR) and in the long term (≥6 months after 
completion of CR) was ranked as shown in Table 2.1.15
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Results
literature search and characteristics of the selected RCts
Our initial search resulted in 2919 eligible articles. We fi nally included 26 RCTs (Figure 
2.1). Of these, 9 RCTs compared CR with no intervention, 10 RCTs compared CR programs 
of diff erent duration and 7 RCTs compared 2 diff erent types of CR (Table 2.2). When 
measuring physical activity, 21 RCTs used a self-report instrument (e.g. questionnaire or 
activity diary), 3 RCTs used a pedometer, and 2 RCTs used both a self-report instrument 
and an accelerometer (Table 2.2). 
records identified 
through database 
search (n=3843)
Medline (n=1646)
Embase (n=1694)
Cinahl (n=209)
PeDro (n=294)
titles review 
(n=2919)
abstract review 
(n=798)
full text review 
(n=206)
28 articles concerning 26 RCTs 
included:
●standard CR vs. no 
intervention (n=9)
●two different durations of CR 
compared to each other (n=10)
●two different types of CR 
compared to each other (n=7)
duplicate entries 
removed (n=924)
articles excluded 
(n=2121)
articles excluded 
(n=592)
articles excluded 
(n=178)
Figure 2.1 Selection of articles 
RCT= randomized controlled trial; CR= cardiac rehabilitation. 
methodological quality of the 26 RCts
The results of the methodological quality assessment are presented in Appendix 2B. 
Fourteen of the 26 RCTs scored 50% or more of the maximum score and were considered 
high quality. The most prevalent methodological fl aws were: patients not blinded (100% 
of included RCTs); care provider not blinded (100% of RCTs); failure to report whether 
co-interventions were avoided (100% of RCTs); and failure to report whether treatment 
allocation was concealed (81% of RCTs).
table 2.1 Strength of evidence
1 strong evidence Consistent (i.e. similar fi nding in >75% of the RCTs) signifi cant fi ndings (p<0.05) in at least 
2 high-quality RCTs.
2 moderate evidence Consistent signifi cant fi ndings in at least 2 low-quality RCTs and/or one high-quality RCT.
3 limited evidence Signifi cant fi ndings in one low-quality RCT.
4 Confl icting evidence Inconsistent (i.e. similar fi ndings in <75% of the RCTs) signifi cant fi ndings in multiple RCTs.
5 No evidence One or more RCT found, but no signifi cant diff erences were reported between groups.
6 No RCt found. No RCT found.
RCT= randomized controlled trial.
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data extraction
Details of the characteristics and results of the included RCTs are presented in Appendix 
2C. 
table 2.2 Treatment specifications for intervention group and control intervention in the 26 RCTs
RCt
measurement 
tool
intervention Control intervention
Home-based/ 
center-based duration
Home-based/ 
center-based duration
Standard CR
vs. no 
intervention
Bertie 199216 pedometer center 4 weeks no intervention n.a.
Higgins 200125 self-reported home 1 year no intervention n.a.
Lidell 199619 self-reported center 6 months no intervention n.a.
Naser 200821 self-reported center 2 years no intervention n.a.
Oldenburg 199522 self-reported center 1 year no intervention n.a.
Ornish 1990+1998*23,24 self-reported home 1 year no intervention n.a.
Otterstad 200320 self-reported center 2 years no intervention n.a.
West 201217 self-reported center 6-8 weeks no intervention n.a.
Engblom 199218 self-reported center 8 months no intervention n.a.
Two different 
durations of CR 
compared to 
each other
Arrigo 200829 self-reported center 1 year center 1-3 months
Hughes 200730
self-reported/ 
accelerometer
center 1 year center 3 months
Carlsson 199733 self-reported center 1 year center 5 weeks
Mildestvedt 200832 self-reported center 2 years center 4 weeks
Giannuzzi 200834 self-reported center 3 years center 6 months
Janssen 201226 pedometer center 8 months center 3 months
Pinto 201127 self-reported center 9 months center 3 months
Reid 200531 self-reported center 1 year center 3 months
Lear 200635 self-reported center 4 years center 4 months
Moore 200628 self-reported center 5 months center 3 months
Two different 
types of CR 
compared to 
each other
Carlson 200041 self-reported center 6 months center 6 months
Izawa 200542 pedometer center 6 months center 6 months
Tingström 200543
self-reported/ 
accelerometer
center 1 year center 1 year
Jolly 200936 self-reported center 9-12 weeks home 3 months
Oerkild 201139 self-reported center 1 year home 1 year
Hansen 200840 self-reported center 3 months center 3 months
Smith 2004+2011*37,38 self-reported center 6 months home 6 months
RCT= randomized controlled trial; CR= cardiac rehabilitation; n.a.= not applicable.
*multiple publications on data of the same RCT and population are presented as originating from a single RCT.
effectiveness of CR on improving physical activity levels
We performed a best-evidence synthesis to summarize short-term effects (<6 months 
after completion of CR) and long-term effects (≥6 months after completion of CR). We 
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categorized RCTs into studies investigating ‘center-based and home-based CR versus no 
intervention’, ‘comparison of CR programs of different durations’ and ‘comparison of 2 
types of CR’. Duration of CR programs also varied greatly (4 weeks till 4 years) within the 
above categories. To further improve meaningful interpretation of results, we analysed 
and presented effects in every category in the following order: CR programs of short du-
ration (1-3 months), CR programs of medium duration (4-11 months) and CR programs 
of long duration (≥12 months). Table 2.2 shows the treatment specifications and Tables 
2.3, 2.4 and 2.5 show the results of the best-evidence synthesis per category.
effectiveness of CR versus no intervention
Seven RCTs investigated the effectiveness of center-based CR, and 2 RCTs investigated 
the effects of home-based CR versus a control group. Controls visited the hospital only 
for routine check-ups or received oral or written information about cardiac disease 
(Table 2.2). 
Center-based CR versus no intervention
For CR of short duration (1-3 months), Bertie et al.16 (low quality, n=110) reported short-
term effects of a 4-week CR program and showed that 3 months after completion of CR, 
the intervention group walked, on average, significantly more miles each day (8.2 miles) 
than the controls (6.6 miles) (p<0.05). West et al.17 (high quality, n=1813) focused on 
long-term effectiveness and reported that 10 months after completion of CR, the per-
centage of active patients (>100kcal/day) was higher in controls (12%) than in patients 
randomized to 6-8 weeks CR (9%) (p=0.05). According to the best evidence synthesis, 
there is limited evidence that, in the short term (<6 months after completion of CR), 
center-based CR of short duration is effective in improving physical activity levels. In the 
long term (≥6 months after completion), there is moderate evidence in favor of controls 
(Table 2.3).
For CR of medium duration (4-11 months), Engblom et al.18 (high quality, n=171) reported 
no short-term effects 4 months after completion of an 8-month CR program. Lidell and 
Fridlund19 (low quality, n=116) performed 2 long-term measurement: at 6 months and 
at 4.5 years. Significant effects were found at the 6-month follow-up (66.7% of interven-
tion group was active versus 27.6% of controls, p<0.001); these improvements were 
not maintained after 4.5 years. As defined in our methods, the measurement closest 
to 1 year after completion of CR was used in the best evidence synthesis (ie, the results 
at 6-month follow-up). The best evidence synthesis revealed that there is no evidence 
that center-based CR of medium duration is effective in the short term (<6 months after 
completion of CR) and limited evidence that it is effective in the long term (≥6 months 
after completion of CR). See Table 2.3.
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For CR of long duration (≥12 months), Otterstad et al.20 (high quality, n=197) found that 
upon completion of a 2-year CR program, 67% of patients exercised for more than 1 
hour every week compared with 46% of controls (p<0.01). Naser et al.21 (low quality, 
n=100) reported that upon completion of a 2-year CR program, 88% of patients were 
vigorously active at least 3 times per week for 20 minutes, whereas this figure was only 
20% in controls (p<0.05). Oldenburg et al.22 (low quality, n=86) investigated a 1-year CR 
program and found no effects upon completion. We conclude that there is conflicting 
evidence for the short-term effectiveness (<6 months after completion of CR) of center-
based CR of long duration. No RCTs focused on long-term effects (Table 2.3).
table 2.3 Evidence for effectiveness of CR interventions versus no intervention 
duration CR RCt
low/ high 
quality
short-term effects
< 6 mo after 
completion of CR
long term-effects
≥6 mo after 
completion of CR
Center-based CR versus no intervention
Short (1-3 mo) Bertie 199216 low + n.a.
West 201217 high n.a. -
Best evidence synthesis: limited evidence moderate evidence#
Medium (4-11 mo) Engblom 199218 high 0 n.a.
Lidell 199619 low n.a. +
Best evidence synthesis: no evidence limited evidence
Long (≥12 mo) Otterstad 200320 high + n.a.
Naser 200821 low + n.a.
Oldenburg 199522 low 0 n.a.
Best evidence synthesis: conflicting evidence no RCT
Home-based CR versus no intervention
Short (1- 3 mo) no RCT
Medium (4-11 mo) no RCT
Long (≥12 mo) Ornish 1990+1998*23,24 high + 0
Higgins 200125 low + n.a.
Best evidence synthesis: moderate evidence no evidence
CR= cardiac rehabilitation; RCT= randomized controlled trial; mo=months; “+”= significant differences in favor 
of intervention; ”-“= significant differences in favor of controls; “0”= no significant differences found; n.a.= not 
applicable.
#moderate evidence in favor of no intervention. 
*multiple publications on data of the same RCT and population are presented as originating from a single RCT.
Home-based CR versus no intervention
No RCTs were found for CR of short duration (1-3 months) or medium duration (4-11 
months).
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For CR of long duration (≥12 months), Ornish et al.23 (high quality, n=48) reported that 
patients in the intervention group (1-year CR) increased from 0.26 exercise sessions/day 
at the start to 0.69 sessions/day on completion of the program; this increase was lower 
for controls (from 0.35 to 0.39 sessions/day) (p=0.0008). There were no significant differ-
ences at 4-year follow-up.24 Higgins et al.25 (low quality, n=105) reported that patients 
participating in a 1-year CR program increased from 35% being active before CR to 72% 
upon completion. This increase was larger than that in controls (53% to 61%) (p<0.001). 
In conclusion, there is moderate evidence that in the short term (<6 months after 
completion of CR) home-based CR of long duration is effective. There is no evidence for 
long-term effectiveness. See Table 2.3.
Comparison of CR programs of different durations 
Ten of the 26 included RCTs compared 2 center-based CR programs of different duration. 
In this category, short-term effects were defined as results measured <6 months after 
completion of the CR program with the longer duration, and long-term effects were 
defined as results measured 6 months or more after completion of the program with the 
longer duration.
CR of medium duration (4-11 months) versus short duration (1-3 months)
Janssen et al.26 (high quality, n=210) reported that upon completion of 8-month CR, 
patients had increased their daily step count by 1142 compared to the start of CR, 
whereas patients randomized to 3-month CR had decreased their daily step count by 
522 by that time (p=0.001). The RCT of Pinto et al.27 (high quality, n=130) showed an 
increased duration of moderate exercise per week 3 months after completion of a CR 
program of 9 months for patients randomized to this longer program compared with 
patients randomized to receive 3-month CR (difference 0.47, standardized values, 
p=0.008). Contrasting results were found by Moore et al.28 (high quality, n=250) who did 
not find short-term differences between 3 and 5-month CR programs. Moore et al. also 
reported long-term effects, but again no differences were found. We conclude that there 
is conflicting evidence that, in the short term (<6 months after completion of the CR 
program of medium duration), CR of medium duration is more effective than CR of short 
duration for improving levels of physical activity. In the long term, there is no evidence 
of effectiveness. (Table 2.4).
CR of long duration (≥12 months) versus short duration (1-3 months) 
Arrigo et al.29 (low quality, n=261) reported that 73% of patients randomized to a 
1-year CR program were physically active at least 3 times a week for 30 minutes upon 
completion of the program, compared with 40% of patients randomized to receive 
1 to 3 months of CR (p<0.0005). Hughes et al.30 (low quality, n=70) found that, upon 
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completion of a 1-year CR program, patients exercised on average 130 minutes per week 
more than patients who had participated in a 3-month CR program (significant, p-value 
not reported). In contrast, 3 other RCTs (1 high quality31, 2 low quality32,33) showed no 
short-term differences between CR of long and short duration. Only 1 RCT also focused 
on long-term effects. Reid et al.31 (high quality, n=392) did not find differences when 
comparing a 1-year program with a 3-month program. In conclusion, there is conflicting 
evidence that, in the short term (<6 months after completion of the CR program of long 
duration), CR of long duration is more effective than CR of short duration. In the long 
term there is no evidence of effectiveness (Table 2.4).
table 2.4 Evidence for effectiveness of two different durations of CR compared with each other
RCt
low/high 
quality
short-term effects
< 6mo after completion of CR
long-term effects
≥6 mo after completion of CR
CR of medium duration (4-11 mo) versus CR of short duration (1-3 mo)
Janssen 201226 high + n.a.
Pinto 201127 high + n.a.
Moore 200628 high 0 0
Best evidence synthesis: conflicting evidence no evidence
CR of long term duration (≥12 mo) versus CR of short duration (1-3 mo)
Arrigo 200829 low + n.a.
Hughes 200730 low + n.a.
Reid 200531 high 0 0
Carlsson 199733 low 0 n.a.
Mildestvedt 200832 low 0 n.a.
Best evidence synthesis: conflicting evidence no evidence
CR of long term duration (≥12 mo) versus CR of medium duration (4-11 mo)
Giannuzzi 200834 high + n.a.
Lear 200635 high 0 n.a.
Best evidence synthesis: conflicting evidence no RCT
CR= cardiac rehabilitation; RCT= randomized controlled trial; mo=month; ”+”= significant differences in favor 
of CR of longer duration; ”-“= significant differences in favor of CR of shorter duration; “0”= no significant differ-
ences found; n.a.= not applicable.
CR of long duration (≥12 months) versus medium duration (4-11 months)
Giannuzzi et al.34 (high quality, n=3241) found that, upon completion of a 3-year CR 
program, patients had a higher physical activity score (23.8% on a self-report question-
naire) compared with patients randomized to a 6-month program (18.8%) (p=0.001). 
Lear et al.35 (high quality, n=302) did not find significant differences in the short term 
when comparing a 4-year with a 4-month program. None of the RCTs looked at long-
term differences. We conclude that there is conflicting evidence in the short term (<6 
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months after completion of the CR program of long duration) that CR of long duration is 
more effective than CR of medium duration. There were no RCTs investigating long-term 
differences (Table 2.4).
Comparison of two types of CR
Center-based CR versus home-based CR
For CR of short duration (1-3 months), Jolly et al.36 (high quality, n=525) compared a 
3-month center-based program with a 3-month home-based program and found no dif-
ferences between the groups in the long term (7 months after completion). We conclude 
that there is no evidence for long-term differences (≥6 months after completion of CR) 
between center-based and home-based CR of short duration in effects on physical activ-
ity level. No RCTs investigated short-term differences (Table 2.5).
For CR of medium duration (4-11 months), Smith et al.37,38 (high quality, n=242) per-
formed 2 long-term measurements: at 1- and 6-year follow-ups. One year after comple-
tion of the 6-month intervention, patients randomized to home-based CR program 
had higher physical activity scores (Physical Activity Scale for the Elderly score= 232.6) 
than patients randomized to the center-based CR program (Physical Activity Scale for 
the Elderly score= 170.0) (p≤0.0001).37 These differences were still significant at 6-year 
follow-up (166.7 for home-based CR versus 139.7 for center-based CR, p≤0.001).38 As 
defined in our methods, the measurement closest to 1 year after completion of CR was 
used for the best-evidence synthesis (ie. the 1-year follow-up). We conclude that there 
is moderate evidence that home-based CR of medium duration is more effective in the 
long-term (≥6 months after completion of CR) than center-based CR. There were no RCTs 
investigating short-term differences (Table 2.5).
For CR of long duration (≥12 months), Oerkild et al.39 (high quality, n=75) found no dif-
ferences between a center-based CR and a home-based CR program of 1 year’s duration 
upon completion of the programs. In conclusion, there is no evidence for a difference in 
effectiveness in the short term (<6 months after completion of CR). There were no RCTs 
investigating long-term differences (Table 2.5).
Low-volume center-based CR versus high volume center-based CR
For CR of short duration (1-3 months), Hansen et al.40 (high quality, n=119) compared 
center-based CR that involved a low-volume training program (3x40min/week endur-
ance exercise for 3 months) with center-based CR that involved a high-volume training 
program (3x60min/week endurance exercise for 3 months). No differences were found 
in the long term (15 months after completion). We conclude that there is no evidence in 
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favor of either a low-volume or a high-volume training program of short duration in the 
long term (≥6 months after completion of CR). There were no RCTs looking at short-term 
differences (Table 2.5).
No RCTs were found for CR programs of medium (4-11 months) and long duration (≥12 
months).
table 2.5 Evidence for effectiveness of two different types of CR compared to each other 
duration RCt
low/high 
quality
short-term effects
<6 mo after 
completion of CR
long-term effects
≥6 mo after 
completion of CR
Center-based CR versus home-based CR 
Short (1-3 mo) Jolly 200936 high n.a. 0
Best evidence synthesis: no RCT no evidence
Medium (4-11 mo) Smith 2004+2011*37,38 high n.a. -
Best evidence synthesis: no RCT moderate evidence
Long (≥12 mo) Oerkild 201139 high 0 n.a.
Best evidence synthesis: no evidence no RCt
low-volume training group versus high-volume training group
Short (1-3 mo) Hansen 200840 high n.a. 0
Best evidence synthesis: no RCT no evidence
Medium (4-11 mo) no RCT
Long (≥12 mo) no RCT
CR including a self-efficacy intervention to increase physical activity versus standard CR
Short (1-3 mo) no RCT
Medium (4-11 mo) Carlson 200041 low 0 n.a.
Best evidence synthesis: no evidence no RCT
Long (≥12 mo) no RCT
CR including self-monitoring to increase physical activity versus standard CR
Short (1-3 mo) no RCT
Medium (4-11 mo) Izawa 200542 low n.a. +
Best evidence synthesis: no RCT limited evidence
Long (≥12 mo) no RCT
CR including problem-based learning to increase physical activity versus standard CR
Short (1-3 mo) no RCT
Medium (4-11 mo) no RCT
Long (≥12 mo) Tingström 200543 low 0 n.a.
Best evidence synthesis: no evidence No RCT
CR= cardiac rehabilitation; RCT= randomized controlled trial; mo=month; “+”= significant differences in favor 
of first-mentioned intervention;”-“= significant differences in favor of second-mentioned intervention;”0”= no 
significant differences found; n.a,= not applicable. *multiple publications on data of the same RCT and popula-
tion are presented as originating from a single RCT.
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CR including a self-efficacy intervention to increase physical activity versus standard CR 
No RCTs found were found for CR of short duration (1-3 months) and long duration (≥12 
months). 
For CR of medium duration (4-11 months), Carlson et al.41 (low quality, n=80) reported 
no significant differences upon completion between a 6-month CR program based on 
Bandura’s self-efficacy theory and designed to enhance confidence for independent 
exercise and a 6-month standard center-based CR program. The best-evidence synthesis 
revealed that, in the short term (<6 months after completion of CR), there is no evidence 
for the effectiveness of a self-efficacy CR intervention. There are no RCTs investigating 
long-term effects (Table 2.5).
CR including self-monitoring to increase physical activity versus standard CR
No RCTs were found for CR of short duration (1-3 months) and long duration (≥12 
months). 
For CR of medium duration (4-11 months), Izawa et al.42 (low quality, n=45) compared 
a 6-month self-monitoring and goal-setting intervention aimed at increasing physical 
activity with a 6-month, standard, center-based CR program. Six months after comple-
tion, the step count in patients randomized to the intervention group was significantly 
higher (10458.7 steps/week) than in patients randomized to standard CR (6922.5 steps/
week) (p-value not reported). In conclusion, in the long term (≥6 months after comple-
tion) there is limited evidence that the self-monitoring and goal-setting intervention is 
more effective than standard CR. There were no RCTs investigating short-term effects 
(Table 2.5).
CR including problem-based learning to increase physical activity versus standard CR
No RCTs were found for CR of short duration (1-3 months) and medium duration (4-11 
months). 
For CR of long duration (≥12 months), Tingström et al.43 (n=207) reported no significant 
differences upon completion of center-based CR including a problem-based learning 
intervention and aimed at increasing physical activity (duration= 1 year) and standard 
center-based CR (also 1 year). The best-evidence synthesis revealed that in the short 
term (<6 months after completion of CR) there is no evidence for a problem-based learn-
ing intervention. There were no RCTs investigating long-term effects (Table 2.5).
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disCussiON
This systematic review provides an overview of the evidence for the effectiveness of 
current standard CR compared with no intervention in improving physical activity levels 
in patients with ACS in the short term (<6 months after completion of CR) and in the 
long term (≥6 months). In addition, we focussed on the optimal duration and type of CR 
to achieve and maintain changes in physical activity level.
Center-based and home-based CR compared to no intervention
When center-based CR programs of different duration were compared with no interven-
tion, both in the short-term (<6 months after completion of CR) and in the long-term 
(≥6 months after completion), at most limited evidence was found for the effectiveness 
of CR. In contrast to our expectations, there is even moderate evidence (based on one 
high-quality study) that controls are more active in the long-term than patients ran-
domized to center-based CR of short duration. However, reported differences were small 
(12% active vs 9% active, P<0.005) and, according to the authors of this article, could 
be due to coincidence.17 We conclude that it seems doubtful whether physical activity 
improvements are reached during center-based CR programs. 
Only 2 RCTs focused on effectiveness of home-based CR compared with no interven-
tion. Outcomes were more promising. In the short term, there was moderate evidence 
of effectiveness for programs of long duration (≥12 months). However, no evidence was 
found for long-term maintenance (≥6 months after completion) of these results. When 
directly comparing home-based CR with center-based CR, moderate evidence also was 
found that home-based programs of medium duration (4-11 months) are more effective 
in the long term. However, no differences were found for programs of short duration (1-3 
months) or long duration (≥12 months). A possible explanation for the somewhat better 
results found after home-based CR may be that physical activity is better incorporated 
into daily routine. Two recent observational studies showed that although physical 
activity increased during center-based CR, patients nevertheless failed to reach recom-
mended levels by the end of the intervention. This was primarily caused by patient non-
activity on the days they did not attend CR.44-46 These results may indicate that patients 
do not easily incorporate physical activity into daily life. Because there is limited research 
investigating the effectiveness of home-based CR, more research on this topic is needed 
before firm conclusions can be drawn. 
Optimal duration of CR
Duration of CR programs investigated in this review ranged from 4 weeks to 4 years. It 
is possible that given more time and guidance, patients can further increase or better 
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maintain their physical activity level. However, conflicting evidence was found that pa-
tients completing a CR program of longer duration are more active shortly after the end 
of this program than patients who have followed a shorter program are at that time. For 
long-term maintenance of this higher activity level, no evidence was found. The optimal 
length of CR has not been studied extensively yet and might depend on the outcome of 
interest.31,47 According to a previous study47, mental health recovery is mainly achieved 
beyond 3 months of CR. However, physical activity and physical function improvements 
peak in the first 3 months of CR, and there is no further improvement after this period.47 
This finding is in line with the results of our review. We also found no clear evidence that 
greater improvements in physical activity are achieved when extending the length of CR 
to a duration beyond 3 months. 
type of CR
In addition to variation in location (home or center) and duration of CR, there is vari-
ability in type of CR. No evidence was found that a higher-training volume is more 
beneficial. There was also no evidence for the short-term effectiveness of performing 
a certain extra intervention during the standard CR period aimed at increasing physical 
activity levels. In the long-term there was limited evidence for the effectiveness of such 
an extra intervention, based on one low-quality study that studied the benefits of a 
behavioral self-monitoring approach as add-on therapy. Promising results were found 
in this study.42 
It is essential that more research will focus on effective interventions to stimulate optimal 
activity levels, because it seems doubtful whether standard CR is sufficient to improve 
and maintain an active lifestyle. Having an active lifestyle is essential in managing cardiac 
risk factors. Previous research showed that patients fail to reach recommended activity 
levels mainly on the days they did not attend CR.44-46 These results may indicate that 
patients do not easily incorporate physical activity into daily life. Therefore, we suggest 
that guidance on how to incorporate activity into daily life using behavioral techniques 
may increase physical activity on days patients do not attend CR and after completion 
of CR. Because the core of CR consists of exercise sessions led by physical therapists, 
they could play an important role in this guidance. Future research should focus on this 
role. Recently, 2 reviews examined what behavioral interventions aimed at increasing 
and maintaining physical activity are most effective for patients with cardiac conditions 
(both participating and not participating in CR). Behavioural interventions identified as 
promising were self-monitoring, goal setting, identifying barriers, and developing plans 
for relapse.48,49 
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limitations 
First, there are large differences between the included RCTs regarding the location, du-
ration and type of the CR intervention and follow-up term. To minimize heterogeneity, 
we defined strict inclusion criteria based on international guidelines2,6,12 to select only 
RCTs investigating CR programs that are currently considered to be standard. We also 
categorized RCTs based on location, type and duration to improve meaningful interpre-
tation of our results. Despite this organization, categories in this review are still relatively 
broad. Furthermore, the amount of studies per category is low. 
Second, two RCTs19,37,38 included in this review performed 2 measurements in the long-
term (≥6 months after completion) (ie, 6 months and 4.5 years19, and 1 and 6 years37,38). 
As defined in our methods the measurement closest to 1 year after completion of CR was 
used in analysis. One-year was arbitrarily chosen. If we would have chosen a follow-up 
time closer to the 4- or 6-year follow-up, it would only have changed our conclusion for 
long-term effectiveness of center-based programs of medium duration as reported by 
Lidell and Fridlund.19 from limited to no evidence; the conclusions based on the results 
of Smits et al.37,38  remain the same.
Third, there was considerable variety in the measurement tools used to assess physical 
activity. In 21 of the 26 included RCTs, physical activity was self-reported using a wide 
variety of questionnaires or diaries. Therefore, we refrained from statistical pooling of 
the results. We used a best evidence synthesis, which is a next best solution and is a 
transparent method commonly applied when statistical pooling is not feasible or clini-
cally viable.15 In addition, it is known that self-report measures often fail to demonstrate 
adequate validity or reliability, making it difficult to draw firm conclusions about the 
magnitude and clinical meaning of improvements.50-53 
Fourth, only 54% of the RCTs were considered to be of high quality according to the 
criteria in the Furlan list.14 There is evidence that a threshold of less than 50% of the 
criteria on the Furlan list is associated with bias.54 The quality of the RCTs was often 
considered as low because information was missing on avoidance of cointerventions 
and on concealment of treatment allocation. Furthermore, patients and care providers 
were not blinded in all RCTs. However, correct blinding is difficult due to the nature of 
the interventions.  
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CONClusiONs
Despite the fact that improving physical activity habits is an important goal of CR, it 
would appear that current standard center-based CR is not sufficient to improve and 
maintain physical activity habits. In this review it was shown that home-based programs 
might be more successful to improve physical activity habits. However, more research 
on this topic is needed before firm conclusions can be drawn. There is a wide variability 
in duration and type of CR programs offered. There is no clear evidence that increas-
ing training volume, extending the duration of CR, or adding an extra intervention to 
CR leads to greater improvements in physical activity levels. Because having an active 
lifestyle is essential in managing cardiac risk factors and reducing mortality, future 
research should focus on finding successful interventions to achieve and maintain an 
active lifestyle.  
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APPeNdixes
Appendix 2A 
Search strings
PubMed
Heart disease - Heart diseases [Mesh] 
Rehabilitation - Rehabilitation[tiab] OR Lifestyle intervention[tiab] OR lifestyle program[tiab] OR life-
style intervention[tiab] OR life-style program[tiab] OR exercise training[tiab] OR aerobic training[tiab] OR 
physical training[tiab] OR exercise therapy[tiab]) OR physical therapy[tiab] OR exercise intervention[tiab] 
Cardiac rehabilitation - Cardiac rehabilitation[tiab] OR cardio rehabilitation[tiab] OR heart 
rehabilitation[tiab]
RCt - ((randomized controlled trial [pt] OR controlled clinical trial [pt] OR clinical trial [pt] OR random-
ized [tiab] OR placebo [tiab] OR clinical trials[mh] OR randomly[tiab] OR trial [ti]) NOT (animals[mh] NOT 
humans[mh])) 
Complete search string: ((Heart disease AND Rehabilitation) OR Cardiac Rehabilitation) AND RCT
Embase
Heart disease - ‘Heart disease’/exp
Rehabilitation - (Rehabilitation OR ((lifestyle OR life-style OR ‘life style’) NEAR/2 (intervention OR 
program OR therapy)):ti,ab OR ((exercise OR aerobic OR physical) NEAR/2 (training OR intervention OR 
therapy))):ti,ab
Cardiac rehabilitation - ‘Cardiac rehabilitation’:ti,ab OR ‘heart rehabilitation’/exp
RCt - (‘randomized controlled trial’:it OR ‘controlled clinical trial’:it OR ‘clinical trial’:it OR randomized:ti,ab 
OR placebo:ti,ab OR randomly:ti,ab OR trial:ti NOT ([animals]/lim NOT [humans]/lim))
Complete search string: ((Heart disease AND Rehabilitation) OR Cardiac Rehabilitation) AND RCT
Cinahl
Heart disease -MH “Heart diseases”
Rehabilitation - SU (Rehabilitation OR “lifestyle intervention” OR “lifestyle program” OR “life-style in-
tervention” OR “life-style program” OR “exercise training” OR “aerobic training” OR “physical training” OR 
“exercise therapy” OR “physical therapy” OR “exercise intervention”)
Cardiac rehabilitation - SU (“Cardiac rehabilitation” OR “heart rehabilitation”) OR MH “cardiac rehabilita-
tion”
RCt - (PT “randomized controlled trial” OR PT “controlled clinical trial” OR SU (randomized OR placebo OR 
randomly) OR TI trial) NOT MH (animals NOT humans) 
Pedro
Cardiac rehabilitation - “cardiac rehabilitation” 
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ABstRACt
Objective: To objectively measure changes in both moderate-to-vigorous physi-
cal activity (MVPA) and sedentary behavior (SB) during and after standard cardiac 
rehabilitation (CR).
design: Prospective cohort study
setting: Outpatient CR center
Participants: Patients (n=135) with acute coronary syndrome (ACS) who com-
pleted CR. 
intervention: Multidisciplinary CR according to current guidelines
main outcome measures: The proportion of time spent in MVPA and SB was 
objectively measured with an accelerometer. The distribution of time in MVPA 
and SB was also determined (e.g. average length of time periods spent in MVPA 
and SB). All measurements were obtained prior to CR, following CR and at one-
year follow-up. 
Results: Patients‘time in MVPA during waking hours increased by 0.65% (≈5 min) 
during CR (p=0.002), and remained increased at one-year follow-up (p=0.037). 
The MVPA distribution did not change. During CR, time spent in SB decreased 
by 2.49% (≈22 min; p<0.001), and SB time became more fragmented with more 
breaks and shorter SB periods (p<0.001). These SB improvements were main-
tained at one-year follow-up (p<0.001). 
Conclusions: Patients with ACS achieved a small improvement in MVPA time 
during CR, but MVPA distribution remained unchanged. More substantial improve-
ments occurred for SB time and distribution. However, by the end of CR, patients 
still spent relatively little time in MVPA and a long time in SB, which is known to be 
detrimental to cardiovascular health. Although CR programs have the potential to 
improve physical behavior, our findings highlight the need to develop adjusted CR 
targets that address amount and distribution of MVPA and SB. 
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iNtROduCtiON
Physical behavior comprises both physical activity (PA) and sedentary behavior (SB).1 PA 
is defined as any bodily movement produced by skeletal muscles that requires energy 
expenditure.2 SB is defined as behavior that consist mainly of sitting or lying and that 
requires very low energy expenditure.3 Recent studies show that PA and SB should be 
considered as distinct behaviors related to health outcomes.4,5 In a general population, 
low levels of moderate-to-vigorous intensity PA (MVPA) have been identified as a leading 
risk factor for mortality and cardiovascular disease.6 Increased levels of SB are indepen-
dently related to an increased risk of diabetes, cardiovascular disease, and mortality.3-5,7 
In addition to volume (total time) of MVPA and SB, increasing evidence suggests that the 
distribution of this behavior over time may also be important. For example, the health 
benefits of daily, short bursts of MVPA may be smaller than those of less frequent, longer 
periods of MVPA.8,9 Taking regular active breaks during sedentary time can counteract 
the harmful effects of prolonged sedentary periods.10,11
In patients with acute coronary syndromes (ACS), it has been shown that more MVPA is 
related to a better cardiovascular risk profile12,13 and lower cardiac mortality.14 Standard 
cardiac rehabilitation (CR) generally addresses MVPA, but not SB. Few studies have 
focused on SB in patients following ACS. Cross-sectional studies show that patients 
with cardiovascular disease spend more time sedentary per day compared to healthy 
individuals,15 and that longer sedentary time at CR completion is associated with poorer 
fitness and higher body mass index.16 
Studies using objective measurement tools to evaluate changes in MVPA and SB volume 
and distribution during standard CR are lacking. Knowledge of these changes may help 
formulate recommendations on future PA and SB targets. Therefore, the objective of the 
present study was to evaluate longitudinal changes in PA and SB volume and distribu-
tion in patients with ACS during and after CR participation. 
metHOds
study sample
The cohort investigated in the current study was originally recruited for a randomized 
controlled trial (RCT) in which they were assigned to the control group, receiving treat-
ment as usual (standard CR). Patients with ACS who were referred to Capri CR between 
September 2011 and August 2014 were invited to participate in this study. Inclusion 
criteria were: diagnosis of ACS; age >18 years; proficiency in Dutch; and absence of 
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physical and cognitive impairments that could limit CR participation. Only patients 
who completed standard CR were included in the current study. Additionally, patients 
needed at least two valid physical behavior measurements (of which one was a baseline 
measurement) for inclusion in the analysis. All participants provided written informed 
consent. The study protocol was approved by the Medical Ethics Committee of the 
Erasmus Medical Center in Rotterdam, The Netherlands. 
measures
Physical behavior
Physical behavior (PA and SB) was measured with a tri-axial accelerometer (ActiGraph 
GT3X+). Patients were asked to wear the accelerometer on the right side of their waist 
for eight consecutive days during waking hours, except when showering or swimming. 
Patients recorded the times they wore the accelerometer in a logbook.
Data processing
Consensus in accelerometer data processing is lacking. There is wide variability in the 
choices made for epoch length, wear time validation and intensity cut-off points, for 
example. We made our choices after extensively reviewing the literature.17-25
Accelerometer data were sampled with a frequency of 30 Hz. The ActiGraph measures raw 
accelerations on three axes and converts this into activity counts and steps. Step numbers 
were processed using Actilife software.26 Counts were summed over 15s time sampling 
intervals (epochs) using Actilife software and converted to Matlab format for further 
processing (Matlab version R2011b). A composite measure called vector magnitude was 
calculated (√(x2+y2+z2)) and used for analysis. Non-wear time was defined as >60 minutes 
of consecutive zeros, with no allowance of epochs with counts above zero. Data were 
analyzed only for patients who wore the accelerometer for ≥4 days and ≥660 min/d. After 
subtracting the non-wear time from the data, each epoch was categorized as:
•	 MVPA:	activities	of	≥672.5	counts17
•	 Light	activity:	activities	of	>37.5		and	<	672.5	counts17 
•	 SB:	activities	of	≤37.5	counts18
Outcome measures 
Volume of physical behavior
Total activity counts were calculated by summation of counts in epochs, and expressed 
as counts per minute. Total time spent in MVPA, light activity, and SB was calculated and 
expressed as a percentage of total daily wear time. The amount of steps was expressed 
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as steps per minute.26 In addition, we calculated the percentage of patients meeting a 
step target of at least 6500 steps/day. According to recent studies, 6500 steps/day is 
needed to prevent cardiovascular disease progression.27,28
Distribution of physical behavior
The mean length of all uninterrupted bouts (time periods) of MVPA and SB with a minimum 
length of 15s (1 epoch) was calculated. Because the lengths of these bouts were not nor-
mally distributed, the natural logarithm of lengths was taken and geometric means were 
calculated. A fragmentation index for both MVPA and SB was calculated as the total number 
of bouts divided by the total volume in minutes. A higher fragmentation index indicates that 
the number of bouts was high and time in MVPA or SB relatively low. In other words, time is 
more fragmented in frequent, shorter bouts than in fewer prolonged periods.19,20 
Also, we were interested in prolonged bouts of MVPA and SB. In accordance with recom-
mendations6,12,29-31, prolonged MVPA was defined as periods ≥10 min. Short MVPA inter-
ruptions may occur in daily life situations such as waiting for a traffic light.21-23 The exact 
length of MVPA interruptions to consider the bout as continuous remains unclear.23 
We chose to allow a maximum of four interruptions (not necessarily consecutive) of 15s 
epochs with counts below 672.5 during a single bout of MVPA. Likewise, because there 
is no standard definition of prolonged SB, we defined prolonged SB as those bouts >30 
min. During a sedentary period, we chose to allow a maximum of three consecutive 
interruptions of 15s epochs with counts above 37.5 during a single bout of SB. Thus, we 
analyzed a prolonged SB bout as ending after at least 1 min of continuous non-SB. In 
making this choice, we considered that interrupting SB every 30 min with a 1 min break 
of non-SB seems a feasible target for interventions. The total time spent in prolonged 
MVPA and SB was calculated and expressed as a percentage of total wear time. We also 
calculated whether participants met the American College of Sports Medicine (ACSM) 
target of ≥150 min of prolonged MVPA bouts per week.30 This guideline is consistent 
with those addressing secondary prevention of cardiovascular disease.6,14,29 Because the 
accelerometer was not always worn for a full week, we calculated the percentage of 
participants reaching an average of 21.4 min prolonged MVPA/day (150 min/ 7 days). 
There are no guidelines currently for recommended volume of SB. 
Procedures 
Cardiac rehabilitation
All patients participated in multi-disciplinary outpatient CR lasting 10-13 weeks, as per 
Dutch guidelines.32 The program was terminated when individual physical and psycho-
social goals were met, as evaluated by an exercise stress test and consultation by a multi-
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disciplinary team consisting of physical therapists, social workers, and cardiologists. The 
program consisted of a 75-min group exercise sessions (twice weekly with a strength 
and aerobic program); and group educational sessions about the medical background 
and risk factors for cardiovascular disease, dietary advice, and emotional coping. If indi-
cated each patient could participate in group counseling sessions on smoking cessation, 
healthy diet, and stress management. If needed, patients were referred for individual 
consultations with a psychologist, social worker, psychiatrist, or dietician. During CR, 
there was no specific MVPA coaching, but general information was given on the health 
benefits of an active lifestyle. There was no specific focus on changing SB. 
Patients also attended usual follow-up appointments with their cardiologist, during 
which general information on the health benefits of PA might be given. We do not have 
exact information on this aspect 
Data collection
Data on physical behavior were obtained the week before CR (T0), during the last week 
of CR (T1), and at follow-up one year after the start of CR (T2). Data on age, gender, and 
working status were collected at T0. 
statistical analysis
Descriptive statistics were used to present baseline characteristics. Independent t-tests 
and Chi-square tests were used to test for differences in baseline characteristics between 
the original study sample and the sample with sufficient valid physical behavior measures. 
For continuous variables, mean differences between T0 and T1 and between T0 and T2 
were analyzed using paired t-tests, after checking whether the within-subject changes 
met the assumptions of normality.  For dichotomous variables, chi-square tests were 
used to test for mean differences between T0 and T1 and between T0 and T2 
A two-sided p-value <0.05 was considered significant. All analyses were performed us-
ing SPSS (version 20).
Results
subjects
A flow diagram of inclusion is shown in Figure 3.1. A total of 245 patients were randomized 
to standard CR and included in this study. Data from 45 patients who did not complete 
CR, for reasons such as lack of time and unwillingness, were excluded. An additional 54 
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patients were excluded because fewer than two valid physical behavior measurements 
were available, and 11 patients because baseline physical behavior measurements were 
lacking. These 65 patients with insuffi  cient physical behavior measurements were on 
average four years younger (p=0.001). Most of the remaining 135 participants were male 
(80%), mean age was 59 years and the attendance rate was 23 CR exercise sessions. (Table 
3.1). ActiGrapha wear time increased between T0 and T1 and between T0 and T2 (Table 3.2). 
Data from logbooks showed that at T0, during which patients are still in the acute phase 
after their cardiac event, patients go to bed earlier and wake up later. To compensate for 
these diff erences, all physical behavior outcomes were expressed relative to wear time. 
In study
n=731
Excluded from analysis
Did not participate in standard CR: n= 486
Did not complete CR: n=45
<2 valid Actigraph measurements: n=54
No baseline Actigraph measurements: n=11
In analysis
n=135
Assessed for eligibility 
n=2039
Declined to participate 
n=1308
Figure 3.1 Flow diagram of participants
CR= cardiac rehabilitation
table 3.1 Baseline characteristics of the study population (n=135) 
Characteristics
Men , % 78.5
Age (years), mean ± SD 58.8 ± 8.5
Body Mass Index (kg/m2), mean ± SD 28.0± 3.8
Employment status, %
   Full time 45.1
   Part time 12.4
   Not employed 42.5
Number exercise sessions, mean ± SD 23.1 ± 5.0
Changes in physical behavior during cardiac rehabilitation
Table 3.2 shows the observed data and outcomes of the paired t-tests for mean changes 
over time in the volume of physical behavior (graphically depicted in Figure 3.2). 
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Total activity counts per minute significantly increased between T0 and T1 (mean differ-
ence=50.56 counts/min, p<0.001), and between T0 and T2 (mean difference=55.04 counts/
min, p<0.001). The step count also increased between T0 and T1 (mean difference=0.67 
steps/min, p=0.002) and between T0 and T2 (mean difference=0.55 steps/min, p=0.017). 
At T0, 39.3% of participants were compliant with a daily step target of 6500. This compli-
ance increased to 51.4% (p<0.001) at T1 and was 46.5% at T2 (p<0.001 vs T0).
table 3.2 Physical behavior over time
t0 (n=135) t1 (n=111) t2 (n=114) t0-t1 (n=111) t0-t2 (n=114)
variable
mean ± 
sd
mean ± 
sd
mean ± 
sd
mean 
difference 
± sd P*
mean 
difference 
± sd P*
wear time
Valid days 6.5 ± 1.1 7.0 ± 1.1 7.1 ± 1.1 0.30 ± 0.95 0.001 0.46 ± 0.98 <0.001
Daily wear time (hours) 14.2 ± 1.0 14.6 ± 1.0 14.7 ± 1.0 0.43 ± 1.37 0.001 0.52 ± 1.21 <0.001
total volume of physical activity
Activity counts /min
544.7 ± 
169.6
599.0 ± 
152.0
596.0 ± 
164.2
50.56 ± 
128.2
<0.001
55.04 ± 
148.2
<0.001
Steps/min 7.3 ± 2.9 8.1 ± 2.6 7.8 ± 2.8 0.67 ± 2.21 0.002 0.55 ± 2.44 0.017
Categories of physical behavior
MVPA (% wear time) 6.3 ± 3.0 7.0 ± 2.7 6.7 ± 3.0 0.65 ± 2.21 0.002 0.50 ± 2.51 0.037
Light activity (% wear time) 28.1 ± 7.1 30.2 ± 6.4 31.0 ± 7.6 1.84 ± 5.65 0.001 2.98 ± 6.49 <0.001
SB (% wear time) 65.6 ± 8.3 62.8 ± 7.4 62.3 ± 8.4 -2.49 ± 6.57 <0.001 -3.48 ± 7.75 <0.001
MVPA= moderate-to-vigorous physical activity; SB= sedentary behavior.
* t-tests.
65.6 62.8 62.3 
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Figure 3.2 Percentage of waking hours spent in SB, light activities, and MVPA
CR= cardiac rehabilitation; SB= sedentary behavior; MVPA= moderate-to-vigorous physical activity.
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Between T0 and T1, the time spent in MVPA and light activity increased (mean differ-
ence=0.65% of waking hours, p=0.002 and mean difference=1.84%, p=0.001 respec-
tively) and time in SB decreased (mean difference=-2.49%, p<0.001). During an average 
day with a wear time of 14.5 hours, this equals a change of +5.7 min in MVPA, +16.0 min 
in light activities and -21.7 min in SB. Differences remained significant between T0 and 
T2. 
distribution of physical behavior
Table 3.3 shows the observed data and the outcomes of the paired t-tests for mean 
changes over time in the distribution of physical behavior. With regard to MVPA, there 
were no significant changes in distribution outcomes. Compliance with the ACSM guide-
lines decreased over time from 17.8% of participants at TO to 13.5% at T1 (p<0.001) and 
13.2% at T2 (p<0.001 vs T0).
table 3.3 Distribution of physical behavior over time
t0 (n=135) t1 (n=111) t2 (n=114) t0-t1 (n=111) t0-t2 (n=114)
variable mean ± sd mean ± sd mean ± sd
mean 
difference 
± sd P*
mean 
difference 
± sd P*
distribution of mvPA bouts
Mean length MVPA bouts (min)a 0.38 ± 0.06 0.39 ± 0.05 0.39 ± 0.06 0.008 ± 0.05 0.111 0.004 ± 0.05 0.381
Fragmentation indexb 1.79 ± 0.53 1.73 ± 0.42 1.86 ± 0.55 -0.05 ± 0.42 0.173 0.05 ± 0.46 0.235
MVPA bouts >10 min 
(%  of wear time)c
0.66 
(0:8.26) †
0.77 
(0:7.79) †
0.49 
(0:6.87) †
-0.03 ± 1.45 0.805 -0.21 ± 1.34 0.096
distribution of sB bouts
Mean length SB bouts (min)a 0.87 ± 0.16 0.82 ± 0.14 0.80 ± 0.15 -0.05 ± 0.14 <0.001 -0.07 ± 0.16 <0.001
Fragmentation indexb 0.49 ± 0.15 0.53 ± 0.14 0.54 ± 0.16 0.04 ± 0.12 0.001 0.06 ± 0.14 <0.001
SB bouts >30min 
(% of wear time)d
39.0 ± 12.0 35.2 ± 11.4 34.5 ± 11.5 -3.10 ± 10.0 0.001 -5.11 ± 10.7 <0.001
MVPA= moderate-to-vigorous physical activity; SB= sedentary behavior.
* t-tests.
a Uninterrupted bouts with a minimum length of 15 seconds (equal to epoch length).
b Total number of bouts divided by total volume of MVPA/SB in minutes. A higher fragmentation index indicates 
that time is more fragmented with shorter periods of uninterrupted MVPA or SB. 
c Prolonged MVPA bouts with a minimum duration of 10 min with allowance for interruptions of 60 non-consec-
utive seconds of non-active time.
d Prolonged SB bouts with a minimum duration of 30 min with allowance for interruptions of 45 consecutive 
seconds of non-sedentary behavior.
† Since the outcomes violated normality assumptions, median (range) values are displayed.
SB bout distribution changed between T0 and T1. The mean length of bouts decreased 
(mean difference=-0.05 min, p<0.001), the fragmentation index increased (mean differ-
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ence=0.04, p=0.001), and time spent in prolonged SB bouts >30 min decreased (mean 
difference=-3.10%, p=0.001). These changes were also significant between T0 and T2. 
For an average day with a wear time of 14.5 hours, the change in time spent in prolonged 
SB was -26.0 min/day between T0 and T1 and -44.4 min/day between T0 and T2.
disCussiON
Our results show a small, but lasting, increase in MVPA time during CR. Distribution mea-
sures revealed that patients with ACS tend to break up their MVPA time into short bouts. 
This pattern did not change during CR. SB volume and distribution changed. During CR, 
SB time decreased nearly 22 min and sedentary time became more fragmented with 
shorter bouts. These improvements were maintained. 
The exact changes in MVPA and SB required to gain health benefits are unclear, making 
it difficult to determine the clinical relevance of our findings. Nevertheless, our results 
indicate that MVPA remains low despite CR. For example, at the end of CR, only half of 
the participants achieved a daily step target of 6500.27,28 Recognizing that PA volume, 
intensity and distribution are all important8, the ACSM guidelines recommend 150 min 
of MVPA per week, in bouts of 10 min or longer. Again, only a minority of our participants 
attained this level and compliance to this guideline even decreased over time. Compli-
ance rates might be underestimated, because these guidelines are based on question-
naires, whereas our data were objectively measured.23 However, the MVPA volume was 
also relatively low at the end of CR compared to that of healthy adults measured by 
objective accelerometers (7.0% vs 10.2% MVPA, respectively).20 Moreover, although 
MVPA time improved during CR, there were no improvements in the distribution of this 
behavior. 
Interpreting the SB outcomes is even more difficult, as there are no existing guidelines for 
comparison. The improvements in volume and distribution of SB during CR seem quite 
substantial and lasting. Less time was spent in SB and this time was more fragmented 
with shorter periods, as is suggested to gain health benefits.10,11 This improvement in SB 
is surprising, as interventions without an SB focus usually do not result in SB changes.33 
However, despite the SB improvements during CR, time in SB was still long (62.8% which 
equals approximately 9 hours) when compared to that of healthy adults (57.5%).20 
Moreover, a meta-analysis has shown that every hour increase in SB beyond seven hours 
is associated with a 5% increase in all-cause mortality.5 Although no reference data are 
available, time spent in prolonged SB also seemed long (> 5 h/day).
Cardiac rehabilitation & physical behavior
81
3
The results of our study are in line with those of other studies showing that cardiac 
patients tend to be sedentary and inactive.15,34,35 Studies focusing on the effects of CR 
and using objective measurement tools are scarce. A recent longitudinal study reported 
comparable small improvements in MVPA after eight weeks of CR;36 however, in contrast 
to our study, patients showed no improvement in SB. Another cross-sectional study 
showed post-CR, step counts and MVPA levels comparable to ours; for SB, lower val-
ues were found (56% vs 62.8% in our study).33 Differences can partly be explained by 
differences in choices related to data processing of accelerometers. This general issue 
of methodological differences in PA and SB research limits comparisons between stud-
ies.21,24,37,38  
Our findings highlight the need to focus on further improvements in PA and SB in pa-
tients with ACS. Multidisciplinary CR teams that specialize in directing lifestyle changes 
can have an important role in helping to improve physical behavior. The focus of CR 
should be to reach more substantial and lasting changes in total MVPA time, but also 
to accrue MVPA time in longer-lasting bouts. Targets for SB improvement should be to 
lower total SB time and frequently interrupt this time. Behavioral interventions contain-
ing self-regulation components (e.g. self-monitoring, goal-setting) seem promising.31,33,39
study limitations
Our study has some limitations. The ActiGraph cutt-off points we used for the PA inten-
sity categories were developed for a healthy population. Patients entering CR often have 
lower cardiovascular fitness levels compared to healthy individuals, which may result in 
under classification of PA intensity.40 Furthermore, the ActiGrapha is not water-resistant 
and could not be worn during swimming activities. Because our participants rarely 
swam, we made no attempt to correct for this limitation. Finally, although the ActiGraph 
GT3X+was found to fairly accurately detect SB, misclassifications such as designating 
“standing still” as “SB” cannot be ruled out.18 Despite these limitations, the use of ac-
celerometers is still a major strength of our study. 
Another limitation is that our study was performed at a single-center with no control 
group. Caution is required when attributing the observed effects to the CR program. 
Baseline measurements were taken after hospital discharge, when patients had not 
yet returned to their daily life activities. The observed improvements might, therefore, 
partly reflect a return to participants’ physical behavior situations that existed before the 
cardiac incident.
Lastly, patients who did not have sufficient physical behavior measurements to be 
included in the analysis were younger on average, which may have biased the results. 
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In addition, the cohort may consist of higher motivated patients that were willing to 
participate in this trial. Information on patients who did not provide informed consent 
is lacking. 
CONClusiONs
Patients with ACS achieved small, but lasting, improvements in MVPA volume during 
CR. More substantial and lasting improvements in SB volume and distribution were 
observed. However, at the end, CR participants still spent a relatively short time in MVPA 
and a long time in SB, which has been shown to be detrimental to cardiovascular health. 
Although CR programs have the potential to improve physical behavior, our findings 
highlight the need to develop adjusted CR targets focusing on volume and distribution 
of MVPA and SB. 
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ABstRACt
Objective: To estimate fatigue during and after a multidisciplinary cardiac reha-
bilitation programme and its association with aerobic capacity. 
design: Longitudinal cohort study. 
Patients: A total of 121 patients with coronary artery disease (79% men), mean 
age 57 years. 
methods: Fatigue was measured with the Fatigue Severity Scale (FSS) and aero-
bic capacity with the 6-min walk test (6MWT). FSS scores ≥ 4 were defined as 
fatigue and > 5.1 as severe fatigue. Measurements were taken before (T0) and 
after rehabilitation (T1) and at 1-year follow-up (T2). 
Results: Fatigue decreased from 3.49 at baseline to 3.03 post-rehabilitation 
(p=0.002) and decreased further to 2.75 at follow-up (p<0.001 vs T0). At baseline, 
17.7% of patients were classified as severely fatigued. After cardiac rehabilitation, 
the prevalence decreased to 10.6% (p<0.001) and to 8.1% at follow-up (p=0.011 
vs T0). Although the prevalence of severely fatigued patients decreased, it was 
still high compared with healthy individuals (3.5%). Aerobic capacity was weakly 
associated with a reduction in fatigue (p=0.030). 
Conclusions: Fatigue decreased during and after cardiac rehabilitation. How-
ever, the prevalence of severely fatigued patients remained high after cardiac 
rehabilitation. Fatigue should be identified at an early stage in order to provide 
additional programmes aiming to reduce severe fatigue.
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iNtROduCtiON
Cardiovascular diseases (CVD) are the leading cause of death worldwide.1 In 2008, 17.3 
million people died from CVD, which represents 30% of global deaths.1 The most com-
mon form of CVD is coronary artery disease (CAD), which caused 7.3 million deaths in 
2008.1 The economic impact of CAD is high, due to high healthcare costs and sickness 
absence.2 
Cardiac rehabilitation (CR) is known to improve the physical and psychological status of 
patients with CAD, thereby reducing both cardiovascular mortality and total mortality.3 
Physical improvements are often seen in aerobic capacity, for which previous interven-
tion studies have shown favourable effects directly after exercise-based CR.3,4
Studies5,6 have shown that illness-related fatigue is one of the most disturbing symptoms 
experienced by patients with CAD.6 This type of fatigue is difficult to manage, because 
it differs from any earlier experience with fatigue unrelated to CAD.6 Another reason 
for the often quite considerable impact of fatigue is that fatigue negatively influences 
physical and mental capacity and therefore quality of life.5 Despite the impact fatigue 
might have, only 2 studies have examined the severity of the problem in patients with 
CAD.5,6 One study6 found that fatigue decreases over time without participation in CR. 
Nevertheless, half of patients still reported fatigue 4 months to 2 years after myocardial 
infarction. It appears that additional interventions, such as CR, are necessary to improve 
long-term fatigue after CAD. Besides the direct influence on fatigue, participation in 
CR may also indirectly improve fatigue. A study5 showed that fatigue levels seem to be 
associated with aerobic capacity in patients with CAD. It may therefore be hypothesized 
that improvements in aerobic capacity, which are known to occur during exercise-based 
CR, lead to a decline in fatigue. However, those studies that have examined the effect 
of CR on fatigue focused only on patients with heart failure and, indeed, reported less 
fatigue after exercise-based CR.7,8
The primary aim of this study was to estimate fatigue in patients with CAD before and 
after CR and at 9 months follow-up. A secondary aim was to explore whether aerobic 
capacity was associated with fatigue. Because fatigue or loss of energy is one of the main 
symptoms of depression6 and depression is common in patients with CAD9, depression 
seems to overlap with illness-related fatigue.6,10 Thus, all analyses were controlled for 
depression.
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Patients and design 
Inclusion criteria were: (I) a diagnosis of acute myocardial infarction or angina pectoris; 
(II) scheduled to participate in the regular CR programme; (III) 18 years of age or older; 
(IV) provided signed informed consent; and (V) proficient in Dutch language. Exclusion 
criteria were: (I) comorbidities; (II) left ventricle ejection fraction of < 40%; and (III) psy-
chological or cognitive impairments that might impair participation in the rehabilitation 
programme.
Between October 2010 and July 2012, 163 consecutive patients were included in this 
single-centre prospective observational cohort study. Of these, 121 patients who had 
completed the CR programme and who had at least 1 fatigue score were included in 
the analysis (Figure 4.1). Reasons given by patients (n=17) for not participating in the 
follow-up measurements were: (I) lack of time, (II) immobility; and (III) unwillingness.
In study
n=163
Post-
rehabilitation
n=121
Follow-up
n=104
Did not complete CR
n=35
No fatigue score
n=7
Lost to follow-up
n=17
Figure 4.1 Patient inclusion in study
CR= cardiac rehabilitation.
Measurements were taken at the following time-points: pre-rehabilitation (T0), post-
rehabilitation (T1), and 1 year after the start of rehabilitation (9-month follow-up) (T2). 
The study was approved by the medical ethics committee of the Erasmus Medical Centre 
in Rotterdam.
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Cardiac rehabilitation programme 
The rehabilitation programme at Capri cardiac rehabilitation centre is based on the 
Dutch guidelines for CR.11 The duration of CR varied from 4 to 13 weeks, depending 
on the patient’s individual improvement. The CR programme was completed when an 
individual’s physical and psychosocial goals were achieved. This was evaluated with an 
exercise test on a bicycle ergometer and a consultation with the multidisciplinary team 
that consisted of a social worker, physical therapist and nurse. 
The patients exercised twice a week. One training session lasted 75 min; the other session 
had additional relaxation exercises and lasted 105 min. The exercise sessions consisted 
of: (I) warming-up exercises; (II) gymnastics exercises; (III) an aerobic programme of 12 
min, which involved a combination of brisk walking and jogging with increasing the 
component of jogging over time; (IV) sports activities; and (V) cooling-down exercises. 
In addition to the regular exercise programme, patients could voluntarily attend edu-
cative medical sessions, risk factor sessions, healthy diet sessions or emotional advice 
sessions. Stress management modules, dietary advice modules and smoking cessation 
programmes were also provided to help adjust the lifestyle behaviour of the patients. 
measures 
Fatigue 
The primary outcome measure was fatigue, which was measured with the Fatigue Sever-
ity Scale (FSS). The FSS consists of 9 questions. Answers are given on a 7-point scale from 
“totally disagree” to “totally agree”. A higher FSS score indicates more severe fatigue.12,13 
Both the mean FSS score, indicating the level of fatigue, and the prevalence of fatigued 
patients and severely fatigued patients were calculated. Patients were classified as being 
fatigued if their FSS score was ≥ 4 and ≤ 5.112 and as being severely fatigued if their FSS 
score was > 5.1.13 The FSS has been found reliable and valid in healthy subjects12, in 
patients with multiple sclerosis12,14 and in patients with recent ischaemic stroke.12
Aerobic capacity
Aerobic capacity was measured with the 6-min walk test (6MWT). The 6MWT is a sub-
maximal exercise test for measuring aerobic capacity.15 During this test, patients walk as 
fast as they can over a distance of 30m during a period of 6 min. The distance walked is 
recorded. Patients were not allowed to run, and standardized words of encouragement 
were given every minute. The 6MWT has been found moderately reliable and moderately 
valid in patients with CAD undergoing CR.16 The 6MWT has been shown to be responsive 
to the relevant clinical changes that occur during CR.16 
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Depression
Depression was measured with the Hospital Anxiety and Depression scale (HADS). 
This questionnaire has subscales for depression and anxiety, each comprising 7 items. 
Answers are given on a 4-point scale from “never” to “almost always”. Higher scores on 
the depression subscale indicate higher levels of depression.17 Patients with a score ≥ 
8 are considered to have signs of depression.18 The HADS is a valid instrument for the 
screening of depression in patients with CAD.17,19
Baseline characteristics
Data on age, gender, body mass index (BMI), waist circumference, blood pressure, car-
diac diagnosis for referral, smoking, diabetes and medication were obtained from the 
patients’ medical files for the purpose of descriptive statistics. In addition, the number of 
training sessions was recorded. 
Procedure 
Depending on their individual preferences, patients completed the questionnaires 
either on paper or digitally. The questionnaires were completed at home. The 6MWT 
was performed either at Capri cardiac rehabilitation centre or at Erasmus Medical Centre 
under the supervision of a nurse, physical therapist or researcher. 
statistical analysis 
Descriptive statistics were used to present baseline characteristics, level and prevalence 
of fatigue, level of aerobic capacity and depression. To test the difference in baseline 
characteristics between the patients who completed CR and the patient who did not, 
independent t-tests and χ2 tests were performed. To assess the changes in prevalence 
of fatigue during and after CR, a χ2 test was performed. To investigate the changes in 
the level of fatigue during and after CR, a generalized estimated equation (GEE) model 
was performed with fatigue as dependent outcome variable and time as categorical 
predicator. A GEE model corrects for missing values and the dependency of observation 
within a subject is taken into account.20 In case time effects in fatigue were found, a 
second GEE model was performed to test whether the changes in fatigue were medi-
ated by aerobic capacity and depression. In this second model, fatigue was used as 
dependent outcome variable and time, aerobic capacity and depression were used as 
predictors. All models were adjusted for age, gender and cardiac diagnosis. Since the 
time between the measurements was not equal, an autoregressive structure was used 
in all models. The outcomes of the GEE analysis are regression coefficients (B), which 
indicate the change in the dependent variable that is associated with a 1 unit change 
in the predictor variable. To examine the difference in baseline characteristics between 
patients who were severely fatigued at follow-up and those who were not, post-hoc 
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independent t-tests and χ2 tests were performed. SPSS version 20 was used for data 
analysis. An overall 2-sided α of 0.05 was set for all analyses.
Results 
Patients 
The majority of patients were men (79%) and mean age was 56.6 years (Table 4.1). The 
main diagnosis for referral to CR was myocardial infarction (75%). The mean number of 
training sessions was 22 (Table 4.1). There were no differences in baseline characteristics 
between the 121 patients who completed the rehabilitation programme and the 35 
patients who did not complete the programme and who were excluded from analysis.
table 4.1 Baseline characteristics of the study population (n=121) 
Baseline characteristics
Men, n (%) 96 (79)
Diagnosis, n (%)
Myocardial infarction
Angina pectoris
91 (75)
30 (25)
Age (years), mean ± SD 56.6 ± 9.1
BMI (kg/m2), mean ± SD 28.1 ± 5.8
Waist circumference (cm), mean ± SD 100.9 ± 13.8
Systolic blood pressure (mmHg), mean ± SD 133.9 ± 19.4
Diastolic blood pressure (mmHg), mean ± SD 79.5 ± 11.4
Number of training sessions, mean ± SD 22 ± 4.6
Smoking, n (%) 29 (25)
Diabetes, n (%) 17 (14)
Medication, n (%)
Aspirin
Statin
Beta blocker 
ACE inhibitor
ADP antagonist
116 (95.9)
118 (97.5)
101 (83.5)
79 (65.3)
99 (81.8)
BMI= body mass index; ACE= angiotensin-converting enzyme; ADP= adenosine diphosphate. 
Fatigue 
Patients with AP (mean FSS 4.05 (standard deviation (SD) 1.59)) were significantly more 
fatigued at baseline than patients with MI (mean FSS 3.31 (SD=1.38), p=0.024). There was no 
difference at baseline in prevalence of fatigued patients between patients with AP (21.4% fa-
tigued, 28.6% severely fatigued) and MI (21.2% fatigued, 14.1% severely fatigued, p=0.131). 
The mean level of fatigue significantly decreased in the total study population from 3.49 
(SD=1.5) at baseline to 3.03 (SD=1.3) post-rehabilitation (B=-0.42, p=0.002) and to 2.75 
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(SD=1.4) at follow-up (B=-0.68, p<0.001 vs T0) (Table 4.2 and Figure 4.2). At baseline, 21.2% 
of the patients were classified as fatigued (mid-grey) and 17.7% as severely fatigued (dark-
grey). The prevalence of fatigued patients decreased to 12.8% post-rehabilitation (p<0.001) 
and to 10.5% at follow-up (p=0.011 vs T0, p<0.001 vs T1). The number of severely fatigued 
patients decreased to 10.6% post-rehabilitation (p<0.001) and to 8.1% at follow-up (p=0.011 
vs T0, p<0.001 vs T1) (Figure 4.2). Those patients who were classified as severely fatigued at 
follow-up, were also severely fatigued prior to CR. Therefore, the fatigued and non-fatigued 
patients did not change into severely fatigued patients. 
table 4.2 Generalized estimating equation model for changes in fatigue scores during and after cardiac 
rehabilitation
Ba 95% Ci P-value
T0-T1 -0.42 -0.68; -0.15 0.002
T0-T2 -0.68 -1.00; -0.36 <0.001
T1-T2 -0.26 -0.51; -0.01 0.042
CI= confidence interval.
T0: n=113. T1: n=94. T2: n=86.
 aB coefficients are unstandardized regression coefficients.
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Figure 4.2 Prevalence and level of fatigue 
FSS= fatigue severity scale. 
Post-hoc analysis revealed differences in baseline characteristics between patients who 
were severely fatigued at follow-up and those who were not. The severely fatigued 
group consisted of significantly more patients with diabetes and women compared with 
fatigued and non-fatigued patients (Table 4.3). At follow-up, the patients with severe 
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fatigue walked a shorter distance on the 6MWT; 449.4m (SD=109.66) compared with 
613.9m (SD=84.8) for those who were not severely fatigued (p=0.026). In addition, the 
severely fatigued patients showed significantly more depressive symptoms (66.7%), 
compared with 16.7% in mildly fatigued patients and 3.3% in non-fatigued patients.
table 4.3 Difference in baseline characteristics between severely fatigued patients and fatigued and non-
fatigued patients at follow-up
severely fatigued 
patients
Fatigued and
non-fatigued patients P-value
Men, % 42.9 83.5 0.010
Diagnosis, %
Myocardial infarction
Angina pectoris
71.4
28.6
75.9
24.1
0.790
Age (years), mean ± SD 58.4 ± 7.6 57.7 ± 9.3 0.845
BMI (kg/m2), mean ± SD 30.6 ± 5.69 28.1 ± 6.5 0.328
Waist circumference (cm), mean ± SD 104.1 ± 19.2 101.0 ± 9.8 0.688
Systolic blood pressure (mmHg), mean ± SD 72.1 ± 14.1 80.6 ± 10.6 0.054
Diastolic blood pressure (mmHg), mean ± SD 132.9 ± 25.3 135.9 ± 19.5 0.701
Smoking, % 14.3 23.0 0.597
Diabetes, % 57.1 10.1 0.001
BMI= body mass index.
Aerobic capacity and depression 
The distance walked during the 6MWT increased by 7.1%, from 581 m (SD=81) at 
baseline to 622 m (SD=87) at post-rehabilitation (B=36.59, p<0.001). At follow-up, the 
distance walked decreased by 3.4% to 601m (SD=93) (B=-18.34, p=0.011 vs T1) (Table 
4.4), but was still higher compared with baseline (B=18.25, p=0.006). 
The mean level of depression decreased from 3.57 (SD=3.6) at baseline to 2.87 (SD=2.9) 
at post-rehabilitation (B=-0.56, p=0.026). This lower level of depression was maintained 
at follow-up (2.67 ± 3.1, B =-0.77, p=0.008 vs T0) (Table 4.4). 
An association was found between distance walked during the 6MWT and fatigue (B=-
0.002, p=0.030) when adjusted for depression. A mean increase in the 6MWT of 1m was 
associated with a mean decrease of 0.002 in the fatigue score (Table 4.4). An association 
was also found between depression and changes in fatigue (B=0.203, p<0.001) (Table 
4.4). A mean decrease of 1 in the score on the depression subscale was associated with 
a mean decrease of 0.203 in the fatigue score.
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table 4.4 Generalized estimating equation model for changes in 6-min walk test and depression before 
and after CR
Ba 95% Ci P-value
6MWT
   T0-T1 36.59 22.16; 51.02 <0.001
   T0-T2 18.25 5.34; 31.16 0.006
   T1-T2 -18.34 -32.55; 4.12 0.011
Depression
   T0-T1 -0.56 -1.06; -0.07 0.026
   T0-T2 -0.77 -1.34; -0.21 0.008
   T1-T2 -0.21 -0.74; 0.32 0.440
Associations
   6MWT and fatigue -0.002 -0.005; 0.000 0.030
   Depression and fatigue 0.203 0.145; 0.260 <0.001
CI= confidence interval; 6MWT= 6-min walk test.
T0: n=99; T1: n=70; T2: n=67.
 aB coefficients are unstandardized regression coefficients.
disCussiON
This study estimated fatigue during and after CR. The level and the prevalence of fatigue 
both decreased. However, one year after the start of rehabilitation, the prevalence of 
severely fatigued patients remained high. In this group of severely fatigued patients, the 
prevalence of depressive symptoms was also high. As hypothesized, aerobic capacity 
was associated with reductions in fatigue scores, even after correction for depressive 
symptoms. 
Our finding of a mean baseline level of fatigue of 3.49 indicates that, on average, this 
patient group is not fatigued. However, since the mean FSS score in healthy populations 
is 3.00 ± 1.0812, the level of fatigue in patients with CAD is higher at baseline. After re-
habilitation and at follow-up, FSS scores were equal to scores in the healthy population. 
Examination of the prevalence of fatigue showed that the findings were encouraging for 
the fatigued patients, but are still a cause of concern for the severely fatigued patients. In 
a healthy population, the prevalence of fatigued individuals (including severely fatigued 
patients) is 18%.12 While the prevalence in patients with CAD was higher than this at 
baseline, this difference was no longer present at follow-up. In contrast, the prevalence 
of severely fatigued patients in the current study was higher than the fure of 3.5% seen 
in the healthy population12, not only at baseline, but also after rehabilitation and at 
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follow-up. The current CR programme thus seems inadequate for reducing fatigue in 
this subgroup of severely fatigued patients. Since fatigue might negatively influence 
physical and mental capacity and thus quality of life6, it is important to know whether 
CR can be optimized to reduce fatigue in this group. The most striking factor shown by 
the characteristics of this subgroup was the very high occurrence of depressive symp-
toms at follow-up. Since one of the main symptoms of depression is fatigue or loss of 
energy21, an extra intervention that focuses on the treatment of depression is likely to 
be beneficial.
To the authors’ knowledge, no previous studies have explored levels of fatigue after CR 
in patients with CAD. However, a treatment effect of CR on vital exhaustion was found 
by one study.5 The features of vital exhaustion are fatigue and loss of energy.22 Another 
study reported a decrease in fatigue from baseline to 4 months and 2 years after infarc-
tion on the Multidimensional Fatigue Inventory scale.6 Since the patients in this second 
study did not participate in CR, it seems that the improvements in fatigue reported in 
our study cannot completely be attributed to CR. It should be noted, however, that while 
48% of the patients in the second study still reported fatigue at 4 months and at 2 years 
after a myocardial infarction6, this was only 23% in our study after participation in CR. 
Besides a direct result of CR on fatigue, CR could also indirectly lead to improvements in 
fatigue. According to the results of previous studies, our study demonstrated a signifi-
cant increase in aerobic capacity during CR. This increase has been shown to improve a 
patient’s ability to perform activities of daily living, including work and leisure activities.23 
These improvements influence the patient’s psychological condition and thus improve 
their quality of life.23 A small decline in aerobic capacity was seen at follow-up; however, 
the distance walked was still higher than baseline. These results are in line with a previ-
ous study.24 Also consistent with our hypothesis was the finding of a positive association 
between aerobic capacity and changes in fatigue. To achieve a level of fatigue equal to 
that of healthy individuals, patients with CAD had to reduce their FSS score on average 
by 0.5. Based on the model, patients would therefore have had to increase the distance 
walked in the 6MWT on average by 250 m. Since the mean improvement was only 33 m, 
the reduction in fatigue was also clearly influenced by other factors. 
Previous research has indicated a strong, positive association between scores on the 
HADS depression subscale and fatigue scores.5 The prevalence of depression is high in 
patients with CAD and overlaps with fatigue.6 In line with these findings, the results 
of our study showed that changes in fatigue were significantly associated not only 
with aerobic capacity, but also with depression. A reduction in depression was associ-
ated with a decline in fatigue. Whereas aerobic capacity was only a weak mediator for 
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changes in fatigue, the decline in fatigue during and after CR seems to have been caused 
mainly by a reduction in depression. This again underlines the importance of focusing 
on depressive symptoms in the group of severely fatigued patients for whom CR does 
not seem to be effective in terms of reducing fatigue.
Further research is required into more causes of fatigue and severe fatigue. Fatigue 
is likely to be influenced not only by the patient’s disease, but also by factors such as 
socio-economic factors and comorbidities.6 It is also important to identify patients with 
severe fatigue at an early stage of the rehabilitation programme so that other additional 
fatigue-relieving strategies can be provided for this group.
study limitations 
This study has some limitations. First, since there was no control group, the effects of CR 
on fatigue remain unclear. The changes in fatigue could be attributed to time rather than 
to exercise-based CR. Ideally, future research should study the effect of CR on fatigue in 
a randomized controlled trial. However, since CR is currently seen as standard care, it 
would be unethical to exclude patients from CR. 
A second limitation is our use of the 6MWT to assess aerobic capacity. The gold standard 
for determining aerobic capacity is measuring oxygen consumption during cardiopul-
monary exercise testing. This test could, however, not be performed for logistic reasons. 
Instead, we used the 6MWT, a test that is often recommended in patients undergoing 
CR. It is well known from previous research that the 6MWT is a valid instrument to esti-
mate aerobic capacity in patients undergoing CR.16 Nevertheless, previous research has 
also shown that there is a learning effect for repeated 6MWTs, which can also result in 
improvements.16 We attempted to reduce this effect by performing a practice session at 
baseline. Despite this, patients who walk only a short distance in the 6MWT at baseline 
have more scope for improvement than those who walk a greater distance, in whom a 
“ceiling effect” may therefore occur.16 
A final limitation is that, since someone’s experience of fatigue may differ during the day, 
their answers may depend on when the questionnaire was completed.6
CONClusiONs
This is the first study, to our knowledge, which investigated the level and prevalence of 
fatigue in patients with CAD during and after CR. Levels of fatigue were improved both 
post-rehabilitation and at follow-up. On average, patients obtained levels of fatigue 
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equal to those in a healthy population. However, after rehabilitation the prevalence of 
severe fatigue remained higher in patients with CAD than in healthy individuals. This 
suggests that the current CR programme might be inadequate for these patients in 
terms of fatigue. Although aerobic capacity was found to be associated with a decline in 
fatigue, the association was weak. Since a stronger association was found between fa-
tigue and depression, interventions that focus on reducing depression might also have a 
positive influence on reducing fatigue in patients with CAD. Patients with severe fatigue 
should be identified in an early stage of rehabilitation so that additional programmes to 
relieve fatigue can be provided.
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ABstRACt
Objective: To asses changes in participation in society (frequency, restrictions, 
satisfaction) during and after cardiac rehabilitation (CR) and to asses associations 
between participation and health-related quality of life (HRQoL).
design: Prospective cohort study.
setting: Outpatient CR center.
Participants: Patients with coronary artery disease (N=121; mean age, 57y; 96 
men [79%]). 
intervention: Multi-disciplinary CR.
main outcome measures: Participation in society was assessed with the Utrecht 
Scale for Evaluation of Rehabilitation-Participation and HRQoL with the MacNew 
heart disease health-related quality of life questionnaire. All measurements were 
performed pre-CR, post-CR, and 1 year after the start of CR.
Results: Frequency of participation did not change during and after CR. The 
proportion of patients experiencing restrictions in participation decreased from 
69% Pre-CR to 40% post-CR (p<0.001) and 29% at one year (p<0.001, vs post-CR). 
Pre-CR, 71% of patients were dissatisfied with their participation. This improved 
to 49% post-CR (p<0.001) and 53% at 1 year (p<0.001, vs pre-CR). Experienced 
restrictions explained 5% to 7% of the improvement in HRQoL during CR and 
satisfaction with participation explained 10% to 19%.
Conclusions: Participation in society improves in patients undergoing CR. 
Despite these improvements, the presence of coronary artery disease is associ-
ated with persistent restrictions and dissatisfaction with participation. Because 
experienced restrictions and dissatisfaction are related to changes in HRQoL, it is 
important to address these aspects of participation during CR. 
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iNtROduCtiON
Cardiac rehabilitation (CR) is multidisciplinary, focusing on improving physical and 
psychosocial functioning of patients with cardiac disease. An important goal of CR is 
to optimize participation in society with regard to different aspects of daily life, such as 
domestic, occupational, and recreational activities.1,2 This goal can be achieved either 
directly, or by improving the conditions for participation, in particular physical capacity 
and mental status.3-7
Only few studies have looked at participation in society in patients attending CR. Most of 
these studies focused solely on work resumption and showed that about 80% of partici-
pants attending CR have returned to work 1 year after hospitalization.8 Return to work 
is, however, only one aspect of daily life. Participation in society also involves domestic 
and recreational activities such as social contacts, going out and housekeeping. Because 
most of the participants attending CR are retired, it is especially important to also focus 
on these non-work-related aspects of daily life as outcome measures of CR. 
Besides being limited in number and merely focusing on work-related aspects, previous 
studies measured only one dimension of participation in society: either frequency or 
restrictions to participation experienced by participants. Participation is, however, a 
multidimensional concept that also consists of the participants’ satisfaction with par-
ticipation.9-11 It is important to take into account all 3 dimensions, since they are only 
weakly related to each other.12
Research in several patient populations has shown that patients who participate in 
society more often and who have greater satisfaction with participation, have a higher 
health-related quality of life (HRQoL).13-15 Similarly, in patients with coronary artery 
disease (CAD), work resumption is associated with an improved HRQoL6,16 whereas their 
experience of restrictions in household tasks is related to a lower HRQoL.17 Because 
HRQoL is not only an indicator of a patient’s well-being, but also an important outcome 
measure for the success of a treatment,18 knowledge about determinants of HRQoL is 
essential for developing successful interventions.
The primary aim of this study was to undertake a multidimensional assessment of par-
ticipation in society (frequency, restrictions and satisfaction) for various aspects of daily 
life (domestic, occupational and recreational activities) before and after CR in patients 
with CAD. When significant time effects were observed for participation, the mediating 
effects of physical capacity and mental status were explored. Our secondary aim was to 
study the mediating effects of participation in society on changes in HRQoL.
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metHOds
study sample
From October 2010 until July 2012, patients who attended CR at Capri Cardiac Rehabili-
tation Center were included in this prospective cohort study. Patients were included if 
they had a diagnosis of acute myocardial infarction or angina pectoris (established ≤ 
8 weeks before inclusion) and were treated with percutaneous coronary intervention, 
coronary artery bypass grafting, and/or medical treatment. Other inclusion criteria were 
age ≥18 years, proficiency in Dutch and signed informed consent. Exclusion criteria were 
left ventricular ejection fraction <40% and physical and cognitive impairments that 
might limit CR.
measures
Participation in society
Participation was assessed with the Utrecht Scale for Evaluation of Rehabilitation-
Participation (USER-Participation), which has been found to have good psychometric 
properties.11,19,20 This questionnaire consists of 32 items (concerning domestic, occupa-
tional, and recreational activities) that address 3 different dimensions of participation: 
frequency, restrictions, and satisfaction. A score (0-100) is calculated for each dimension, 
with higher scores indicating better participation. The first 59 patients filled out a first 
version of the USER-Participation, whereas the subsequent 62 patients filled out the 
final version. Because both versions showed high agreement on all scales (intraclass 
correlation coefficients 0.947-0.982), they can be used interchangeably.21  
To further quantify participation, item scores were dichotomized. For the frequency 
scale, “none at all” and “never” were defined as “not participating”, and participation for 
“≥ 1 hour per week” and “once or more than once a month” as “participating”. In line with 
the study of van der Zee et al,12 the item scores for the restriction scale and satisfaction 
scale were dichotomized into restrictions/ no restrictions and satisfied/ not satisfied.12 
Although no reference values were available, in cases where 20% or more of the study 
sample did not participate, felt restricted or dissatisfied with regard to a certain aspect 
of daily life, this arbitrary proportion was considered relatively high. 
Mediating variables
Two potentially mediating variables on time effects in participation in society were 
specified: physical capacity and mental status. Physical capacity was measured with a 
6-minute-walk test, a reliable and valid submaximal-exercise test that was found to be 
responsive to relevant clinical changes during CR. The 6-minute walk distance correlates 
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well with outcomes on the criterion standard maximum exercise test.22 Mental status 
was measured using the subscale for depression of the Hospital Anxiety and Depression 
Scale (HADS). The HADS is a valid measurement for the screening of depressive mood in 
patients with CAD.23,24
Health-related quality of life
HRQoL was assessed with the MacNew heart disease health-related quality of life 
questionnaire. The Dutch MacNew is valid and reliable25 and has shown to be a useful 
evaluation instrument for CR.18 The questionnaire consists of 26 items. A global score 
(1-7) was calculated, as well as subscores (1-7) for the physical, emotional and social 
domains, with higher scores indicating improved HRQoL.
Procedure 
The study protocol was approved by the Medical Ethics Committee of the Erasmus Medi-
cal Center in Rotterdam. 
All patients participated in a multidisciplinary-outpatient CR program. The core of the 
program consisted of group exercise sessions (strength and aerobic) twice a week. Par-
ticipants were also offered group-education sessions on risk factors for cardiovascular 
disease. Participation in a smoking cessation program, nutritional counseling, and stress 
management were optional. If necessary, individual consultations with psychiatrists, 
psychologists, social workers and dieticians were provided. The duration of the program 
varied between 4 and 13 weeks. The CR program was terminated when individual 
physical and psychosocial goals were met, as evaluated by an exercise stress test and 
consultation of a multidisciplinary team that consisted of physical therapists, social 
workers, and cardiologists.  
All measures were obtained at the start of CR (T0), after CR (T1), and at follow-up 1 year 
after the start of CR (T2). 
Data on age, gender, employment before CR, marital status, risk factors (diabetes, smok-
ing, hypertension, body mass index), and reason for referral (diagnosis) were obtained 
from the medical charts.
statistical analysis
Scores on the restriction scale of the USER-Participation violated the normality assump-
tion and showed severe negative skewness. For this reason, scores were dichotomized. 
A maximum score of 100 was given the value of ‘1’ (no restrictions) and a score <100 a 
value of ‘0’ (restrictions experienced). Data on other measures were normally distributed. 
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Descriptive statistics were used to present baseline characteristics. To estimate changes 
in participation between baseline, post-CR and follow-up, three generalized estimating 
equation (GEE) analyses were performed with frequency of participation, restrictions 
and satisfaction as dependent outcome variables and time as a categorical predictor. A 
GEE model was chosen because it corrects for missing values and because corrections 
are made for the dependency of observations within 1 individual.26 In case of significant 
time effects, additional analyses were performed to evaluate possible mediating effects 
of physical capacity and depressive mood. 
To assess whether participation in society is mediating changes in HRQoL, another 
GEE model was used with HRQoL as outcome variable and time as predictor. In case of 
significant time effects, participation was added to the model as possible mediator. The 
model was corrected for mediating effects of physical capacity and depressive mood on 
participation in society.
Since time points were unequally spaced, an autoregressive structure was used in all 
models. All baseline variables (Table 5.1) were considered possible confounders for all 
models. In case the variable changed the regression coefficient or odds ratio (OR) >10%, 
this variable was included in the model as a confounder. 
For continuous variables, outcomes are displayed as regression coefficients (B), which 
indicate the change in the dependent variable that is associated with an increase in the 
specified time unit. For dichotomized variables outcomes are displayed as OR’s, which 
indicates the increase (over the specified time period) in the odds that the dependent 
variable changes. Mediation was expressed as the percentage of change in the overall 
time effect after adding the potential mediator to the model. A 2-sided p-value <0.05 
was considered significant. All analyses were performed using SPSS version 20 (SPSS 
Inc., Chicago, Illinois). 
Results
subjects
A total of 163 patients started CR and were eligible for this study (Figure 5.1). Data from 
35 patients who did not complete CR for reasons such as lack of time and unwillingness 
were excluded. The number of dropouts in this study was similar to that described in 
the literature (20% - 25%).27,28 Data from another 7 patients were excluded, because 
they failed to return any of the questionnaires. There were no significant differences in 
baseline characteristics between patients excluded from analysis and those included. Of 
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the remaining 121 patients, a total of 17 patients were lost to follow-up, for reasons such 
as lack of time, illness, and unwillingness. 
Most of participants were men (n=96, 79%), mean age was 57 years, and 79 participants 
(65%) were employed. For further baseline characteristics see Table 5.1. 
table 5.1 Baseline characteristics of the study population (n=121) 
Baseline Characteristics
demographics
   Sex, number of men (%) 96 (79)
   Age in years, mean ±SD 56.6 ± 9.1
   Employment, n (%)
      Employed (full time/part time) 79 (65)
      Unemployed 8 (7)
      Home/retired 34 (28)
   Marital status, n (%)
      Married/partner 93 (77)
      Single 28 (23)
Risk factors
   Blood pressure in mmHG, mean ±SD
      Systolic 134.0 ± 19.4
      Diastolic 79.5 ± 11.4
   BMI, mean ±SD 28.0 ± 5.8
   Diabetes, n (%) 17 (14)
   Smoking, n (%) 29 (25)
Rehabilitation characteristics
   Diagnosis, n (%)
      Myocardial infarction 91 (75)
      Angina pectoris 30 (25)
   Number of training sessions, mean ±SD 22 ± 4.6
BMI= body mass index.
Participation in society
Frequency of participation
Table 5.2 lists the outcomes of the GEE regression model for time and frequency, which 
is graphically depicted in Figure 5.2a. Frequency of participation did not change during 
and after CR (see Table 5.2).  
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table 5.2 Results of GEE analysis for changes in frequency of participation, satisfaction with participation 
and restrictions in participation
scale time period
Regression coeffi  cient  
B† 95%  Confi dence interval P-value
Frequency1 T0-T1 2.121 -0.086: 4.328 0.060
T0-T2 0.155 -2.454: 2.763 0.908
T1-T2 -1.966 -4.595: 0.663 0.143
Satisfaction2 T0-T1 6.915 4.125: 9.706 <0.001§
T0-T2 8.435 4.903: 11.967 <0.001§
T1-T2 1.520 -1.506: 4.546 0.325
scale time period Odds ratioǂ 95%  Confi dence interval P-value
Restrictions2,* T0-T1 3.077 1.952: 4.848 <0.001§
T0-T2 5.843 3.363: 10.152 <0.001§
T1-T2 1.899 1.186: 3.040 0.008§
1GEE model corrected for confounding eff ect of age, smoking status and employment.
2 No confounders identifi ed.
* Because scores violated the normality assumption, dichotomized scores were used in the analysis.
† Regression coeffi  cients (B) indicate that for an increase in the specifi ed time unit, the outcome variable changes 
with the regression coeffi  cient B.
ǂOdds ratio indicates the increase (over the specifi ed time period) in the odds of feeling unrestricted.  
§P<0.05 considered signifi cant.
In study
n=163
Post-
rehabilitation
n=121
Follow-up
n=104
Did not complete 
CR n=35
No outcome on 
participation in 
society n=7
Lost to follow-up
n=17
Figure 5.1 Patient fl owchart
CR= cardiac rehabilitation.
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Table 5.3 shows the results of the dichotomized item scores (prevalence of nonparticipa-
tion). Although total participation time did not change, we did see some changes in 
percentage of patients that did not participate in a certain activity. At T0, 39% of patients 
were not working (paid employment), and at T1 this decreased to 34%. At follow-up 
(T2), 42% were not working. With regard to leisure and social activities, at T0 >20% of 
patients participated less than once a month in going out, outdoor activities, and physi-
cal exercise. At T1 and T2, this only remained above 20% for going out. 
Participation restrictions
At T0, the mean score on the restriction scale was 82.8 ± 18.3 (median 85.4). This in-
creased to 94.5 ± 8.9 (median 100) at T1 and 93.0 ± 17.2 (median 100) at T2 (see Figure 
5.2a and Table 5.2). Because scores violated the normality assumption, dichotomized 
scores (restrictions experienced/no restrictions experienced) were used in the analysis. 
At T0, most patients experienced restrictions (69%) in one or more aspects of daily life. 
At T1, this improved to 40% (OR=3.077, 95% confidence interval (95% CI) =1.952-4.848) 
and at T2 this improved further to 29% (OR=1.899, 95% CI=1.186-3.040). See Figure 5.2b.
At T0, restrictions were experienced mainly during work (33% of patients involved in 
this activity), housekeeping (38%), physical exercise (49%), and outdoor activities (36%). 
At T1, restrictions persisted for work (28%) and physical exercise (22%). At T2, during 
work this improved to 9%, but 21% still experienced restrictions during physical exercise 
(Table 5.3). 
Satisfaction with participation
At T0, the mean score on the satisfaction scale was 71.8 ± 16.1 (median 75.0). This in-
creased to 79.0 ± 14.6 (median 80.0) at T1 (B = 6.862, p<0.001). There were no significant 
changes between T1 and T2 (mean score 79.6 ± 15.8, median 82.5), see Figure 5.2a and 
Table 5.2. At T0, 71% of patients were dissatisfied with one or more aspects of daily life. 
This improved to 49% at T1 and was 53% at T2 (see Figure 5.2b). 
At T0, dissatisfaction was seen in work (27% of working patients dissatisfied), house-
keeping (37%), physical exercise (44%), going out (36%), outdoor activities (37%), and 
contact with friends/acquaintances (33%). At T1, dissatisfaction persisted only in contact 
with friends (27%). However, at follow-up (T2) more than 20% of patients were once 
more dissatisfied with housekeeping, physical exercise, going out, and contact with 
friends (Table 5.3).
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table 5.3 Prevalence of nonparticipation, restrictions and dissatisfaction in different aspects of daily life 
(dichotomized item scores)
Not participating (%)
Frequency scale t0 t1 t2
Paid work 39* 34* 42*
Unpaid work 80* 77* 69*
Education 93* 95* 89*
Housekeeping 5 0 1
Physical exercise 22* 3 9
Going out 45* 28* 24*
Outdoor activities 33* 19 18
Leisure indoors 14 11 19
Visits to family/friends 13 8 5
Visits from family/friends 7 14 9
Telephone/computer contact 6 6 5
Restrictions (%)
Restriction scale t0 t1 t2 
Work/education 33* 28* 9
Housekeeping 38* 19 16
Mobility 21* 6 15
Physical exercise 49* 22* 21*
Going out 21* 4 6
Outdoor activities 36* 9 12
Leisure indoors 8 6 3
Partner relationship 17 16 15
Visits to family/friends 23* 4 5
Visits from family/friends 14 6 5
Telephone/computer contact 9 1 1
dissatisfied (%)
satisfaction scale t0 t1 t2
Work/education 27* 18 12
Housekeeping 37* 18 20*
Mobility 19 10 13
Physical exercise 44* 15 23*
Going out 36* 16 20*
Outdoor activities 37* 14 16
Leisure indoors 18 14 10
Partner relationship 8 10 13
Family relationships 8 8 11
Friends & acquaintances 33* 27* 36*
*A percentage above 20% was considered high.
Cardiac rehabilitation & participation in society
113
5
Mediating effects
Physical capacity explained 1.6% of changes in satisfaction with participation and 9% of 
changes in restrictions. Depressive mood explained 20% of changes in satisfaction and 
had no mediating effect on restrictions (Table 5.4). 
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Figure 5.2 (A) Improvements in mean score for frequency, restrictions, and satisfaction scale during and 
after CR; (B) Improvements in prevalence of restrictions and dissatisfaction during and after CR
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mediating effect of participation in society on changes in HRQol
Table 5.5 lists the outcomes of the GEE regression model with HRQoL and the mediating 
effects of participation in society. Both global HRQoL and subscores improved signifi-
cantly over time. Satisfaction with participation explained changes over time in global 
HRQoL (19%), physical HRQoL (18%), emotional HRQoL (25%), and social HRQoL (10%), 
whereas experienced restrictions explained 5%, 7%, 1%, and 2% respectively. Frequency 
of participation did not explain changes in HRQoL.
table 5.5 Mediating effects of participation in society on changes in HRQoL
time effect mediating effect participation scores*
Outcome variable
Regression coefficient Bǂ
(95% Confidence interval) P-value Frequency Restriction satisfaction
Global HRQoL1
0.224
(0.123: 0.326)
<0.001§ † 5% 19%
Physical HRQoL2
0.323
(0.192: 0.454)
<0.001§ 1% 7% 18%
Emotional HRQoL3
0.141
(0.037: 0.245)
0.008§ † 1% 25%
Social HRQoL4
0.212
(0.085: 0.340)
0.001§ 1% 2% 10%
HRQOL= health related quality of life.
*Mediation was expressed as the percentage of change in the overall time effect after adding the potential me-
diator to the GEE model.
ǂRegression coefficients (B) indicate that for a unit increase in the specified predictor variable, the outcome vari-
able changes with the regression coefficient B.
1GEE models corrected for confounding effect of physical capacity, depressive mood and smoking status.
2GEE model corrected for confounding effect of physical capacity, depressive mood, smoking status and body 
mass index.
3GEE model corrected for confounding effect of physical capacity, depressive mood, age, sex, smoking status and 
marital status.
4GEE model corrected for confounding effect of physical capacity, depressive mood, age, smoking status, body 
mass index and blood pressure.
§P<0.05 considered significant.
 †No mediating effect found.
table 5.4 Mediating effects of physical capacity and depressive mood on changes in participation in so-
ciety*
mediating variable
Participation in society
satisfaction Restrictions
Physical capacity  (6-minute walk test) 2% 9%
Depressive mood  (HADS) 20% †
*Mediation was expressed as the percentage of change in the overall time effect after adding the potential me-
diating variable to the GEE model.
†No mediating effect found.
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disCussiON
This study shows that participation in society improves during CR. Although no changes 
were seen in frequency of participation, considerable improvements were seen for 
experienced restrictions and satisfaction. Despite these improvements, 1 year after the 
start of CR one third of patients still felt restricted and half of the patients were dissatis-
fied with one or more aspects of daily life. Improvements in HRQoL during CR were for 
a considerable extent (10%-25%) explained by satisfaction with participation and were 
also influenced by experienced restrictions (1%-7%). Frequency of participation did not 
explain improvements in HRQoL. These findings underline the importance – both when 
conducting research and during rehabilitation – of also considering the restrictions 
experienced by patients and their satisfaction with participation, instead of focusing 
solely on frequency of participation. 
Few comparable studies have focused on participation in society during CR. Our results 
at follow-up are similar to the results from a validation study of the USER-participation 
in patients with cardiac disease obtained 4 months after CR.11 Scores at T2 are higher in 
our population than in those with other disorders such as chronic pain and neurological 
disorders.11 This is to be expected because these patient groups have more severe mo-
bility problems. Our HRQoL results are also comparable to the results of studies in other 
patient groups. In a study with older adults and patients with brain injuries, results also 
suggested that mainly experienced problems in participation and not the frequency of 
participation are related to changes in HRQoL.14,15
There was no control group in this study, so caution is required when attributing the 
improvements observed in participation directly to CR. Part of the improvements could 
also be due to spontaneous recovery over time. Besides spontaneous recovery or direct 
improvements, changes in participation could also be reached indirectly during CR by 
improving the conditions for participation, in particular physical capacity and depres-
sive mood. There is plenty of evidence found in controlled studies that CR does lead to 
changes in physical capacity and depressive mood.29,30 Improvements in physical capac-
ity could lead to lower physical strain4 and subsequently explain the decrease in restric-
tions and dissatisfaction. Depressive mood was shown in other studies to be a predictor 
of work resumption in patients with cardiac disease.5,6 Additional analysis in our study 
indeed showed that changes in satisfaction with participation were for a considerable 
extent mediated by depressive mood. Improvements in restriction were influenced by 
physical capacity. So, the improvements observed in participation are partially achieved 
indirectly by improvements in physical capacity and depressive mood achieved during 
CR. Because we could explain only 9% of improvements in experienced restrictions and 
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20% of improvements in satisfaction, further improvements could be a direct effect of 
CR or spontaneous recovery. However, other possible mediators such as fatigue and 
self-efficacy should be investigated in future studies. Knowing more about these factors 
could help to improve CR to target persisting restrictions and dissatisfaction.
In this study we found persistent restrictions and dissatisfaction with participation. 
Because restrictions and dissatisfaction are related to HRQoL, it is important to address 
these aspects of participation during CR. We explored in what areas of daily life most 
problems were experienced. Previous studies focused mainly on work resumption. In 
our study, one third of patients was not working before diagnosis and most patients who 
worked before the event returned to work at the completion of CR without experiencing 
major problems. This finding is in line with previous studies.8 The high percentage of 
patients being retired demonstrates the importance to not only focus on work resump-
tion but also on other aspects of daily life. 
Persisting restrictions (and dissatisfaction) were mainly experienced during the perfor-
mance of physical exercise. It might be that the strain of these activities is high and 
physical training during CR inadequate for problem-free resumption. However, because 
we found that physical capacity was only weakly related to changes in experienced 
restrictions, other factors responsible for the persisting restrictions must be explored. 
For going out and taking part in outdoor activities, restrictions were low 1 year after 
CR, but dissatisfaction was high and frequency of performance low. In this respect, our 
results are somewhat contrasting with a previous study that showed that most patients 
have returned to outdoor activities 12 weeks after diagnosis.31 During housekeeping 
tasks we also found high dissatisfaction. Problems might even have been underesti-
mated, because most of our study participants were men. Woman are in general more 
involved in and responsible for household tasks and report more stress and limitations.17 
The dissatisfaction seen during exercise, going out, outdoor activities, and housekeep-
ing could partly be caused by depressive feelings. We found that depressive mood is 
related to dissatisfaction with participation. A more individualized approach during 
CR focusing on these areas in which problems are experienced might help to optimize 
patients’ participation and consequently HRQoL.
The fact that the aspect of daily life with which patients were most dissatisfied 1 year 
after CR was their contact with friends and acquaintances (36% dissatisfied) – while 
satisfaction with partner and family relationships was high  – suggests that there is also 
room for improvement in social contact outside the family home. As social support is 
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important because it is related to health outcomes,32-34 future studies should focus on 
this topic, to find out whether CR could help. 
study limitations
Studies investigating participation in society are limited by the lack of a standard scale 
for measuring this concept.9,35 The USER-Participation measures not only frequency, but 
also restrictions and satisfaction; it also has good psychometric properties.11,19,20
Another limitation is the lack of a control group in this study and caution is required 
when attributing the effects that we found to CR. To our knowledge, there are no ran-
domized trials that published results of changes in several aspects of participation in 
society (more than return to work) during CR. 
CONClusiONs
Although no changes were seen in frequency of participation, considerable improve-
ments were seen for experienced restrictions and satisfaction. Despite improvements, 
the presence of CAD is associated with persistent restrictions and dissatisfaction with 
participation. Because experienced restrictions and dissatisfaction are related to HRQoL, 
it is important to also address these aspects of participation in society during CR, and 
not only frequency of participation. A more individualized approach during CR focusing 
on areas in which restrictions and dissatisfaction are experienced might help to optimize 
patients’ participation and HRQoL.
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ABstRACt
The majority of cardiac rehabilitation (CR) referrals consist of patients who have 
survived an acute coronary syndrome (ACS). Although major changes have been 
implemented in ACS treatment since the 1980s, which highly influenced mor-
tality and morbidity, CR programs have barely changed and only few data are 
available on the optimal CR format in these patients. We postulated that standard 
CR programs followed by relatively brief maintenance programs and booster ses-
sions, including behavioural techniques and focusing on incorporating lifestyle 
changes into daily life, can improve long-term adherence to lifestyle modifica-
tions. These strategies might result in improved (cardiac) mortality and morbidity 
in a cost-effective fashion. In the OPTImal CArdiac REhabilitation (OPTICARE) trial 
we will assess the effects of two advanced and extended CR programs that are 
designed to stimulate permanent adoption of a heart-healthy lifestyle, compared 
with current standard CR, in ACS patients. We will study the effects in terms of 
cardiac risk profile, levels of daily physical activity, quality of life and health care 
consumption.
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iNtROduCtiON
Healthy lifestyle management is becoming increasingly important in the Western world, 
as the incidence of obesity, hypertension, and diabetes is taking on epidemic propor-
tions.1-3 According to the World Health Organisation, 75% of cardiovascular diseases could 
be prevented by optimal lifestyle management.4 Indeed, the INTERHEART investigators 
have demonstrated that 90% of (first) myocardial infarctions (MI’s) could be attributed 
to nine modifiable risks, including hypertension, diabetes, and hypercholesterolemia.5 
Furthermore, smoking cessation, physical activity, moderate alcohol consumption and 
combined dietary changes are associated with mortality risk reductions of 20–45% in 
patients with coronary artery disease (CAD).6 
Several cardiac rehabilitation (CR) programs have been developed since the 1980s for 
CAD patients, which offer a variety of interventions that aim to stimulate an active 
and healthy lifestyle. In meta-analyses it has been demonstrated that these programs 
effectively reduce the 1-year incidence of total mortality, cardiovascular mortality and 
nonfatal MI.7,8 However, these initial beneficial results were not maintained during 
longer-term follow-up.9 The lifestyle changes adopted during the rehabilitation period 
were probably not incorporated into daily routine. 
Throughout the past decades, patients who are referred for CR constitute a heteroge-
neous and dynamically changing population. Nowadays, the majority of CR referrals 
consist of patients who have survived an acute coronary syndrome (ACS). Major changes 
have been implemented in ACS treatment since the 1980s, which have highly influenced 
mortality and morbidity. Currently, most ACS patients undergo percutaneous coronary 
intervention (PCI) in the acute phase, and receive antiplatelet therapy, lipid lowering 
therapy and other cardio protective medication during long-term follow-up. As a result, 
ACS patients usually have preserved left ventricular function and, consequently, a good 
survival.10,11 Also, the duration of the hospital stay after ACS is considerably reduced; the 
current average is approximately only 5 days.12 Interestingly, CR programs have barely 
changed since the 1980s, and only few data are available on the optimal CR format in 
ACS subjects.13-15 
The favourable developments in ACS treatment have, however, an important downside: 
ACS patients have less time for reflection on the event they experienced. The contact 
time with healthcare professionals during the acute phase is limited, whereas in this 
period patients might be most open to accept (lifestyle) advice to avoid future cardiac 
events. In order to adapt and maintain a heart-healthy lifestyle, ACS patients therefore 
probably need more guidance in the subacute phase than is currently offered in CR 
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programs. Recently, some successful maintenance programs have been presented.16-18 
However, these programs consist of high frequency contacts during long-term follow-
up, and may therefore not be cost-effective. We postulated that CR programs followed 
by relatively brief maintenance programs and booster sessions, including behavioural 
techniques and focusing on incorporating lifestyle changes into daily life, can also im-
prove long-term adherence to lifestyle modifications.16,19,20 These strategies might result 
in improved (cardiac) mortality and morbidity in a cost-effective fashion. 
In the OPTImal CArdiac REhabilitation (OPTICARE) trial we will assess the effects of two 
advanced and extended CR programs that are designed to stimulate permanent adop-
tion of a heart-healthy lifestyle, compared with current standard CR, in ACS patients. 
We will study the effects in terms of cardiac risk profile, levels of daily physical activity, 
quality of life and health care consumption. 
OBJeCtives
Primary objective
The primary objective of OPTICARE is to evaluate the effectiveness of extended CR pro-
grams in patients who have experienced an ACS. The programs combine physical activi-
ties, psychosocial counselling and personal coaching. Effectiveness will be expressed in 
terms of levels of daily physical activity and (reduction in) estimated cardiovascular risk, 
which will be measured by the Systematic Coronary Risk Evaluation (SCORE) function.21
secondary objectives
We have defined the following secondary objectives:
•	 To	evaluate	the	effects	of	the	extended	CR	programs	on	physical	fitness,	body	mass	
index (BMI), waist circumference, health care consumption, quality of life, return to 
work, occurrence of anxiety and depression, and cardiovascular events; 
•	 To	evaluate	which	health	benefits	(cardiac	risk	profile,	physical	fitness,	quality	of	life,	
anxiety, depression, participation, fatigue, health care consumption) are associated 
with improved levels of physical activity; 
•	 To	investigate	whether	extended	CR	is	more	cost-effective	than	standard	care.
metHOds
The OPTICARE trial is a multicentre, open, multidisciplinary randomised controlled trial 
with a 6-month follow-up. The PRospective Open, Blinded Endpoint (PROBE) design will 
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be applied, and an independent Clinical Event Committee will verify all cardiac events. 
22 The protocol and procedures of OPTICARE were approved by the Medical Ethics Com-
mittee of Erasmus MC Rotterdam, the Netherlands. 
Each patient will receive oral and written information on the trial objectives, study 
design, and advantages and disadvantages of study participation. A signed informed 
consent form by the patient is a prerequisite for participation in the trial. 
Patient selection
OPTICARE is designed for patients with a documented ACS who are referred for CR. 
ACS is defined as persistent (>20 min) chest pain suggestive of myocardial ischaemia, 
which is unresponsive to nitro-glycerine and which is accompanied by ST-T changes 
(electrocardiographic evidence) and/or cardiac troponin elevations (biochemical evi-
dence), regardless of in-hospital treatment. A total of 10 hospitals in the broader region 
of Rotterdam—The Hague refer their ACS patients to the local Capri Centre, which offers 
a standard CR program that is consistent with the Dutch guidelines.23,24
Allocated treatment
Eligible patients who consent to participate in the trial will be randomly allocated to 
one of three treatment strategies (Table 6.1), following inclusion and exclusion criteria 
as mentioned in Table 6.2. Randomisation will be performed by using sequentially 
numbered, opaque, sealed envelopes with information on allocated treatment. The 
envelopes will be prepared by an independent statistician, who uses a random number 
generator to construct the treatment sequence. The allocation process will be monitored 
to preserve randomness and concealment. 
table 6.1 Treatment arms
CR-only •	 Standard	CR
CR+t •	 Standard	CR
•	 5	Telephone	calls	after	completion	of	standard	CR	for	6	months	with	an	interval	of	5	a	6	weeks
CR+F •	 Standard	CR	with	obligation	to	participate	in	the	multifactorial	lifestyle	and	cardiovascular	risk	
factor management group sessions
•	 3	Counselling	sessions	during	standard	CR	with	an	interval	of	1	month	to	promote	an	active	
lifestyle 
•	 3	Multifactorial	lifestyle	and	risk	factor	group	sessions	after	completion	of	standard	CR	(at	
4/6/12 months post randomization)
•	 Titration	of	medication	to	LDL	level<=1.8	mmol/l	and	SBP<=140	mmHg
CR-only= standard cardiac rehabilitation; CR+T= cardiac rehabilitation plus individual telephonic counselling; 
CR+F= cardiac rehabilitation plus face-to-face group counselling; SBP= systolic blood pressure.
Chapter 6
130
1) CR-only
Standard care (or: CR-only) consists of standard CR according to the Dutch guidelines as 
is currently offered to all patients referred to Capri Cardiac Rehabilitation. 
CR-only is a group exercise program of 1.5 h that is offered 2 times a week for 12 weeks 
under the supervision of a physiotherapist. Participation in multifactor lifestyle and car-
diovascular risk factor group education sessions is offered to all patients, and comprises: 
information on cardiovascular disease risk factors, medical information, dietary advice, 
and advice on coping with emotions. If indicated, there is an option to participate in a 
smoking cessation program, nutritional counselling sessions, stress management ses-
sions or an individually based psychological program. 
At the start of the program, each patient will undergo an intensive interview to determine 
his/her individual program. Only the physical training program is strictly obligatory; the 
counselling and group sessions will be attended upon motivation of each patient.
2) CR+T (CR+ Telephonic counselling)
The 2nd strategy is based on the COACH study that demonstrated favourable effects 
of personal coaching.20 In the CR+T arm of the trial, standard CR is extended with five 
telephone coaching sessions with an interval of 5–6 weeks during the first 6 months 
after completion of standard CR. The coaching sessions intend to keep the patient aware 
table 6.2 Inclusion and exclusion criteria
inclusion criteria •	 Recent	acute	coronary	syndrome
•	 Age	over	18	years
•	 Proficient	in	the	Dutch	language
•	 Providing	written	informed	consent
exclusion criteria •	 Heart	failure	and/or	impaired	left	ventricular	function	(left	ventricular	ejection	fraction	<40	%)
•	 Angina	NYHA	Class	II–IV
•	 Psychological	or	cognitive	impairments	which	may	limit	cardiac	rehabilitation
•	 Congenital	heart	disease
•	 Chronic	obstructive	pulmonary	disease	Gold	classification	≥II
•	 Diabetes	with	organ	damage
•	 Locomotive	disorders	that	will	preclude	participation	in	an	exercise	training	program
•	 Implantable	cardio-defibrillator	(ICD)
•	 Renal	failure	needing	follow-up	by	a	nephrologist
•	 Intermittent	claudication	impairing	CR	exercises
CR= cardiac rehabilitation.
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of his or her cardiovascular risk factors, and on methods learned to improve cardiovas-
cular health. The personal coaching is offered by specialised nurses, who are trained to 
stimulate patients to pursue the target levels for their particular coronary risk factors. 
This COACH based strategy consists of coaching the patient in a process of continuous 
improvement in coronary risk factors. Patients are stimulated to develop a personal 
plan of action in which they measure their coronary risk factors (e.g. at their general 
practitioner’s office), define their targets, act upon, measure again, etc. Patients are also 
persuaded to adopt and adhere to appropriate lifestyle measures, including a healthy 
diet, persistent smoking cessation, and daily physical activities at moderate intensity.
3) CR+F (CR+ Face-to-face counselling)
The 3rd strategy, CR+F, is another extension of standard CR. Patients who are allocated 
to this strategy have a commitment during CR to participate in the multifactorial lifestyle 
and cardiovascular risk factor management group sessions (rather than participation on 
a voluntary basis). Besides, during standard CR patients will participate in three group 
counselling sessions under the supervision of a physiotherapist to promote an active 
lifestyle (aiming at regular exercise of moderate intensity for 30 min at least 5 times 
a week). The intrinsic motivation of the patient to change behaviour will be encour-
aged by the motivational interviewing technique which has shown to be effective in 
improving activity levels in daily life.25,26 To provide feedback on the patient’s home 
activity, pedometers (Yamax Digiwalker SW-200) will be provided.27 Finally, at 4, 6 and 12 
months after the start of the program the patients will again be required to participate 
in multifactor lifestyle and cardiovascular risk factor group sessions of 2 h each in which 
maintenance of healthy lifestyle behaviour (including physical activity) is discussed to 
increase long-term adherence. These group sessions are led by physiotherapists, social 
workers, dietician, nurses and physicians and are based on self-regulation. Finally, in pa-
tients randomised to CR+F, the cholesterol and blood pressure levels will be monitored 
and medication will be adjusted when needed. The target level will be: LDL ≤1.8 mmol/l 
and systolic blood pressure (SBP) <140 mmHg. 
data collection
Apart from the baseline clinical characteristics, the following data will be collected by 
the OPTICARE team in all patients at baseline (i.e. prior to CR), at the end of standard CR, 
and at 1 year and 1.5 year after inclusion:
1) The 10-year CVD mortality risk according to the SCORE risk chart, which is based on 
the following factors21:  
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•	 Age
•	 Sex
•	 Total	cholesterol	and	HDL	cholesterol	measured	in	blood	samples	after	fasting	for	a	
minimum of 8h
•	 Systolic	blood	pressure	as	measured	by	a	trained	nurse
•	 Smoking	status	determined	during	an	interview	by	one	of	the	social	workers	of	the	
Capri cardiac rehabilitation centre. The concentration of carbon monoxide in breath 
will be measured using a breath analyser (Smokerlyzer®).
2) The level of everyday physical activity:
The level of everyday physical activity is objectively measured with a validated 
accelerometry-based activity monitor (Actigraph GT3X, Fort Walton Beach, Florida), for 
7 consecutive days in the home situation. The Actigraph is a small device worn on a 
belt around the waist that measures and records movement, movement intensity and 
duration. The Actigraph is the most widely used (commercially available) accelerometer 
and different studies report acceptable to good validity.28
3) A broad spectrum of characteristics and risk factors that determine cardiovascular 
health:
•	 Medication
•	 Blood	 glucose,	 blood	 lipids,	 and	 glomerular	 filtration	 rate.	 All	 blood	 samples	 are	
taken after a minimum of 8 h of fasting
•	 Body	mass	index	(BMI)	and	waist	circumference
•	 Physical	fitness	assessed	by	a	6-minute	walk	test	and	a	5	times	sit-to-stand	test
•	 Working,	marital,	and	educational	status
•	 Information	on	 return-to-work,	quality	of	 life,	 anxiety	 and	depression,	health	 care	
consumption, illness perception, medication adherence, perceived physical activity, 
fatigue, self-efficacy, type D personality, social participation and movement fear. We 
will use validated questionnaires to obtain these data (Table 6.3). 
study endpoints and sample size
The primary study endpoint is the SCORE Risk Score that is measured 1.5 years post 
randomisation. The RESPONSE trial29 studied the effectiveness of a nurse-coordinated 
outpatient risk management program in cardiac patients. That strategy was associated 
with a 17% reduction in SCORE Risk Score as compared with standard care.21 Based 
on these data, and taking into account the more intensive interventions that we will 
perform, we expect in both the CR+F and in the CR+T arm at least a 20% reduction in 
the SCORE Risk Score at 1.5 years: from 5.40 to 4.32 points with an estimated standard 
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deviation (SD) of 4.5. With 274 patients in each treatment arm, the study has 80% power 
(beta-error=0.02) to detect this difference with an alpha-error of 0.05 (2-sided test). We 
will enrol a total of 300 patients in each treatment arm, taking into account a 10% drop-
out rate. 
table 6.3 Questionnaires
•	 KVL	H:	Quality	of	Life	Questionnaire38
•	 HADS:	Hospital	Anxiety	and	Depression	Scale39
•	 IPQ:	Illness	Perception	Questionnaire40
•	 IPAQ:	Self-perceived	level	of	daily	physical	activity:	International	Physical	Activity	Questionnaire41
•	 FSS:	Fatigue	Severity	Scale42
•	 DS14:	Type-D	personality43
•	 USER	P:	User-Participation44
•	 AVI	scale:	“Angst	Voor	Inspanning”(i.e.	fear	of	movement:	self-designed	questionnaire)
•	 Smoking	behaviour,	self-designed	questionnaire
•	 EQ5D45
•	 GSE:	General	Self-Efficacy46
Secondary endpoints include all-cause mortality, cardiovascular mortality, non-fatal 
myocardial infarction, rehospitalisation for heart failure, re-hospitalisation for angina, 
admission to the emergency room, non-fatal stroke, and coronary intervention. All 
clinical endpoints will be monitored and verified by an independent Clinical Event Com-
mittee. 
Cost effectiveness analysis
A cost-effectiveness analysis will be performed in accordance with the current Dutch 
guidelines (Guidelines for Pharmacoeconomic Evaluations).30 Costs will therefore be 
calculated from both the health care sector and the societal perspective (where all costs 
are included in the analysis regardless of who incurs them). Costs will include direct 
medical costs, patient costs, and productivity losses. Unit prices for the most important 
cost items will be determined using the micro-costing method, which is based on a 
detailed inventory and measurement of all resources used. The primary health outcome 
will be quality-adjusted life-years. Short-term costs and effectiveness will be based on 
observed outcomes measured in this trial. Lifetime costs and health outcomes will be 
calculated with a Markov model using data from this trial in combination with litera-
ture data. Future costs and life-years will be discounted at 4% and 1.5% respectively. 
Extensive (probabilistic) sensitivity analyses and value of information analysis will be 
performed. Cost-effectiveness will be assessed by calculating the incremental cost-
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effectiveness ratio, which is the difference between the mean costs of two treatment 
strategies divided by the difference in their mean effects (e.g. life years).31 
disCussiON
Over the past years it has been demonstrated that standard CR reduces morbidity and 
mortality in patients with CAD.7,8,14,15 An extended CR program consisting of supervised 
30 min aerobic exercise, comprehensive lifestyle and risk factor counselling sessions may 
even further benefit patients in the long term, as shown in the GOSPEL trial.16 However, 
it should be realised that in this trial multiple (11 sessions in 3 years) and thus costly 
interventions were done. In the COACH trial a limited number of telephone interven-
tions also had beneficial effects.20 However, in that trial only approximately half of the 
patients underwent CR and the beneficial effect of the COACH intervention in the CR 
subgroup is unknown. This is an important limitation of the COACH trial since standard 
CR is recommended in the Dutch guidelines.24 In the OPTICARE study we will investigate 
in a separate study arm whether the COACH approach (CR+T arm) still has beneficial ef-
fects in patients who suffered from an ACS and who subsequently underwent standard 
CR. In addition, the effects of a more time-consuming CR+F arm, including a limited 
number of extra sessions to promote a healthy lifestyle with a focus on physical activity, 
will be studied. 
Secondary prevention after an ACS has several components. Preventive medication 
should be started and titrated to optimal doses by the physician according to current 
guidelines.11 In addition, modifiable risk factors (diabetes, hypertension, cholesterol, 
smoking, overweight, sedentary lifestyle) should be inventoried and appropriate action 
should be taken in a combined effort of the patient and physician. In most studies the 
pharmacological components of the program showed benefits11,16,20, but strategies 
to promote smoking cessation and in particular physical activity and weight loss are 
needed. Therefore, in this study, we will focus on reaching long-term lifestyle changes, 
with a special focus on increasing the level of physical activity. Lifestyle inactivity is an 
important cardiovascular risk factor and related to several cardiac risk factors such as 
lipid profile, blood pressure and body composition.32 Despite the well-known beneficial 
effects of CR on physical fitness, mortality and quality of life31,33, only little is known about 
the effects of CR programs on the level of daily physical activity after CR. In some studies 
positive effects on daily physical activity after CR have been shown9,34, but it has also 
been reported that physical activity tends to decline 6 to 12 months after completion of 
standard CR.9,35 Furthermore, results from a study in patients with chronic heart failure 
suggest that improved physical fitness does not automatically result in a more active 
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lifestyle.36 The CR+F arm aims to incorporate daily physical activity in one’s life and thus 
promotes long-term adherence by maintenance programs and booster sessions at 4, 6 
and 12 months post randomisation. 
In this era of financial constrains it is essential to not only show beneficial effects of an 
intervention but also the cost-effectiveness of the intervention. This may be particularly 
true for comparing the less intensive CR+T arm, involving just some telephone contacts, 
with the more extensive CR+F arm. Therefore, a full ex-post economic evaluation of both 
extended CR programs and standard CR will be performed.37 
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ABstRACt
Background: Standard cardiac rehabilitation (CR) is insufficient to help patients 
achieve an active lifestyle. The effects of two advanced and extended behavioral 
CR interventions on physical activity (PA) and sedentary behavior (SB) were as-
sessed.
methods: In total, 731 patients with ACS were randomized to 1) 3 months of 
standard CR (CR-only); 2) 3 months of standard CR with three pedometer-based, 
face-to-face PA group counseling sessions followed by 9 months of aftercare with 
three general lifestyle, face-to-face group counseling sessions (CR+F); or 3) 3 
months of standard CR, followed by 9 months of aftercare with five to six general 
lifestyle, telephonic counseling sessions (CR+T). An accelerometer recorded PA 
and SB at randomization, 3 months, 12 months, and 18 months.
Results: The CR+F group did not improve their moderate-to-vigorous intensity 
PA (MVPA) or SB time compared to CR-only (between-group difference= 0.24% 
MVPA, P=.349; and 0.39% SB, P=.529). However, step count (between-group dif-
ference= 513 steps/day, P=.021) and time in prolonged MVPA (OR=2.14, P=.054) 
improved at 3 months as compared to CR-only. The improvement in prolonged 
MVPA was maintained at 18 months (OR=1.91, P=.033). The CR+T group did not 
improve PA or SB compared to CR-only.
Conclusions: Adding three pedometer-based, face-to-face group PA counsel-
ing sessions to standard CR increased daily step count and time in prolonged 
MVPA. The latter persisted at 18 months. A telephonic after-care program did not 
improve PA or SB. Although after-care should be optimized to improve long-term 
adherence, face-to-face group counseling with objective PA feedback should be 
added to standard CR. 
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iNtROduCtiON
Physical behavior comprises both physical activity (PA) and sedentary behavior (SB).1 
Patients with acute coronary syndrome (ACS) who have higher levels of moderate-
to-vigorous intensity PA (MVPA; e.g., brisk walking or biking) have more favorable 
cardiovascular risk profiles and lower cardiac mortality.2,3 Independent of PA time, SB 
time is also related to health outcomes such as Body Mass Index (BMI) and mortality.4,5 
In addition to the total time (volume) of physical behavior, the way physical behavior is 
distributed (accumulated in shorter or longer periods) might be important. For example, 
it has been suggested that MVPA yields greater health benefits when accumulated in 
periods lasting at least 10 min.6-8 With regard to SB, regular active breaks may counteract 
the harmful effects of prolonged sedentary periods.9
An important goal of cardiac rehabilitation (CR) for patients with ACS is the adoption 
of a healthy lifestyle. Although CR reduces cardiovascular risk factors, improves quality 
of life, and improves physical fitness10,11, standard CR seems insufficient to improve the 
amount of PA performed outside the supervised CR settings.12,13 Furthermore, standard 
CR generally does not target SB, and although some SB improvements do occur, patients 
with ACS remain sedentary following program completion.13
We hypothesized that patients with ACS need more guidance to improve physical 
behavior. Adding behavioral interventions with self-regulation techniques, such as 
self-monitoring and goal-setting, seems the most promising approach.14,15 Findings 
from previous studies that investigated the effectiveness of adding behavioral inter-
ventions aiming to improve daily PA to CR16-18 are limited because they rely largely on 
self-reported measures of PA that have poor validity and reliability.19 Additionally, most 
protocols were designed to evaluate short-term effectiveness only and the investigated 
novel behavioral interventions often were not integrated into existing CR programs. To 
successfully implement behavioral components into daily clinical practice, pragmatic 
trials are needed that use existing infrastructure.
In the OPTImal CArdiac REhabilitation (OPTICARE) RCT, standard CR and two advanced 
and extended behavioral CR interventions (one using face-to-face group counseling 
and one using individual telephonic counseling) were evaluated in patients with ACS. 
The OPTICARE trial was designed as a pragmatic trial in an outpatient rehabilitation 
setting. The primary objective described in this paper was to evaluate the short-term 
and long-term effectiveness of the novel behavioral CR interventions on PA volume. The 
secondary aim was to evaluate SB volume as well as PA and SB distribution over time.
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metHOds
study design
The OPTICARE study is an RCT that has been described in detail elsewhere.20 OPTICARE 
is registered at ClinicalTrials.gov (NCT01395095).
setting and participants
Patients referred to Capri Cardiac Rehabilitation (an outpatient rehabilitation center 
with several locations in the Netherlands) between November 2011 and August 2014 
were invited to participate. Inclusion criteria were ACS diagnosis, age >18 years, and 
proficiency in Dutch. Exclusion criteria were the presence of severe physical and/or 
cognitive impairments that could limit CR participation.20 The OPTICARE protocol was 
approved by the Medical Ethics Committee of the Erasmus Medical Center in Rotterdam, 
the Netherlands (MEC-2010-391). All patients provided written informed consent.
Randomization and intervention
Patients were randomized by trained research assistants using sequentially numbered, 
opaque and sealed envelopes that were prepared by an independent statistician who 
used a computer random number generator. Patients were randomized (1:1:1) to one of 
the following groups (see for the timeline of the interventions also Appendix 7A):
1) CR-only: Standard CR was in line with the guidelines2,21 and comprised two 75 min 
group exercise sessions per week for 3 months consisting of gymnastic exercises, run-
ning/brisk walking, sports activities and relaxation exercises. Additionally, patients were 
invited to participate in educational sessions addressing healthy diet, emotional coping, 
and cardiovascular disease risk factors. When indicated, patients could participate in 
group counseling sessions addressing diet, stress management, and smoking cessation, 
or an individual psychologic program. Only general information was given on health 
benefits of PA. SB was not addressed. There was no aftercare at the end of the 3 month 
CR program (initial phase).
2) CR+F: During the initial phase patients participated in standard CR as described above 
with the addition of three face-to-face, group PA counseling sessions (four to eight pa-
tients per session) lasting 75 min each. The sessions were facilitated by a physical thera-
pist trained in motivational interviewing.22 The content of the sessions was based on 
the following evidence-based behavioral change techniques: information about health 
behavior, self-monitoring, goal setting, feedback, barrier identification, and relapse 
prevention.14,23,24 Pedometers (Yamax Digiwalker SW-200) were used to provide daily PA 
feedback and to facilitate goal-setting. The physical therapist coached the patient to set 
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specific and realistic personal PA goals. In addition, a booklet with assignments focusing 
on goal setting, barrier identification and relapse prevention was used. Information was 
provided about the health benefits of breaking up SB time.
After the initial 3 month period, a 9 month after-care program was offered that consisted 
of three face-to-face group sessions (six to eight patients per session). Every session 
consisted of a 1 hour exercise program followed by a 1 hour behavioral counseling pro-
gram. The exercise program served as self-monitoring of aerobic capacity and also in-
tended to stimulate interaction between patients in the group. The counseling sessions 
focused on permanent adoption of a healthy lifestyle (healthy diet, optimal PA, smoking 
cessation, medication adherence and stress management), but also on psychosocial 
problems. During the sessions information on health consequences of health behaviors 
was repeated and there was a focus on relapse prevention. The behavioral counseling 
sessions were led alternatingly by a physical therapist, a social worker, and a dietician 
who were all trained in motivational interviewing.
3) CR+T: Patients participated in the initial phase only in standard CR (see CR-only). After 
the initial 3 month period, a 9 month telephonic after-care program was offered that 
was based on the COACH program.25 This program consisted of five to six individual 
telephone coaching sessions with specialized nurses who were trained in motivational 
interviewing.22 Patients received information on risk factors and were encouraged to 
measure their coronary risk factors (cholesterol, blood pressure, glucose, weight) and 
define personal goals. Furthermore, psychosocial problems were discussed and patients 
were coached to develop a personal plan for a heart-healthy lifestyle (diet, PA, smoking 
cessation, medication adherence). During follow-up calls, progress was discussed. At the 
end of every phone call patients received a written overview of the topics that were 
discussed and the agreements made. SB was not addressed.
measurements
Physical behavior measurement and processing
Measurements were performed directly after randomization (T0), at completion of 
standard CR (T3m, 3 months after randomization), completion of after-care (T12m, 12 
months after randomization), and 6 months after completion of after-care (T18m, 18 
months after randomization) (Appendix 7A). Measurements were performed by trained 
research assistants. Both patients and testers were not blinded to group allocation. 
Patients were asked to wear a tri-axial accelerometer for 8 consecutive days during wak-
ing hours. Because consensus is lacking for how to process accelerometer data (e.g., 
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determination of epoch length and cut-off points), the existing literature was consulted 
to determine data processing procedures, which have been described previously.13  In 
short; data were sampled at 30 Hz. The ActiGraph converts accelerations on three axes 
(vertical, horizontal and perpendicular axes) into activity counts and steps. Steps were 
processed using Actilife software. Counts were summed over a sampling interval (ep-
och) of 15 seconds using Actilife software and further processed using Matlab version 
R2011b. The vector magnitude (a composite measure of counts on the three axes) was 
used for analysis. Data were only included in the analysis when the accelerometer was 
worn for at least 4 days with a minimum of 660 min per day. In our data, a minimum of 
660 min/day proved to be the most optimal threshold, which is a threshold that mini-
mizes excluding measurements of patients that spend a long time in bed and maximizes 
excluding measurements of patients that did not wear the Actigraph a full valid day13 
Non-wear time was defined as a minimum of 60 min of consecutive zeros. After subtract-
ing the non-wear from the data, each 15 sec epoch was categorized as:
•	 MVPA:	activities	of	≥672.5	counts26
•	 Light	activity:	activities	of	>37.5	and	<672.5	counts26
•	 SB:	activities	of	≤37.5	counts27
Physical behavior outcomes
After data processing, the following outcome measures were obtained:
Volume of physical behavior
•	 Duration	of	time	spent	in	MVPA	and	SB,	expressed	as	a	percentage	of	wear	time
•	 Step	count,	expressed	as	average	steps	per	minute	of	wear	time
Distribution of physical behavior over time 
•	 Prolonged	 MVPA	 was	 defined	 as	 periods	 of	 at	 least	 10	 min,	 in	 accordance	 with	
recommendations.2,8 In daily life, short MVPA interruptions seem reasonable (e.g., 
waiting for a traffic light). Therefore, a maximum of four (not necessarily consecutive) 
non-MVPA epochs were allowed during a prolonged MVPA period. Total time spent 
in prolonged MVPA was expressed as a percentage of wear time.
•	 Prolonged	SB	was	defined	as	periods	lasting	at	least	30	min.	Although	clear	recom-
mendations for SB are lacking, this time was chosen because interrupting SB every 
30 min seems to be a feasible target for interventions. A sedentary period could 
include multiple short interruptions with a maximal duration of three consecutive 15 
sec epochs of non-SB time. Thus, we defined a prolonged SB period as ending after 
at least 1 min of continuous non-SB. Total time spent in prolonged SB periods was 
expressed as percentage of wear time.
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Attaining physical behavior recommendations
We investigated whether patients were meeting physical behavior recommendations. 
We calculated the number of patients that walked at least 6500 steps/day, which has 
been previously recommended for prevention of cardiac disease progression.28,29 We 
also calculated whether participants met a target of ≥150 min of prolonged MVPA bouts 
per week.30 This guideline is consistent with those addressing secondary prevention 
of cardiovascular disease.3,31,32 Because not all participants wore an accelerometer for 
a full week, we calculated the number of participants achieving a mean of 21.4 min of 
prolonged MVPA/day (150 min/7 days). For SB, currently no guidelines are available.
sample size calculation
This RCT was designed to evaluate effects on cardiovascular risk profile (described in 
a separate paper) and physical behavior (current paper). A sample size calculation was 
performed for both outcome measures. Based on previous studies33,34, it was hypoth-
esized that patients randomized to CR+T or CR+F would reach a mean of 25 (+/-20) and 
32 (+/-23) MVPA min/day at T18m, respectively, compared with a mean of 16 (+/-13) 
MVPA min/day in patients randomized to CR-only. To show differences between the 
newly developed interventions and CR-only with 80% power (based on a two-sided test 
with alpha = 0.05), 202 patients were needed per treatment arm. A drop-out rate of 20% 
was anticipated, thus the recruitment was targeted to enroll 245 patients per arm, or 735 
total patients. This study size was sufficient to enable a post-hoc comparison between 
CR+F and CR+T, depending on actual findings, with adjustment for multiple testing. The 
required sample size was smaller than the number needed to evaluate cardiovascular 
risk profile differences. For logistic reasons, patient inclusion was restricted to the Rot-
terdam site of Capri for this part of the study.
statistical analysis
Descriptive statistics were used to present baseline characteristics. Data on relative time 
in prolonged MVPA violated the normality assumptions, even after transformation. A 
large group of patients did not spend any time in prolonged MVPA, leading to a severe 
positive skew. Therefore, this outcome was dichotomized, and a value of ‘0’ was given to 
those patients with no periods of prolonged MVPA and ‘1’ to those patients with at least 
one period of prolonged MVPA.
Intention-to-treat (ITT) analysis with full datasets is preferred to avoid bias in RCTs.35 
However, patients who quit CR before T3m had no post-baseline accelerometry mea-
surements; thus, a full ITT analysis was not possible. Only patients with at least one valid 
post-baseline physical behavior measurement were included in the analysis. A priori, it 
was decided to impute only missing baseline values and not post-baseline outcomes 
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(study endpoints). We used generalized estimating equations (GEE) with exchangeable 
correlation structures to evaluate study endpoints. A GEE model was chosen because 
it corrects for missing values and because corrections are made for the dependency of 
observations within one individual.36 GEE models use all available data of the dependent 
outcome and not only complete cases. Imputation of endpoints (in our case T3m, T12m, 
T18m) is therefore not needed.36 First, overall models were made for each outcome mea-
sure, including group allocation, and baseline values of the outcome measure to correct 
for baseline differences between patients. Next, the factor time and an interaction term 
between group and time were added to the overall model to compare between-group 
differences at the different time points. For continuous variables, the regression coef-
ficient (B) of the group variable (representing between-group differences) is displayed. 
For dichotomous variables, between-group differences are displayed as odds ratios 
(ORs). All models were adjusted for age and sex. Missing values at baseline were im-
puted five times (multiple imputation) by predictive mean matching, using all available 
baseline characteristics and physical behavior outcomes at all time points as predictors. 
For all analyses, pooled results are reported.
To evaluate possible bias, baseline values (using t-tests and Chi-square tests) were 
compared for patients included and excluded from the main analysis. Additionally, two 
sensitivity analyses were performed: (1) ITT analysis: identical GEEs on all randomized 
patients after multiple imputation (five times) of missing data on all time points; and (2) 
per-protocol (PP) analysis: identical GEEs on patients that attended at least 75% of all 
sessions.
A P value <.05 was considered significant. All analyses were performed using SPSS ver-
sion 20 (IBM Corp, Armonk, USA).
Results
Patients
A total of 731 patients with ACS were randomized (Figure 7.1), 130 patients quit CR 
prematurely, and 112 additional patients did not have a post-baseline measurement. 
The 242 patients who did not complete the study were, on average, 4.5 years younger 
(P<.001), more likely to have had a past MI (13% vs 7%, P=.011), and more likely to 
smoke (65% vs 34%, P<.001). The remaining 489 patients who were included in the main 
analysis had a mean age of 59 years, and most were treated with percutaneous coronary 
intervention (Table 7.1). 
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Outcomes 
At each time point, 69% to 86% of patients provided usable physical behavior measure-
ments (Appendix 7B). Unsuccessful measurements resulted from technical problems, 
failure of measurements to meet the minimum required duration, or patient inability 
to visit the rehabilitation center for application of the accelerometer due to lack of time 
or motivation. At T0, 86 (17.5%) missing physical behavior outcomes were imputed. At 
other measurement times, missing data was not imputed.  
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Figure 7.1 Consort fl ow diagram
CR= cardiac rehabilitation; CR+F= cardiac rehabilitation plus face-to-face group counseling; CR+T= cardiac re-
habilitation plus telephonic counseling; CR-only= standard cardiac rehabilitation; m=month.
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table 7.1 Baseline participant characteristics (n=489) 
Characteristics
CR+F
(n=161)
CR+t
(n=165)
CR-only
(n=163)
demographics
   Male, n (%) 129 (80) 141 (86) 131 (80)
   Age in years, mean (SD) 58.8 (9) 58.2 (9) 59.1 (8)
   Partnered, n (%)† 116 (81) 116 (87) 125 (84)
   Employed, n (%)‡ 78 (61) 75 (62) 72 (53)
   Education, n (%)§
      High 38 (27) 44 (33) 40 (27)
      Intermediate 97 (67) 83 (62) 101 (68)
      Low 9 (6) 6 (5) 7 (5)
therapeutic intervention at index event, n (%)
   No revascularization 12 (7) 15 (9) 14 (8)
   PCI 130 (81) 124 (75) 129 (79)
   CABG 20 (12) 27 (16) 21 (13)
Cardiac history, n (%)
   Myocardial infarction 9 (6) 15 (9) 11 (7)
   Angina 8 (5) 10 (6) 11 (7)
   PCI 12 (8) 15 (9) 16 (10)
   CABG 2 (1) 1 (1) 4 (3)
   Stroke/TIA 9 (6) 3 (2) 4 (3)
Risk factors, n (%)
   Diabetes 19 (12) 18 (11) 21 (13)
   Dyslipidemia 45 (28) 64 (39) 75 (46)
   Family history 87 (54) 80 (49) 93 (57)
   Smoking (pre-ACS) 62 (39) 61 (37) 49 (30)
   Hypertension 70 (44) 68 (41) 68 (42)
   Overweight 126 (79) 127 (77) 124 (76)
medication, n (%)
   Acetylsalicylic acid 157 (98) 161 (98) 160 (98)
   Oral anticoagulant 8 (5) 11 (7) 6 (4)
   Thienopyridine 137 (86) 131 (79) 142 (87)
   Cholesterol lowering medication 157 (98) 159 (96) 160 (98)
   Beta-blocker 136 (85) 141 (86) 136 (83)
   ACE inhibitor 116 (73) 115 (70) 116 (71)
   Angiotensin II receptor blocker 19 (12) 22 (13) 21 (13)
   Calcium blocker 19 (12) 24 (15) 19 (12)
   Nitrate 70 (44) 50 (30) 57 (35)
   Diuretic 17 (11) 23 (14) 19 (12)
   Psychotropic 6 (4) 13 (8) 11 (7)
CR+F = cardiac rehabilitation plus face-to-face group counseling; CR+T = cardiac rehabilitation plus telephonic 
counseling; CR-only = standard cardiac rehabilitation; PCI = percutaneous coronary intervention; CABG = coro-
nary artery bypass graft; TIA = transient ischemic attack; ACS = acute coronary syndrome. 
†Data missing for n=17 (CR+F), n=31 (CR+T), and n=14 (CR-only).
‡Data missing for n=33 (CR+F), n=44 (CR+T), and n=28 (CR-only).
§Data missing for n=17 (CR+F), n=32 (CR+T), and n=15 (CR-only).
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Intervention effects of CR+F compared to CR-only
Figure 7.2 displays observed study endpoints over time (for exact values see Appendix 
7C). With respect to volume of physical behavior, there were no overall intervention 
effects for MVPA time (between-group difference=0.24%; 95% CI=-0.27 to 0.76; P=.349) 
and SB time (between-group difference= 0.39%; 95% CI=0.82 to 1.59; P=.529). However, 
we did find overall intervention effects for step count (between-group difference= 0.45 
steps/min of wear time; 95% CI=0.03 to 0.86; P=.035) and for prolonged MVPA (OR=2.01; 
95% CI=1.30 to 3.14; P=.002; Table 7.2). Overall effects were also noted for achieving 
≥6500 steps/day (OR=1.77; 95% CI=1.20 to 2.60; P=.004; Table 7.2). 
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Figure 7.2 Volume of physical behavior and distribution over time
CR+F= cardiac rehabilitation plus face-to-face group counseling; CR+T= cardiac rehabilitation plus telephonic 
counseling; CR-only= standard cardiac rehabilitation; m=month.
*Significant intervention effect for CR+F compared to CR-only. 
Those patients randomized to CR+F participated in extra PA counseling sessions be-
tween T0 and T3m. Compared to CR-only patients, CR+F patients at T3m improved their 
step count with 0.59 steps per min of wear time more (95% CI=0.09 to 1.09; P =.021). 
This difference corresponds to an additional 513 steps per 14.5 hours of daytime waking 
hours. Furthermore, the odds of having prolonged MVPA periods ≥10 min were 2.14 
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times higher in the CR+F group compared to CR-only (95% CI=0.99 to 4.62; P=.054). 
Those patients randomized to CR+F also participated in a face-to-face, after-care pro-
gram between T3m and T12m. Although between-group differences in increases in step 
count were not maintained long-term, the odds of spending time in prolonged MVPA 
were still 1.86 times higher at T12m (95% CI=1.04 to 3.32; P=.037) and 1.91 times higher 
at T18m (95% CI=1.05 to 3.44; P=.033) compared to CR-only.
At T3m and T12m, patients in the CR+F group were more likely to meet ≥6500 steps/
day compared to those in the CR-only group (OR=2.00; 95% CI=1.19 to 3.35; P=.009; 
and OR=1.81; 95% CI=1.07 to 3.09; P=.028, respectively). This difference was no longer 
significant at T18m. 
Intervention effects of CR+T compared to CR-only
There were no overall intervention effects for MVPA time (B=-0.15%; 95% CI=-0.65 to 0.34; 
P=.544) or step count (B=-0.14 steps/min of wear time; 95% CI=-0.58 to 0.30; P=.536). 
There were also no intervention effects noted with respect to SB time, PA distribution, 
and SB distribution (Table 7.2). 
Outcome sensitivity analyses
For the sensitivity ITT analysis, all 731 randomized patients were analyzed after imputa-
tion at all time points. This analysis showed smaller intervention effects compared to the 
main analysis. The 428 patients who did participate in at least 75% of scheduled sessions 
were analyzed in the sensitivity PP analysis. That analysis showed slightly larger effects 
(Appendix 7D and 7E).
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 table 7.2 Main analysis: generalized estimating equation models† of intervention effects 
Physical behavior
CR+F (n=161)  vs CR-only (n=163) CR+t (n=165) vs CR-only (n=163)
B‡ Ci P B‡ Ci P
volume 
  MVPA overall 0.24 -0.27:0.76 0.349 -0.15 -0.65:0.34 0.544
  (% of wear time) ΔT0-T3m 0.34 -0.24:0.92 0.245 -0.48 -1.01:0.04 0.073
ΔT0-T12m 0.22 -0.42:0.85 0.502 -0.11 -0.78:0.55 0.736
ΔT0-T18m 0.08 -0.62:0.77 0.832 0.17 -0.52:0.86 0.621
  Step count overall 0.45 0.03:0.86 0.035* -0.14 -0.58:0.30 0.536
  (nr of steps per min of ΔT0-T3m 0.59 0.09:1.09 0.021* -0.44 -0.91:0.03 0.067
  wear time) ΔT0-T12m 0.22 -0.30:0.74 0.408 -0.06 -0.66:0.53 0.835
ΔT0-T18m 0.44 -0.16:1.03 0.150 0.12 -0.48:0.72 0.692
  SB overall 0.39 -0.82:1.59 0.529 0.35 -1.07:1.77 0.632
 (% of wear time) ΔT0-T3m 0.59 -0.80:1.98 0.404 0.51 -0.98:1.99 0.505
ΔT0-T12m 0.44 -1.12:2.00 0.583 0.40 -1.49:2.29 0.679
ΔT0-T18m 0.10 -1.62:1.83 0.905 0.10 -1.86:2.06 0.918
distribution 
  MVPA bout >10min overall 2.01§ 1.30:3.14 0.002* 1.02§ 0.69:1.50 0.935
  (% of wear time) § ΔT0-T3m 2.14§ 0.99:4.62 0.054 0.77§ 0.42:1.45 0.425
  ΔT0-T12m 1.86§ 1.04:3.32 0.037* 1.30§ 0.76:2.25 0.341
ΔT0-T18m 1.91§ 1.05:3.44 0.033* 0.83§ 0.48:1.44 0.505
  Prolonged SB (≥30min) overall 0.76 -1.02:2.53 0.403 1.08 -0.98:3.14 0.303
  (% of wear time) ΔT0-T3m 0.57 -1.56:2.69 0.602 0.80 -1.52:3.12 0.499
  ΔT0-T12m 1.42 -0.79:3.63 0.208 1.36 -1.09:3.81 0.277
ΔT0-T18m 0.29 -2.15:2.73 0.815 1.14 -1.56:3.85 0.408
Achieving guidelines, %
150 min prolonged overall 1.60§ 0.97:2.64 0.069 1.02§ 0.58:1.77 0.957
MVPA/week§ ΔT0-T3m 1.75§ 0.89:3.47 0.107 0.81§ 0.37:1.75 0.590
ΔT0-T12m 1.60§ 0.80:3.17 0.184 1.00§ 0.47:2.12 0.995
ΔT0-T18m 1.45§ 0.71:2.98 0.306 1.32§ 0.65:2.66 0.409
6500 steps/day§ overall 1.77§ 1.20:2.60 0.004* 0.90§ 0.60:1.34 0.594
ΔT0-T3m 2.00§ 1.19:3.35 0.009* 0.90§ 0.54:1.51 0.700
ΔT0-T12m 1.81§ 1.07:3.09 0.028* 0.87§ 0.51:1.47 0.606
ΔT0-T18m 1.45§ 0.83:2.52 0.190 0.92§ 0.53:1.59 0.768
CR+F = cardiac rehabilitation plus face-to-face group counseling; CR+T = cardiac rehabilitation plus telephonic 
counseling; CR-only = standard cardiac rehabilitation; CI=confidence interval; MVPA = moderate-to-vigorous 
physical activity; SB = sedentary behavior; m=months.
†All analyses were adjusted for baseline values, sex, and age. The CR-only group is the referent group for all analy-
ses.
‡The regression coefficient (B) represents the between-group difference and thus the intervention effect relative 
to CR-only at the specified time point.
§For dichotomous variables odds ratios are displayed.
*P < .05.
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disCussiON
Neither the novel behavioral CR interventions improved MVPA time (eg, brisk walking 
or sports activities) compared to standard CR. However, results from the CR+F group 
showed that integrating pedometer-based face-to-face group PA counseling into the 
initial phase of CR improved PA by an additional 500 steps/day, which is an encouraging 
result. PA distribution over time also improved, with MVPA accumulating more often in 
prolonged periods of at least 10 minutes, which is recommended for optimal health. 
As patients in the CR+F group progressed through the face-to-face after-care program, 
improvements in step count partly diminished. However, improvements in prolonged 
PA were maintained. The CR+T group experienced no benefit compared to CR-only.
Consistent with previous intervention studies in healthy subjects37, our results show 
that achieving lasting PA change is a challenge. Nevertheless, we were encouraged 
by improvements in the CR+F group daily step count. A previous study showed that 
6500 steps per day corresponds to the minimum energy expenditure (1500 kcal/week) 
needed to prevent disease progression in patients with ACS.28 After the initial phase of 
CR and after completion of the after-care program, more patients in the CR+F group 
met this step count goal compared to those in the CR-only group (62% vs 49% at T3m; 
60% vs 47% at T12m). In addition to step volume improvement, there were long-lasting 
improvements in time in prolonged MVPA compared to CR-only. Nevertheless, this im-
provement did not translate to differences in achievement of 150 min/week of exercise 
in prolonged MVPA. Adherence rates with this last guideline may be underestimated, 
however, because the guideline is based on self-report, whereas our data were objec-
tively measured.38
In a previous publication, we concluded that the novel interventions do not result in rel-
evant improvements in cardiovascular risk factors such as lipid profile, blood pressure, 
BMI and waist circumference.39 This could suggest that the improvements we found 
with regard to PA were insufficient to yield improvements in cardiovascular health. An 
alternative explanation is that the association between PA and cardiovascular health is 
masked by the effects of cardio protective medication. The majority of patients were 
taking aspirins, statins, beta-blockers, and ACE-inhibitors which resulted in already 
well-controlled lipids and blood pressure at baseline (‘ceiling effect’). Regardless of 
the correct explanation, adoption of an active lifestyle remains important since PA can 
influence cardiovascular mortality through other pathways (e.g. by improving coronary 
blood flow, augmenting cardiac function or enhancing endothelial function).40 In addi-
tion, PA was previously found to be associated to other health outcomes such as fitness 
and several chronic diseases.40,41 
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Time spent sedentary remained high for all groups. Although general advice was given 
to CR+F participants about the health benefits of regularly breaking up SB time, the fo-
cus of these sessions concerned PA; this focus might explain the lack of effects. Likewise, 
the CR+T group did not improve their time in SB after PA counseling. Previous studies 
support the finding that PA interventions do not affect sedentary time.15
To our knowledge, this is the first study investigating the effects of a physical behavior 
counseling program integrated into the initial phase of multidisciplinary CR. A large 
meta-analysis summarizing the effect of PA interventions among healthy subjects found 
improvements in step count of the same magnitude as seen in CR+F participants in our 
study.37
After the initial phase of CR, the CR+F group participated in a face-to-face after-care 
program focused on multiple lifestyle components. Previous studies investigating the 
effectiveness of such interventions have mainly relied on less well-validated self-report-
ed PA.17-19 A previous study that used objective pedometry to measure intervention ef-
fectiveness showed larger and longer-lasting effects in daily step count compared to our 
study.42 However, patients in that study were measured using the same (non-blinded) 
pedometers as used during the investigated intervention for feedback, which may have 
biased their findings. Our study adds the finding that increased step count does not 
necessarily translate to increased MVPA time. A possible explanation is that a part of the 
walking activities was classified as light intensity. Another explanation is that the extra 
walking activities were compensated for by decreasing other MVPA activities. Future 
research is needed to determine whether increasing total stepping activities (indepen-
dent of intensity) or increasing total MVPA time is more important for health.
In contrast to our study, two previous studies investigating the effects of the COACH 
program on which our telephonic after-care program (CR+T) was based, did show PA 
improvements.25,43 These outcomes were also self-reported, which may explain the 
discrepancy between those studies and our present study.
Although the increases in step count achieved by the CR+F group are encouraging, 
optimization of the intervention is needed. Results of our study suggest future direc-
tions. Firstly, our finding that patients responded to objective feedback on walking 
activities (in our study provided by pedometers) by increasing their daily step count is 
consistent with a previous review that emphasized the importance of self-monitoring 
for PA change.14 Possibly, our counseling sessions could be improved by not only provid-
ing feedback on walking activities, but also on volume and distribution of total MVPA 
and SB, which is possible with new technologies. Secondly, our after-care programs that 
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focused on several heart-healthy lifestyle components simultaneously were ineffective 
in improving PA compared to the pedometer-based counseling sessions during the 
initial phase of CR. Like Conn et al37,44, we hypothesize that for successful improvements 
in physical behavior, sessions may need to focus exclusively on PA and SB. Studies in-
vestigating the effects of CR after-care programs focusing solely on PA have provided 
inconsistent results thus far, suggesting that further research is needed to determine the 
optimal format.45,46 Patients probably require ongoing attention, which could be feasible 
using E-health solutions.47
Although after-care optimization is needed, we recommend that face-to-face group 
counseling sessions, including objective PA feedback, be added to standard CR. The 
CR+F intervention was imbedded in an existing and reimbursed CR program and con-
sisted of a small number of additional sessions performed in groups. Therefore, costs of 
the intervention are estimated to be relatively low. However, for successful implementa-
tion and reimbursement, a detailed economic evaluation of our intervention is needed. 
limitations
We included only patients who had at least one follow-up measurement. This method 
may have biased our results. To test for bias, we performed two sensitivity analyses. 
Because between-group differences were more pronounced in patients attending at 
least 75% of sessions and less pronounced when we performed a stricter ITT analysis 
that included all randomized patients, our results are probably valid primarily in more 
adherent patients.
Objective PA measurement is the method of choice, as it is more valid than self-reported 
measures.19 However, accelerometry also has limitations. Firstly, cut-off points used 
for PA intensity categories were developed for a healthy population. Consequently, 
PA intensity may be underestimated for patients with lower fitness levels. Secondly, 
incorrect categorizing of “standing still” as “SB” in our study cannot be ruled out. Finally, 
participants were aware that their PA was being measured, which may have influenced 
their behavior. Because our measurement period lasted at least 4 days, we expect this 
effect to be minimal and equal between groups.
CONClusiONs
None of the investigated novel CR programs were successful in increasing total MVPA. 
However, adding three pedometer-based, face-to-face group counseling sessions that 
focused exclusively on changing physical behavior during the initial phase of CR was 
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effective in improving daily step count and increasing time spent in prolonged MVPA. 
After the face-to-face after-care program focusing on several healthy lifestyle compo-
nents ended, only improvement in prolonged MVPA was maintained. The intervention 
was not successful in changing SB. The telephonic after-care program that focused on 
several healthy lifestyle components did not improve PA or SB. Although after-care op-
timization is needed to improve long-term adherence, we recommend that face-to-face 
group counseling sessions including objective PA feedback be added to standard CR.
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APPeNdixes
CR-only 
CR+F 
Face-to-Face 
CR+T 
Telephone 
standard CR 
3 group sessions  
including exercise program and 
lifestyle counseling 
5-6 individual telephonic lifestyle 
counseling sessions 
standard CR 
3 physical activity 
counseling  
sessions 
standard CR 
Follow-up 
T0            initial phase           T3m                    after-care                             T12m           follow-up          T18m 
Follow-up 
Follow-up 
Appendix 7A Treatment allocation 
CR= cardiac rehabilitation; CR+F= cardiac rehabilitation plus face-to-face group counseling; CR+T= cardiac re-
habilitation plus telephonic counseling; CR-only= standard cardiac rehabilitation; m=month.
Appendix 7B Usable physical behavior measurements, failed measurements, no-shows, and drop-outs at 
each time point
measurement
time
group (n)
successful
measurements
n (%)
Failed
measurements†
n (%)
measurement not 
performed
n (%)
drop-out
n (%)
t0 CR+F (161) 128 (79) 8 (5) 25 (16) 0
CR+t (165) 135 (82) 9 (5) 21 (13) 0
CR-only (163) 140 (86) 12 (7) 11 (7) 0
t3m CR+F (161) 134 (83) 10 (6) 17 (11) 0
CR+t (165) 139 (84) 11 (7) 15 (9) 0
CR-only (163) 126 (77) 20 (12) 17 (11) 0
t12m CR+F (161) 121 (75) 10 (6) 24 (15) 6 (4)
CR+t (165) 119 (72) 10 (6) 34 (21) 2 (1)
CR-only (163) 134 (82) 9 (5) 19 (12) 1 (1)
t18m CR+F (161) 112 (69) 16 (10) 27 (17) 6 (4)
CR+t (165) 117 (71) 18 (11) 27 (16) 3 (2)
CR-only (163) 130 (80) 12 (7) 19 (12) 2 (1)
CR+F= cardiac rehabilitation plus face-to-face group counseling; CR+T= cardiac rehabilitation plus telephonic 
counseling; CR-only= standard cardiac rehabilitation; m= months.
†Failure to obtain measurements resulted from technical problems or because the measurement did not meet 
the minimum required duration of 4 days.
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ABstRACt
Objective: The OPTICARE (OPTImal CArdiac REhabilitation) randomised con-
trolled trial compared two advanced and extended cardiac rehabilitation (CR) 
programmes to standard CR for patients with acute coronary syndrome (ACS). 
These programmes were designed to stimulate permanent adoption of a heart-
healthy lifestyle. The primary outcome was the SCORE (Systematic COronary Risk 
Evaluation) 10-year cardiovascular mortality risk function at 18 months follow-up. 
methods: In total, 914 patients with ACS (age, 57 years; 81% men) were ran-
domised to: (1) 3 months standard CR (CR-only); (2) standard CR including three 
additional face-to-face active lifestyle counselling sessions and extended with 
three group fitness training and general lifestyle counselling sessions in the first 9 
months after standard CR (CR+F); or (3) standard CR extended for 9 months with 
five to six telephone general lifestyle counselling sessions (CR+T). 
Results: In an intention-to-treat analysis, we found no difference in the SCORE 
risk function at 18 months between CR+F and CR-only (3.30% vs 3.47%; p=0.48), 
or CR+T and CR-only (3.02% vs 3.47%; p=0.39). In a per-protocol analysis, two of 
three modifiable SCORE parameters favoured CR+F over CR-only: current smok-
ing (13.4% vs 21.3%; p<0.001) and total cholesterol (3.9 vs 4.3 mmol/L; p<0.01). 
The smoking rate was also lower in CR+T compared with CR-only (12.9% vs 
21.3%; p<0.05). 
Conclusions: Extending CR with extra behavioural counselling (group sessions 
or individual telephone sessions) does not confer additional benefits with re-
spect to SCORE parameters. Patients largely reach target levels for modifiable risk 
factors with few hospital readmissions already following standard CR.
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iNtROduCtiON
Most cardiac rehabilitation (CR) referrals are for patients with acute coronary syndrome 
(ACS). Although major changes have been implemented in ACS treatment during recent 
decades, CR programmes have changed little since the 1980s, and little data are avail-
able about optimal CR format. Most patients with ACS undergo percutaneous coronary 
intervention acutely and receive cardio protective medication during long-term follow-
up. As a result, the prognosis for these patients has improved significantly1, and hospital 
stays have been reduced to 3–4 days. Consequently, healthcare professionals have 
limited time to increase patient awareness of important lifestyle changes, and CR has 
become even more important. Although current CR has been shown to reduce mortal-
ity and non-fatal myocardial infarction (MI)2,3, these benefits do not persist over long 
term follow-up.4 Patients with ACS likely would benefit from more guidance during the 
subacute phase. 
The OPTICARE (OPTImal CArdiac REhabilitation) randomised controlled trial (RCT) 
compared two extended CR programmes with standard CR in patients with ACS. One 
programme included face-to-face group counselling sessions, whereas the other was 
based on individual telephone contact between patients and a personal coach. Both 
novel programmes focused on incorporating lifestyle changes into daily life and in-
cluded behavioural techniques such as goal setting and relapse prevention, which have 
previous evidence of effectiveness.5,6 We designed OPTICARE to evaluate the long-term 
effects of extended CR on the SCORE (Systematic COronary Risk Evaluation) function 
and its modifiable components of systolic blood pressure (SBP), total cholesterol and 
smoking behaviour.7 The novel interventions may provide additional emotional sup-
port, and consequently, improve quality of life, anxiety and depression.
metHOds
The OPTICARE trial was an open, randomised controlled superiority trial; the full study 
design has been published previously.8 The trial, which was registered at ClinicalTrials.
gov (NCT01395095), used the PROBE (PRospective Open, Blinded Endpoint) design.9 The 
protocol was approved by the Medical Ethics Committee of Erasmus Medical Center, 
Rotterdam, the Netherlands (MEC-2010391). All patients provided written informed 
consent prior to enrolment.
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Patients 
OPTICARE was designed for patients with documented ACS who were referred for 
CR (see cardiovascular event definition in Appendix 8A). A total of 10 hospitals in the 
greater region of Rotterdam-The Hague referred patients with ACS to the local Capri 
Cardiac Rehabilitation Center. Exclusion criteria are provided in Appendix 8A.
treatment allocation 
For a complete explanation of interventions, please see Appendix 8A.
Standard CR (CR-only) 
Standard care consisted of CR based on the Dutch, European Society of Cardiology, and 
American College of Cardiology/ American Heart Association guidelines (Figure 8.1).10,11 
This CR programme consisted of a group exercise programme with 1.5-hour training 
sessions offered twice weekly for 12 weeks, under the supervision of a physiotherapist. 
Participation in multifactor lifestyle and cardiovascular risk factor group education ses-
sions was offered to all patients.
CR-only 
CR+F 
Face-to-Face 
CR+T 
Telephone 
standard CR 
3 group sessions  
including fitness training and 
lifestyle counselling 
5-6 telephonic lifestyle 
counselling sessions 
standard CR 
3 physical activity 
counselling  
sessions 
standard CR 
Follow up 
T0                             3 Months                                                  12 Months                           18 Months 
Follow up 
Follow up 
Figure 8.1 Study design and treatment allocation 
CR= cardiac rehabilitation; CR-only= standard CR; CR+F = standard CR extended with face-to-face group coun-
selling sessions; CR+T= standard CR extended with telephone counselling sessions; m=month.
Standard CR extended with group counselling sessions (CR+F) 
During the 12-week period of standard CR, three additional face-to-face physical activ-
ity group counselling sessions were organised (Figure 8.1). Additionally, patients were 
required to participate in face-to-face group sessions at 4, 6 and 12 months, which each 
lasted 2 hours and consisted of a 1-hour exercise programme and a 1-hour behavioural 
counselling session on a heart-healthy lifestyle (eg, physical activity and healthy diet).
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Standard CR extended with individual telephone counselling sessions (CR+T) 
In the CR+T arm, standard CR was extended with five to six individual telephone coach-
ing sessions at 5 to 6-week intervals following completion of standard CR (Figure 8.1). 
Patients were coached to develop a personal plan for a heart-healthy lifestyle. The 
personal coaching was offered by the Medical Service Center of the health insurance 
company ‘Zilveren Kruis’, which consisted of specialised nurses.
Randomisation 
Patients were randomly allocated to one of the three groups in a 1:1:1 ratio. Randomisa-
tion was performed using sequentially numbered, opaque, sealed envelopes, which were 
prepared by an independent statistician using a computer random number generator. 
Allocation was monitored throughout recruitment by a contract research associate to 
preserve randomness and concealment. Randomisation was performed at the start of 
CR, which was, on average, 6 weeks after ACS and 1–2 weeks after the first outpatient 
clinic visit after ACS diagnosis.
Outcome measures 
The primary endpoint was the SCORE risk function at 18-month follow-up (ie, 6 months 
after completion of interventions) to assess improvements in long-term adherence. 
SCORE has been validated to estimate 10-year risk of cardiovascular death based on age, 
sex, total cholesterol, SBP and smoking behaviour.7,12 For all SCORE calculations, base-
line age was used. SCORE was not computed until after the last patient completed the 
study. Secondary endpoints included modifiable factors comprising the SCORE, number 
of modifiable risk factors on target (ie, SBP≤140 mm Hg, diastolic blood pressure ≤90 
mm Hg, body mass index (BMI) ≤25, waist circumference ≤94 cm for men and ≤80 cm 
for women, low-density lipoprotein (LDL) <1.8 mmol/L, total cholesterol ≤4.5 mmol/L, 
smoking cessation, no anxiety, no depression), quality of life (MacNew Questionnaire)13 
and the presence of anxiety and depression (Hospital Anxiety and Depression Scale 
(HADS)).14 Cut-off values for depression and anxiety were scores of 8 or higher on 
respective subscales of the HADS (see Appendix 8A). During each visit, weight, waist 
circumference, SBP, BMI, total cholesterol, high-density lipoprotein cholesterol, LDL cho-
lesterol and triglycerides were assessed. Clinical events were verified by an independent 
committee. All measurements were performed at baseline (start of standard CR), at 3 
months (end of standard CR) and at 18 months after randomisation.
sample size calculation 
An earlier study found a 17% reduction in SCORE for patients participating in a nurse-
coordinated intervention programme compared with patients receiving standard care.15 
Based on those data and considering that more intensive interventions were used in the 
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present study, at least a 20% reduction in SCORE at 18 months was expected for both 
CR+F and CR+T groups (decrease from 5.40 to 4.32 points, with an estimated SD of 4.5 
(superiority design)) (Cohen’s effect size d=0.24). With 274 patients in each treatment 
arm, the study had 80% power (beta=0.20) to detect this difference with a two-sided 
alpha of 0.05. In total, 914 patients were enrolled to account for a 10% expected dropout 
rate.18 In all analyses, CR+F was compared with CR-only, and CR+T was compared with 
CR-only.
statistical analysis 
Primary analysis: intention-to-treat 
All randomised patients’ data were included in the intention-to-treat (ITT) analysis. The 
continuous, non-normally distributed, SCORE risk function was reported as median and 
IQR, and groups were compared using Wilcoxon’s rank-sum test. The difference in SCORE 
risk function delta (Δ) scores between 18 months and baseline was compared between 
CR+F and CR-only and between CR+T and CR-only, using a Student’s t-test. Secondary 
continuous outcome variables were presented as mean, SD, and 95% CIs, and 18-month 
outcomes and Δ (18 months to baseline) were compared using Student’s t-tests. Nor-
mality was checked with the Kolmogorov-Smirnov tests. Categorical variables were 
compared using χ2 tests or Fisher’s exact tests where appropriate. There was no need 
to correct for multiple testing. SPSS software (V.24.0, SPSS) was used for the statistical 
analyses.
Secondary analyses: per-protocol 
Patient completion of 75% of standard CR (at least 18 training sessions) and 75% of the 
extended programmes (at least four of six group counselling sessions and at least three 
of five telephone sessions) was required to be included in the per-protocol analyses. 
The same analyses described for the ITT analyses were performed for the per-protocol 
analyses. Results from these two statistical strategies were compared.
Results
Between November 2011 and August 2014, a total of 914 patients with ACS were ran-
domised and included in the ITT analysis (CR+F: n=309; CR+T: n=299; CR-only: n=306; 
Figure 8.2). Main reasons to decline participation in this trial were transportation issues, 
motivation and lack of time. Randomly allocated treatment was completed by 60.5% of 
patients in the CR+F group, 56.8% in the CR+T group and 82.3% in the CR-only group. 
The three groups were well balanced with respect to baseline characteristics (Table 8.1). 
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The mean patient age was 57 years, and 81% were male. The pre-ACS smoking rate of 
43% had decreased to 15% by randomisation. At baseline, more than 75% of patients 
met blood pressure targets, and nearly 70% met total cholesterol targets. At that time, 
97% of patients were taking aspirin and statins, 84% beta blockers and 70% ACE inhibi-
tors. 
CR+F versus CR-only 
ITT analyses 
The median SCORE at 18 months was 3.30% (25%–75% IQR, 1.01–5.59) in the CR+F 
group and 3.47% (25%–75% IQR, 0.86– 6.28) in the CR-only group (p=0.48; Figure 8.3). 
The between-group diff erence in SCORE between baseline and 18 months was not 
signifi cant (p=0.19). Of the three modifi able SCORE parameters, only total cholesterol at 
18 months (p<0.001) and a decrease in total cholesterol at 18 months diff ered between 
groups (p=0.013; Figure 8.4). Changes to health-related quality of life (HRQL), anxiety 
and depression did not diff er between groups (Appendix 8H).
CR+F: standard CR extended with  
face-to-face group counselling 
sessions 
CR+T: standard CR extended 
with telephone counselling 
sessions 
CR+F 
Face-to-Face 
N=309 
262 completed 
standard CR 
(84.7%) 
187 completed 
CR+F 
(60.5%) 
CR+T 
Telephone 
N=299 
250 completed 
standard CR 
(83.6%) 
170 completed 
CR+T 
(56.8%) 
CR-only 
N=306 
252 completed 
CR-only 
(82.3%) 
OPTICARE trial 
N=914 
ITT 
analysis 
PP 
analysis 
1 
252 completed 
standard CR 
(82.3%) 
CR-only: standard 
CR 
Eligible 
N=3120 
Figure 8.2 CONSORT (CONsolidated Standards Of Reporting Trials) fl ow diagram
CR= cardiac rehabilitation; CR+F = standard CR extended with face-to-face group counselling sessions; CR+T= 
standard CR extended with telephone counselling sessions; CR-only= standard CR; ITT= intention-to-treat; PP= 
per-protocol.
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table 8.1 Patients characteristics by treatment group
CR+F CR+t CR-only P-values
N=309 N=299 N=306
Age (years), mean (±SD) 57.5 (±9.2) 57.1 (±9.7) 57.4 (± 9.3) 0.91
Male 245 (79.3%) 246 (82.9%) 246 (80.4%) 0.52
Therapeutic intervention at index event 0.37
   No revascularization 22 (7.1%) 29 (9.7%) 25 (8.2%)
   PCI 250 (80.9%) 224 (74.9%) 239 (78.1%)
   CABG 37 (12.0%) 46 (15.4%) 42 (13.7%)
Cardiac history
   Myocardial infarction 22 (7.1%) 31 (10.4%) 27 (8.8%) 0.37
   PCI 25 (8.1%) 29 (9.7%) 35 (11.4%) 0.32
   CABG 4 (1.3%) 2 (0.7%) 7 (2.3%) 0.23
   Angina 14 (4.5%) 18 (6.0%) 20 (6.5%) 0.54
   Stroke/TIA 12 (3.9%) 4 (1.3%) 8 (2.7%) 0.26
Risk Factors
   Diabetes 44 (14.2%) 34 (11.4%) 43 (14.1%) 0.51
   Dyslipidaemia 90 (29.1%) 100 (33.4%) 122 (39.9%) 0.018
   Family history 165 (53.4%) 148 (49.5%) 167 (54.6%) 0.43
   Current Smoking (pre-ACS) 138 (44.7%) 127 (42.9%) 129 (42.2%) 0.79
   Hypertensions 135 (43.7%) 119 (39.8%) 120 (39.2%) 0.47
   Renal Impairment* 11 (3.7%) 13 (4.2%) 6 (2.0%) 0.28
Cardiac medication
   Acetylsalicyllic acids 293 (94.8%) 291 (97.3%) 297 (97.1%) 0.19
   Thienopyridines 262 (84.8%) 244 (81.6%) 264 (86.3%) 0.27
   Statins 289 (93.5%) 282 (94.3%) 298 (97.4%) 0.07
   Beta blockers 251 (81.2%) 240 (80.3%) 257 (84.0%) 0.47
   ACE inhibitors 215 (69.6%) 203 (67.9%) 214 (69.9%) 0.84
Educationǂ 0.51
   High 70 (28.8%) 75 (32.6%) 69 (28.3%)
   Intermediate 156 (64.2%) 147 (63.9%) 163 (66.8%)
   Low 17 (7.0%) 8 (3.5%) 12 (4.9%)
Marital statusǂ 0.45
   Married/partnered 198 (81.1%) 192 (83.5%) 196 (80.3%)
   Single 17 (7.0%) 22 (9.6%) 19 (7.8%)
   Widower 9 (3.7%) 4 (1.7%) 13 (5.3%)
   Divorced 20 (8.2%) 12 (5.2%) 16 (6.6%)
Working statusǂ 0.54
   Full time 122 (50.0%) 110 (47.6% 109 (44.5%)
   Part time 29 (11.7%) 19 (8.0%) 21 (8.8%)
   Unemployed 15 (6.3%) 17 (7.5%) 14 (5.7%)
   Retired 57 (23.4%) 56 (24.5%) 74 (30.4%)
   Other 21 (8.6%) 28 (12.3%) 26 (10.6%)
ACS= acute coronary syndrome; CABG= coronary artery bypass graft; CR= cardiac rehabilitation; CR+F= CR 
extended with face-to-face counselling sessions; CR+T= CR extended with telephone counselling sessions; CR-
only=standard CR; PCI= percutaneous coronary intervention; TIA= transient ischemic attack.
*Renal impairment: eGRF<60 ml/min.
ǂEducational, marital status and working status were available in 230 (CR+F), 244 (CR+T) and 244 (CR-only) pa-
tients.
OPTICARE: cardiovascular health outcomes
171
8
Per-protocol analyses 
In the per-protocol analyses (CR+F: n=187; CR-only: n=252; Figure 8.2), the median 
SCORE results were similar to those from the ITT analyses (Figure 8.3). However, two 
of three individual SCORE parameters favoured CR+F. Current smoking increased from 
randomisation to 18 months by 2.9% in the CR+F group and 10.4% in the CR-only group 
(p<0.001). The smoking rate at 18 months was also lower in the CR+F group compared 
with the CR-only group (13.4% vs 21.3%; p<0.05; Figure 8.4). Furthermore, total choles-
terol at 18 months and Δ (18 months to baseline) favoured CR+F (both p<0.01). 
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Figure 8.3 SCORE (Sytematic COronary Risk Evaluation) risk function (median, 25th-75th percentiles and 
minimum and maximum)
CR= cardiac rehabilitation; CR+T= standard CR extended with telephone counselling sessions; CR-only= stan-
dard CR; CR+F = standard CR extended with face-to-face group counselling sessions.
In contrast to the ITT results, per-protocol analysis showed that CR+F patients had 
higher HRQL on emotional and physical subscales at 18 months compared with CR-only 
patients (emotional subscale, p=0.004; physical subscale, p=0.015;  Appendix 8H). Fur-
thermore, CR+F patients had lower anxiety scores compared with CR-only patients at 18 
months (p=0.036). However, the Δ scores (18 months to baseline) were similar between 
groups.
CR+t versus CR-only 
ITT analyses 
The median SCORE at 18 months was 3.02% (25%–75% IQR, 0.36–5.68) in the CR+T 
group and 3.47% (25%–75% IQR, 0.86–6.28) in the CR-only group (p=0.39; Figure 8.3). 
The difference in SCORE between baseline and 18 months did not differ between both 
groups (p=0.25). At 18 months, all three modifiable parameters of SCORE were similar for 
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the CR+T and CR-only groups. Anxiety, depression and HRQL did not differ at 18 months 
or from baseline to 18 months (Appendix 8I).
Per-protocol analyses 
In the per-protocol analyses (CR+T: n=170; CR-only: n=252; Figure 8.2), the median 
SCORE results were similar to those from the ITT analyses (Figure 8.3). Although smok-
ing rates increased from randomisation to 18 months for both groups, the increase was 
greater in the CR-only group compared with the CR+T group (10.4% vs 4.6%; p<0.05; 
Figure 8.4). At 18 months, the CR+T group smoking rate was lower than that of the CR-
only group (12.9% vs 21.3%; p<0.05). 
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Figure 8.4 Smoking behaviour (percentages) and total cholesterol (median, 25th-75th percentiles and mini-
mum and maximum)
CR= cardiac rehabilitation; CR+T= standard CR extended with telephone counselling sessions; CR-only= stan-
dard CR; CR+F = standard CR extended with face-to-face group counselling sessions; ns= not significant.
In contrast to the ITT analysis, per-protocol analysis showed that CR+T patients had 
higher HRQL on emotional subscales at 18 months compared with CR-only patients 
(p=0.04;  Appendix 8I). In contrast, anxiety and depression did not differ between 
groups. The Δ (18 months to baseline) scores were similar between groups.
Cardiovascular risk factors on target 
Of nine modifiable risk factors in the ITT analysis, a mean of 4.50 were on target in the 
CR+F group compared with 4.39 in the CR-only group (p=0.58), and 4.35 were on target 
in the CR+T group (p=0.82 vs CR-only). In contrast, the per-protocol analysis showed that 
OPTICARE: cardiovascular health outcomes
173
8
5.35 risk factors of the CR+F patients were on target versus only 4.78 of the CR-only pa-
tients (p=0.002) and 5.04 of the CR+T patients (p=0.18 vs CR-only). ITT analyses showed 
that, at 18 months, more patients in the CR+F versus CR-only group were on target for 
LDL cholesterol (31% vs 21%; p=0.012) and total cholesterol (77% vs 64%; p=0.002; Ap-
pendix 8B). There were no differences in the percentage of patients on target for any of 
the outcome measures between the CR+T and CR-only groups (Appendix 8C). 
Appendix 8D and 8E (ITT),  Appendix 8F and 8G (per-protocol) and Figure 8.5 show mean 
values for the measured cardiovascular risk factors at all time points.
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Figure 8.5 Systolic blood pressure and waist circumference (median, 25th-75th percentiles and minimum 
and maximum) 
CR= cardiac rehabilitation; CR+T= standard CR extended with telephone counselling sessions; CR-only= stan-
dard CR; CR+F = standard CR extended with face-to-face group counselling sessions; ns= not significant; SBP= 
systolic blood pressure.
Adverse cardiac events 
Eighteen months after randomisation, 83 rehospitalisations occurred in the CR+F group 
and 79 in the CR+T group, compared with 70 in the CR-only group (p=0.25 and p=0.44, 
respectively; Table 8.2). Two patients died from causes unrelated to the CR interventions, 
eight experienced ST-elevation myocardial infarction and 11 experienced non-ST-
elevation myocardial infarction. There were no between-group differences.
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disCussiON
Extending CR with either face-to-face group counselling or individual telephone coun-
selling did not improve SCORE risk function. Standard CR was associated with similar 
health outcomes compared with extended CR. Nevertheless, total cholesterol did im-
prove slightly when CR was extended to include group counselling sessions. Likewise, 
adherent patients who completed extended interventions were less likely to smoke after 
either novel intervention. Adherent patients in the extended group counselling arm also 
showed increased numbers of modifiable risk factors on target, decreased anxiety and 
improved HRQL.
Our hypothesis that intensified and extended CR would improve SCORE risk function 
was not supported. One possible explanation for this lack of effect may be a need for 
table 8.2 Adverse cardiac events at 18 months: intention-to-treat analysis
P-values
CR+F  
(n=309)
CR+t  
(n=299)
CR-only 
(n=306)
CR+F vs  
CR-only
CR+t vs 
CR-only
Total number of events 83 (26.8%) 79 (26.4%) 70 (22.9%) 0.25 0.44
Mortality 1 (0.3%) 1 (0.3%) 0 (0.0%) 0.56 0.56
Readmissions for ACS
   STEMI 1 (0.3%) 5 (1.7%) 2 (0.7%) 0.56 0.24
   NSTEMI 5 (1.6%) 3 (1.0%) 3 (1.0%) 0.49 0.98
   Unstable angina 4 (1.2%) 3 (1.0%) 2 (0.7%) 0.40 0.64
Other CVD admissions
   Stable angina 14 (4.5%) 13 (4.3%) 9 (3.0%) 0.65 0.64
   Chest pain 16 (5.2%) 12 (4.0%) 11 (3.6%) 0.58 0.53
   Ventricular fibrillation 6 (1.9%) 2 (0.7%) 2 (0.7%) 0.16 0.98
   Atrial Fibrillation 0 (0%) 1 (0.3%) 0 (0%) Na 0.31
   Arrhythmias 0 (0%) 1 (0.3%) 0 (0%) Na 0.31
   CVA 0 (0%) 0 (0%) 0 (0%) Na Na
Interventions
   CAG 8 (2.6%) 5 (1.7%) 7 (2.3%) 0.81 0.59
   PCI 9 (2.9%) 9 (3.0%) 12 (3.9%) 0.98 0.85
   CABG 1 (0.3%) 0 (0%) 2 (0.7%) 0.56 0.16
   Cardiac ER 18 (5.8%) 24 (8.0%) 20 (6.5%) 0.55 0.90
ACS= acute coronary syndrome; CABG= coronary artery bypass graft; CAG= coronary angiography; CR= cardiac 
rehabilitation; CR+F= CR extended with face-to-face counselling sessions; CR+T= CR extended with telephone 
counselling sessions; CR-only=standard CR; CVA= cerebrovascular accident; CVD= cardiovascular disease; ER= 
emergency room; Na= not available; NSTEMI= non-ST-elevation myocardial infarction; PCI= percutaneous coro-
nary intervention; STEMI= ST-elevation myocardial infarction.
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longer follow-up. Second, standard CR control intervention was associated with very 
low SCORE outcomes, so detecting a difference for novel interventions would be dif-
ficult. Our study power calculation was based on the RESPONSE study intervention 
effect,15 which resulted in a SCORE of 4.4% after a nurse-coordinated intervention. In 
comparison, our study showed a SCORE of 3.5% after standard CR alone. Thus, standard 
CR was already successful in achieving targeted health outcomes and no additional 
resources are needed. Patients in our standard CR group reached optimal targets for 
ACS risk factors at high rates: 75% for SBP, 64% for total cholesterol and 27% still smoked. 
These low-risk factor levels corresponded to low 18-month event rates of 3% death from 
MI and 25% non-fatal cardiovascular events. A comparable patient population in the 
RESPONSE study had a higher event rate of 31%.15 
One could hypothesise that longer lasting or more intense programmes could have 
led to better outcomes in our study. Recently, successful CR maintenance programmes 
that differed in organisation, meeting intensity and frequency, and content have been 
studied in comparable patient samples.15,17-19 However, these studies all compared their 
intervention programme to usual care, which does not usually include CR. The differ-
ence in study design explains why we failed to find a difference between control and 
experimental groups in our study. Individual risk factor outcomes were comparable 
for patients in all three study arms; thus, different CR structure does not appear to be 
related to results. A recent RCT that also compared extended behavioural CR to standard 
CR showed similar improvements in SBP, smoking cessation and total cholesterol.20
Consistent with our results, the EuroAspire study showed that blood pressure and lipid 
management have improved during recent years.21,22 In that study, however, lifestyle 
habits had deteriorated.22 Our extended programmes were designed to stimulate per-
manent adoption of a heart-healthy lifestyle in patients with ACS to improve coronary 
disease risk factors. Although extended CR was not shown to benefit SCORE results, fu-
ture research should focus on potential impact of such programmes on healthy lifestyle 
components such as physical activity and fitness. Adoption of a healthy lifestyle remains 
important because of its direct effect on cardiovascular mortality and several chronic 
diseases. We will focus on those factors in forthcoming research. 
Psychosocial parameters such as HRQL, anxiety and depression are additional important 
outcome parameters. The CR goal in patients with ACS to improve emotional health 
may be reached through extended interventions that provide additional emotional 
support.17 Indeed, per-protocol analysis showed lower anxiety scores for patients in 
the CR+F group compared with the CR-only group and quality of life improvement in 
the CR+F group compared with the CR-only group. However, these differences seem to 
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result mainly from baseline differences. Patients with higher anxiety scores and lower 
HRQL were more likely to drop out during the extended programme and not be included 
in the per-protocol analysis. Future studies should focus on developing programmes to 
support this group. 
Our results suggest that no additional resources are needed because standard CR is al-
ready successful in helping patients achieve target health outcomes. Because referral for 
CR is very low worldwide,23 and our results show a high dropout rate, it seems important 
that future studies focus on finding interventions that appeal to CR non-attenders and 
determine actual reasons for non-referral prospectively. Because our study showed that 
adherence was already low for an intervention consisting of only a few telephone calls, 
creating more appealing interventions may be challenging.
limitations
Adherence with extended programmes was very low in our study. We anticipated a 
premature dropout rate of 10%; however, 15%–20% of patients quit standard CR, and 
an additional 25% did not complete extended counselling. This high dropout rate may 
have resulted in bias. Because intervention effects were most pronounced for patients 
completing 75% or more of the additional sessions, our results are probably valid mainly 
for more adherent patients. There may be an additional bias from patients’ willingness to 
participate in this trial, which is a general issue found in RCTs. Our study mainly enrolled 
young patients with relatively few risk factors. Future studies should focus on older 
patients with more complicated health status. 
The SCORE risk function was originally developed for primary prevention.7 Because of 
the lack of a validated risk function assessment for secondary prevention, we selected 
the SCORE risk function for 10-year cardiovascular risk as the primary outcome for our 
secondary prevention trial. The SCORE risk function has been used to quantify the ef-
fectiveness of secondary prevention in two previous CR RCTs.15,24 Although the absolute 
SCORE function estimates are inaccurate for secondary prevention, the SCORE differ-
ence between groups provides an estimate of the relative overall impact of a risk factor 
intervention.
CONClusiONs
Extending CR with extra behavioural counselling sessions, either face-to-face in groups 
or individual telephone counselling, did not confer additional benefit with respect to 
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SCORE. Patients largely reached target levels of modifiable risk factors following stan-
dard CR, with few hospital readmissions.
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APPeNdixes
Appendix 8A
Detailed methods
Exclusion criteria
Patient’s ≥ 18 years with a recent acute coronary syndrome (ACS) and proficient in the Dutch language 
were eligible for the study. Exclusion criteria were heart failure and/or impaired left ventricular function (left 
ventricular ejection fraction <40 %), angina NYHA Class II–IV, psychological or cognitive impairments which 
may limit cardiac rehabilitation, congenital heart disease, chronic obstructive pulmonary disease Gold clas-
sification ≥II, diabetes with organ damage, locomotive disorders that will preclude participation in an exercise 
training program, implantable cardio-defibrillator (ICD), renal failure needing follow-up by a nephrologist and 
intermittent claudication impairing cardiac rehabilitation (CR) exercises.
Allocated treatment
1) Standard CR (CR-only; Figure 8.1) Standard care consisted of CR according to the Dutch and European 
Society of Cardiology (ESC) guidelines.10-11 This was a group exercise program with training sessions of 1.5 
hours offered 2 times a week for 12 weeks under supervision of a physiotherapist. The training sessions 
were performed in groups of circa 15-20 patients and consisted of strength exercises, an aerobic program 
(running/brisk walking, aiming for an intensity of 13 points at the BORG scale) and relaxation. In addition, 
participation in multifactor lifestyle and cardiovascular risk factor group education sessions was offered 
to all patients, and comprised: information on cardiovascular risk factors, medical information, dietary 
advice, and advice on coping with emotions. If indicated, there was an option to participate in a smoking 
cessation program, nutritional counseling sessions, stress management sessions or an individually based 
psychological program. Only the training program was strictly obligatory; the counseling and group 
sessions were attended upon motivation of each patient.
2) Standard CR extended with group counseling sessions (CR+F; Figure 8.1). During the 12-week period 
of standard CR (as described above), three extra face-to-face (F) physical activity group counseling 
sessions were organized. These 75 minute sessions with 6-8 patients were under supervision of a phys-
iotherapist and aimed at regular physical activities of moderate intensity for 30 min at least 5 days a 
week. In addition, at 4, 6 and 12 months after the start of the program the patients were again required 
to participate in face-to-face multifactor lifestyle and cardiovascular risk factor group sessions of 2 hours 
each, comprising a 1-hour exercise program (comparable to the exercise program described for standard 
CR) and a 1-hour counseling session in which long-term maintenance of healthy lifestyle behavior (e.g. 
healthy diet, smoking cessation, physical activity) and psychosocial problems were discussed. These 
group sessions were led alternating by a physiotherapist, social worker, dietician, nurse and physician 
trained in motivational interviewing. All additional group sessions were performed in small groups of 6-8 
patients and were based on self-regulation techniques (e.g. goal-setting, self-monitoring, and develop-
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ing plans for relapse) that were proven successful to change lifestyle.5,6 Finally, in patients randomized 
to CR+F the cholesterol and blood pressure levels were monitored and medication was adjusted when 
needed. The target level was: LDL ≤1.8 mmol/l and systolic blood pressure <140 mmHg.
3) Standard CR extended with telephone counseling sessions (CR+t; Figure 8.1). The third strategy was 
based on The COACH Program© that demonstrated favorable effects in Australia.25 In the CR+T arm of 
the trial, standard CR (as described above) was extended with 5-6 telephone coaching sessions with an 
interval of 5–6 weeks during the first months after completion of standard CR. In line with the group 
sessions, the telephone coaching sessions were also based on successful self-regulation techniques, such 
as goal setting and relapse prevention.5,6 Patients were stimulated to develop a personal action plan in 
which they defined and self-monitored their lifestyle (e.g. smoking cessation, healthy diet, and active 
lifestyle) and coronary risk factor (e.g. blood pressure, cholesterol, BMI) targets, acted upon, measured 
again, etc. The coaching program was terminated when patient and coach felt that personal goals were 
met, with a maximum of 6 phone calls. The personal coaching was offered by the Medical Service Center 
of the health insurance company “Zilveren Kruis”, which consisted of specialized nurses, trained in the 
motivational interviewing technique.26
Definition cardiovascular events
ACS was defined as persistent (>20 min) chest pain suggestive of myocardial ischemia, which is unre-
sponsive to nitroglycerin and which was accompanied by ST-T changes (electrocardiographic evidence) 
and/or cardiac troponin elevations (biochemical evidence), regardless of in-hospital treatment. Myo-
cardial infarction (MI) was diagnosed by elevated creatine kinease-MB greater and elevated troponin. 
(N)STEMI was defined (no) ST-elevation myocardial infarction. Unstable angina was defined as NSTEMI 
without elevated troponin. Cerebrovascular accident (CVA) was defined as a focal, central neurological 
deficit lasting >72 hours which resulted in irreversible brain damage or body impairment. Repeat re-
vascularization was defined as any repeat percutaneous coronary intervention (PCI) or coronary artery 
bypass graft (CABG). Stable angina was diagnosed as short-lasting (5-10 minutes) chest discomfort 
provoked by exercise and released by rest or nitroglycerine. Chest pain was defined as chest discomfort 
with non-angina characteristics. Ventricular Fibrillation (VF) was diagnosed as disorganized electrical 
activity in the ventricles. Atrial Fibrillation (AF) was diagnosed as disorganized electrical activity in the 
atria. Arrhythmias was diagnosed as any electrical disturbance other than VF/AF. 
Study parameters
Assessments were made at Capri rehabilitation center at baseline (i.e. prior to CR), at the end of standard 
CR (at 12 weeks), and at 18 months (Figure 8.1). During the assessment patients underwent extensive 
cardiac and psychological examination. 
The following demographic parameters were collected: sex, age and smoking status before the index 
event. Collected clinical variables included diabetes, hypertension, dyslipidemia, renal impairment 
(eGFR), cardiovascular history, BMI, waist circumference, cardiac medication. Blood pressure was mea-
sured by using a validated sphygmomanometer. Blood samples were analyzed by the local laboratories 
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for total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides and creatinine clearance. Smoking 
status was determined during an interview and by measuring the concentration of carbon monoxide in 
breath using a breath analyzer (piCO Smokelyzer). Educational level was measured with a questionnaire 
at baseline. Educational level was divided into low, intermediate and high. Low educational level was 
considered when the patient’s highest achieved education level was primary school. Intermediate level 
was considered when the highest level was secondary school or secondary vocational. High educational 
level was considered when patients completed a higher professional education or university. 
The MacNew Heart Disease Health-related Quality of Life (HRQL) instrument
The MacNew Heart Disease HRQL questionnaire [MacNew] is a self-administered modification of the 
original HRQL instrument.13 The MacNew consists of 27 items which fall into three domains (a physical 
limitations domain scale, an emotional function domain scale, and a social function domain scale). The 
time frame for the MacNew is the previous two weeks. The maximum possible score in any domain is 7 
(high HRQL) and the minimum is 1 (poor HRQL). With an internal consistency and intraclass correlation 
coefficients ≥0.73, reliability was high.
Anxiety and depression
The Dutch version of the HADS was completed by patients at baseline. The HADS has a subscale for 
depression (HADS-D) and a subscale for anxiety (HADS-A). Each subscale consists of seven items (score 
range: 0–3). Levels of depression and anxiety were considered clinically relevant at a cut-off score of 8 
on each subscale.14 The Dutch HADS has been proven to be a valid and reliable instrument to detect 
symptoms of anxiety and depression.14
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Appendix 8B Cardiovascular risk factors on target. CR+F vs CR-only pre CR (T0), post-CR (T1) and at 18 
months (T2)
Baseline (t0) 3 months (t1) 18 months (t2) P-values
CR+F CR-only CR+F CR-only CR+F CR-only CR+F vs CR-only
n=309 n=306 n=251 n=235 n=257 n=252 t0 t1 t2
Systolic blood pressure ≤ 140 mmHg, % 77 76 86 86 75 75 0.60 0.92 0.86
Diastolic blood pressure ≤ 90 mmHg, % 89 92 95 94 91 93 0.28 0.56 0.54
Body mass index ≤ 25kg/m2, % 23 24 23 22 22 24 0.76 0.93 0.55
Waist circumference,  
  men ≤ 102cm, females ≤ 88 cm, %
46 46 56 55 52 44 0.96 0.81 0.15
LDL cholesterol ≤ 1.8 mmol/L, % 27 26 31 26 31 21 0.87 0.23 0.012
Total cholesterol ≤4.5 mmol/L, % 70 67 81 68 77 64 0.45 0.002 0.002
HDL cholesterol ≥1.0 mmol/L, % 60 58 66 57 69 67 0.67 0.05 0.71
Triglyceride, mmol/L ≤ 1.7, % 68 64 75 64 72 67 0.30 0.019 0.19
Current smoking, % 17.1 14.0 25.2 27.1 26.9 27.5 0.29 0.60 0.87
Data are percentages; p-values are Chi-squared tests. 
CR+F= CR extended with face-to-face counselling sessions; CR-only= standard CR.
Appendix 8C Cardiovascular risk factors on target. CR+T vs CR-only pre CR (T0), post-CR (T1) and at 18 
months (T2)
Baseline (t0) 3 months (t1) 18 months (t2) P-values
CR+t CR-only CR+t CR-only CR+t CR-only CR+t vs CR-only
n=299 n=306 n=249 n=235 n=248 n=252 t0 t1 t2
Systolic blood pressure ≤ 140 mmHg, % 78 76 90 86 74 75 0.38 0.22 0.76
Diastolic blood pressure ≤ 90 mmHg, % 92 92 95 94 90 93 0.92 0.58 0.31
Body mass index ≤25 kg/m2, % 26 24 27 22 23 24 0.64 0.26 0.67
Waist circumference,
men ≤ 102cm, females ≤ 88 cm, % 49 46 54 55 45 44 0.58 0.81 0.92
LDL cholesterol ≤1.8 mmol/L, % 25 26 27 26 24 21 0.79 0.71 0.50
Total cholesterol ≤4.5 mmol/L, % 68 67 66 68 69 64 0.78 0.74 0.27
HDL cholesterol ≥1.0 mmol/L, % 65 58 65 57 70 67 0.10 0.06 0.47
Triglyceride, mmol/L ≤1.7, % 66 64 67 64 71 67 0.59 0.55 0.37
Current smoking, % 14.7 14.0 21.1 27.1 25.8 27.5 0.81 0.08 0.51
Data are percentages; p-values are Chi-squared tests. 
CR+T= CR extended with telephone counselling sessions; CR-only= standard CR.
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Appendix 8d Cardiovascular risk factors. CR+F vs CR-only pre CR (T0), post-CR (T1) and at 18 months (T2): 
Intention-to-treat analysis
Baseline (t0) 3 months (t1) 18 months (t2) P-values
CR+F CR-only CR+F CR-only CR+F CR-only CR+F vs CR-only
n=309 n=306 n=251 n=235 n=257 n=252 t0-t1 t0-t2
Systolic blood pressure, mmHg 
(SD)
131.0 (19.7) 130.6 (18.9) 126.0 126.5 132.8 133.1 0.93 0.79
Diastolic blood pressure, mmHg 
(SD) 
80.1 (10.5)
78.8 (10.6) 76.6 80.7 79.0 79.4 0.12 0.22
Weight, kg (SD) 86.4 (15.1) 86.7 (14.9) 86.3 85.9 87.1 87.0 0.09 0.39
Body mass index, kg/m2 (SD) 28.0 (4.0) 28.0 (3.9) 28.0 27.8 28.2 28.1 0.11 0.48
Waist circumference, cm (SD) 101.2 (11.8) 101.9 (10.8) 99.8 99.7 102.6 102.6 0.14 0.27
Total cholesterol, mmol/L (SD) 4.2 (0.9) 4.2 (1.0) 4.0 4.2 4.1 4.3 0.002 0.013
HDL cholesterol, mmol/L (SD) 1.1 (0.3) 1.1 (0.3) 1.1 1.1 1.2 1.2 0.40 0.93
LDL cholesterol, mmol/L (SD) 2.4 (0.8) 2.4 (0.8) 2.3 2.5 2.3 2.5 0.001 0.009
Triglyceride, mmol/L (SD) 1.7 (1.3) 1.7 (1.0) 1.5 1.6 1.5 1.7 0.59 0.21
Current smoking (%) 17.1 14.0 25.2 27.1 26.9 27.5 <0.001 0.34
Data are mean (SD) or percentages; p-values are Student’s t-tests or Chi-squared tests. 
CR+F= CR extended with face-to-face counselling sessions; CR-only= standard CR.
Appendix 8e Cardiovascular risk factors. CR+T vs CR-only pre CR (T0), post-CR (T1) and at 18 months (T2): 
Intention-to-treat analysis
Baseline (t0) 3 months (t1) 18 months (t2) P-values
CR+t CR-only CR+t CR-only CR+t CR-only CR+t vs CR-only
n=299 n=306 n=249 n=235 n=248 n=252 t0-t1 t0-t2
Systolic blood pressure, mmHg (SD) 129.6 (19.6) 130.6 (18.9) 125.2 126.5 133.3 133.1 0.52 0.18
Diastolic blood pressure, mmHg 
(SD) 
78.7 (10.6) 78.8 (10.6) 79.9 80.7 80.1 79.4 0.54 0.28
Weight, kg (SD) 86.9 (15.2) 86.7 (14.9) 86.5 85.9 87.2 87.0 0.29 0.93
Body mass index, kg/m2 (SD) 27.9 (4.2) 28.0 (3.9) 27.8 27.8 28.0 28.1 0.24 0.90
Waist circumference, cm (SD) 101.4 (11.3) 101.9 (10.8) 100.0 99.7 102.5 102.6 0.12 0.57
Total cholesterol, mmol/L (SD) 4.2 (0.9) 4.2 (1.0) 4.2 4.2 4.3 4.3 0.57 0.29
HDL cholesterol, mmol/L (SD) 1.2 (0.3) 1.1 (0.3) 1.2 1.1 1.3 1.2 0.22 0.91
LDL cholesterol, mmol/L (SD) 2.4 (0.8) 2.4 (0.8) 2.5 2.5 2.4 2.5 0.86 0.29
Triglyceride, mmol/L (SD) 1.6 (1.0) 1.7 (1.0) 1.7 1.6 1.7 1.7 0.04 0.25
Current smoking (%) 14.7 14.0 21.1 27.1 25.8 27.5 <0.001 0.31
Data are mean (SD) or percentages; p-values are Student’s t-tests or Chi-squared tests. 
CR+T= CR extended with telephone counselling sessions; CR-only= standard CR.
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Appendix 8F Cardiovascular risk factors. CR+F vs CR-only pre CR (T0), post-CR (T1) and at 18 months (T2): 
Per-protocol analysis
Baseline (t0) 3 months (t1) 18 months (t2) P-values
CR+F CR-only CR+F CR-only CR+F CR-only CR+F vs CR-only
n=187 n=252 n=176 n=234 n=176 n=226 t0-t1 t0-t2
Systolic blood pressure, mm Hg 
(SD)
131.2 (20.4) 132.0 (18.9) 125.7 126.6 132.4 133.9 0.88 0.88
Diastolic blood pressure, mm Hg 
(SD) 
80.4 (10.7) 79.1 (12.0) 76.8 77.1 78.9 79.6 0.09 0.22
Weight, kg (SD) 86.0 (14.9) 86.8 (15.2) 86.0 86.0 86.1 87.1 0.12 0.93
Body mass index, kg/m2 (SD) 27.7 (3.9) 28.0 (3.9) 27.8 27.7 27.8 28.1 0.12 0.98
Waist circumference, cm (SD) 100.5 (11.8) 101.8 (10.8) 98.7 99.7 100.9 101.7 0.27 0.37
Total cholesterol, mmol/L (SD) 4.0 (0.8) 4.2 (1.0) 3.9 4.2 3.9 4.3 0.007 0.009
HDL cholesterol, mmol/L (SD) 1.2 (0.3) 1.1 (0.3) 1.2 1.1 1.2 1.2 0.68 0.96
LDL cholesterol, mmol/L (SD) 2.3 (0.7) 2.4 (0.8) 2.2 2.4 2.2 2.5 0.002 0.001
Triglyceride, mmol/L (SD) 1.6 (1.5) 1.7 (1.0) 1.4 1.6 1.4 1.6 0.49 0.36
Current smoking (%) 10.5 10.9 14.4 19.8 13.4 21.3 <0.001 <0.001
Data are mean (SD) or percentages; p-values are Student’s t-tests or Chi-squared tests. 
CR+F= CR extended with face-to-face counselling sessions; CR-only= standard CR.
Appendix 8g Cardiovascular risk factors. CR+T vs CR-only pre CR (T0), post-CR (T1) and at 18 months (T2): 
Per-protocol analysis
Baseline (t0) 3 months (t1) 18 months (t2) P-values
CR+t CR-only CR+t CR-only CR+t CR-only CR+t vs CR-only
n=170 n=252 n=168 n=234 n=153 n=226 t0-t1 t0-t2
Systolic blood pressure, mm Hg (SD) 129.5 (0.5) 132.0 (18.9) 124.3 126.6 132.9 133.9 0.87 0.21
Diastolic blood pressure, mm Hg 
(SD)
78.5 (10.6) 79.1 (10.2) 76.5 77.1 79.2 79.6 0.92 0.54
Weight, kg (SD) 86.8 (13.8) 86.8 (15.2) 86.2 86.0 86.5 87.1 0.53 0.55
Body mass index, kg/m2 (SD) 27.7 (3.7) 28.0 (3.9) 27.6 27.7 27.6 28.1 0.47 0.55
Waist circumference, cm (SD) 101.1 (10.3) 101.8 (10.8) 99.5 99.7 101.9 101.7 0.39 0.63
Total cholesterol, mmol/L (SD) 4.1 (0.9) 4.2 (1.0) 4.1 4.2 4.2 4.3 0.97 0.55
HDL cholesterol, mmol/L (SD) 1.2 (0.3) 1.1 (0.3) 1.2 1.1 1.3 1.2 0.43 0.31
LDL cholesterol, mmol/L (SD) 2.3 (0.7) 2.4 (0.8) 2.5 2.4 2.4 2.5 0.83 0.29
Triglyceride, mmol/L (SD) 1.5 (0.9) 1.7 (1.0) 1.6 1.6 1.4 1.6 0.026 0.75
Current smoking (%) 8.3 10.9 10.6 19.8 12.9 21.3 <0.001 0.031
Data are mean (SD) or percentages; p-values are Student’s t-tests or Chi-squared tests. 
CR+T= CR extended with telephone counselling sessions; CR-only= standard CR.
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ABstRACt
Purpose: To investigate secondary effects of two novel behavioral lifestyle inter-
ventions integrated into cardiac rehabilitation on aerobic capacity, fatigue, and 
participation in society and to explore mediating effects of physical activity and 
sedentary behavior.
methods: In the OPTICARE trial, 914 patients with acute coronary syndrome (ACS) 
were randomized to 1) 3 months of standard cardiac rehabilitation (CR-only); 2) 
CR-only with additional face-to-face physical activity group counseling sessions 
plus 9 months of after-care with general lifestyle group counseling (CR+F); or 3) 
CR-only plus 9 months of after-care with individual, general lifestyle telephone 
counseling sessions (CR+T). Aerobic capacity (6-minute walk test), fatigue (Fa-
tigue Severity Scale), and participation in society (Utrecht Scale for Evaluation 
of Rehabilitation-Participation) were measured at randomization, 3 months, 12 
months, and 18 months.
Results: Generalized estimating equation analysis revealed favorable interven-
tion effects for CR+F (compared to CR-only) in aerobic capacity up to 12 months 
(B= 12.49 m; 95% confidence interval [CI], 0.53 to 24.46; P= .041) and in preva-
lence of fatigue until at least 18 months (odds ratio [OR]= 0.47; 95% CI =0.26 to 
0.84; P= .010). No additional improvements were seen for participation in society. 
No intervention effects were found for CR+T. Exploratory analysis showed that 
improvements in aerobic capacity in CR+F were mediated by improvements in 
physical activity. No mediating effects were found for improvements in fatigue. 
Conclusions: Extending cardiac rehabilitation with a face-to-face behavioral 
group intervention was successful in sustaining aerobic capacity gains for up to 
12 months and for reaching long-term goals for improvements in fatigue. The 
benefits in aerobic capacity seem to be mediated by improvements in daily 
physical activity. A telephonic behavioral intervention provided no additional 
benefits.
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iNtROduCtiON
Cardiac rehabilitation (CR) programs focus on the adoption of a healthy lifestyle and 
optimization of cardiovascular risk factors.1-3 CR is an essential component of treatment 
for patients with acute coronary syndrome (ACS), as it decreases the risks of death and 
re-hospitalization.4,5 Other important gauges of CR success are improvements in aerobic 
capacity, fatigue, and participation in society. To date, CR results for these outcomes 
have been suboptimal.6,7 Although aerobic capacity has been shown to increase during 
CR7,8, these gains decline after program completion.7,9 Maintenance of improvements 
is important because aerobic capacity is related to re-hospitalization and mortality.10,11 
Fatigue and participation in society also improve during CR6,7, but perceived levels of 
fatigue and restrictions and dissatisfaction with participation in society remain high 
after CR completion.6,7 Further improvements to fatigue and participation in society are 
important, as both outcomes affect quality of life.6,12 
In the OPTICARE randomized controlled trial (RCT), two novel CR interventions based on 
behavioral techniques (one offered face-to-face in groups and one offered individually 
by phone) were evaluated in patients with ACS.13 The primary aim of these interven-
tions was to further improve cardiovascular health and physical activity.13 Although the 
novel interventions did not lead to additional improvements in cardiovascular health14, 
additional improvements in physical activity were observed.15 Because the novel 
interventions addressed a wide range of health behaviors and psychosocial problems, 
the interventions may more broadly affect aerobic capacity, fatigue, and participation 
in society. Previous studies have shown that behavioral lifestyle interventions can lead 
to improvements in these outcomes.16-18 In addition to direct effects of the novel in-
terventions, improvements may be mediated by improvements in physical activity and 
sedentary behavior. Previous studies show that physical activity and sedentary behavior 
are independently associated with aerobic capacity19,20 and that they can influence 
fatigue.21 With respect to participation in society, patients undergoing CR have reported 
being most dissatisfied with participation in exercise, outdoor activities, and domestic 
activities.6 Because the novel interventions aimed to increase daily physical activity, 
improvements could also lead to improved participation in society.
The objective of the current study was to evaluate the effects of the two novel behav-
ioral lifestyle interventions in comparison to standard CR on the secondary outcomes 
aerobic capacity, fatigue, and participation in society. Additionally, in case significant 
intervention effects were found, we explored whether these effects were mediated by 
changes in physical activity and sedentary behavior. 
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study design  
This study is part of the OPTICARE randomized controlled trial. The study, which has 
been described in detail previously,13 was prospectively registered at ClinicalTrials.gov: 
NCT01395095.
setting and participants
Patients referred for CR were invited to participate in the OPTICARE trial. Inclusion crite-
ria were ACS diagnosis, age greater than 18 years, and Dutch language proficiency. The 
exclusion criterion was the presence of severe physical or cognitive impairment that 
could limit CR participation.13 The Medical Ethics Committee of the Erasmus Medical 
Centre in Rotterdam, the Netherlands approved this study (MEC-2010-391). All patients 
provided written informed consent.
Randomization and intervention 
Randomization was performed using sealed envelopes that had been prepared by an 
independent statistician using randomly generated numbers. Patients were randomized 
to CR-only or to one of the two novel interventions: CR+F or CR+T (Figure 9.1).
CR-only
CR+F
Face-to-Face
CR+T
Telephone
standard CR
3 group sessions 
including exercise program and 
lifestyle counseling
5-6 individual telephonic lifestyle 
counseling sessions
standard CR
3 physical activity 
counseling 
sessions
standard CR
follow-up
T0 initial phase       T3m                      after-care T12m         follow-up T18m
follow-up
follow-up
Figure 9.1 Treatment allocation and measurement time points 
CR-only= standard cardiac rehabilitation; CR+F= cardiac rehabilitation plus face-to-face group counseling; 
CR+T= cardiac rehabilitation plus individual telephonic counseling; m= months.
1) CR-only: Standard CR1,2 lasted 3 months. In this period, patients completed two 75-
min exercise sessions per week that consisted of strengthening exercises, brisk walk-
ing or jogging, and relaxation exercises. Additionally, patients could participated in a 
three-session educational program about a heart-healthy diet, coping with emotions, 
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and cardiovascular risk factors. Based on motivation and indication, patients could also 
participate in group counseling sessions addressing stress management, healthy diet, or 
smoking cessation. If clinically indicated, patients were referred to a dietician, psychia-
trist, psychologist, or social worker for individual treatment. At the end of the 3-month 
CR program (initial phase), no after-care was offered.
2) CR+F: During the initial phase, patients participated in the standard 3-month CR pro-
gram plus three 75-minute counseling sessions designed to increase physical activity 
level. All sessions were conducted face-to-face in small groups of four to eight patients. 
During the sessions, patients were coached by a physical therapist trained in motiva-
tional interviewing.22 The content of this intervention was based on evidence-based 
behavioral change techniques: information about health behavior, self-monitoring, goal 
setting, feedback, barrier identification, and relapse prevention.23,24 Pedometers (Yamax 
Digiwalker SW-200; Yamax, Inc., Tokyo, Japan) were used to provide the patients with 
continuous objective feedback about daily physical activity level. During these sessions, 
information was also provided about the benefits of frequently interrupting sedentary 
time.
After the initial 3-month CR program, a 9-month after-care program was offered. This 
program consisted of three 2-hour group sessions with four to eight patients. Each ses-
sion comprised 1 hour of exercise and 1 hour of healthy lifestyle counseling. The exercise 
sessions, which were similar to those offered during CR, served to help patients self-
monitor aerobic capacity and stimulate interaction between patients in the group. The 
counseling sessions focused on permanent adoption of a healthy lifestyle (ie, healthy 
diet and optimal physical activity), but also on psychosocial problems. During these 
sessions, patients were coached alternatingly by a dietician, social worker, and physical 
therapist, all of whom were trained in motivational interviewing.
3) CR+T: This intervention was based on the existing Coaching Patients on Achieving 
Cardiovascular Health (COACH) program.25 During the initial phase, patients participated 
only in standard CR. After the initial phase, patients participated in a 9-month individual 
after-care program comprised of five to six telephone coaching sessions. The coaching 
was performed by specialized nurses who were trained in motivational interviewing.22 
During the coaching sessions, patients were encouraged to self-monitor their coronary 
risk factors (eg, weight, blood pressure, or cholesterol) and make an action plan. Addi-
tionally, patients developed a personal plan for permanent adoption of a heart-healthy 
lifestyle (ie, healthy diet and sufficient physical activity). Progress was discussed during 
each session.  
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Outcomes
Functional aerobic capacity
The 6-minute walk test (6MWT) was performed according to American Thoracic Society 
guidelines.26 Patients were asked to walk back and forth along a 30-meter corridor, 
covering as many meters as they could during 6 minutes without running. Standard-
ized encouragement was given every minute, and the distance walked was recorded in 
meters. The 6MWT has been found to be a suitable outcome measure for evaluating the 
effects of CR on (functional) aerobic capacity.27 The 6MWT was performed at the start of 
the second CR exercise session to avoid a possible learning effect27 and to accommodate 
patients who may fear exercise. During the first exercise session, patients were familiar-
ized with a walking protocol.
Fatigue 
Fatigue was measured using the 9-item Fatigue Severity Scale (FSS).28-30 The outcome is 
a continuous score between 0 and 7, with higher scores indicating more severe fatigue. 
Fatigue prevalence was calculated in addition to the FSS score.7,30,31 Being fatigued was 
defined as a score of one standard deviation above the mean score for healthy persons 
(score higher than 4) and being severe fatigued as a score of two standard deviations 
above the mean score for healthy persons (score higher than 5.2).30 
Participation in society 
Participation in society was assessed using the Utrecht Scale for Evaluation of Rehabilita-
tion-Participation (USER-P),32 a 32-item questionnaire that addresses three subdomains 
of participation: frequency, perceived restrictions, and satisfaction. Questions within 
these subdomains concern domestic, occupational, and recreational activities. For each 
subdomain, a separate score from 0 to 100 was calculated, with higher scores indicating 
better participation. 
Potential mediating factors
Physical activity and sedentary behavior were measured using a tri-axial accelerometer 
(ActiGraph GT3x, Actigraph, Pensacola, FL, USA). Patients were asked to wear the acceler-
ometer for 8 consecutive days, except while sleeping and during bathing. Actigraph data 
were sampled at 30 Hz. The ActiGraph captures accelerations on three axes and converts 
this into activity counts that reflect the intensity of performed activities. Using Actilife 
Software (Actigraph, Pensacola, FL, USA), activity counts were summed over 15-second 
sampling epochs (time intervals) after subtracting non-wear time. Non-wear intervals 
were deﬁned as at least 60 min of consecutive zero counts. A valid day was defined 
as a wear time of at least 11 hours, and measurements were included in the analysis 
OPTICARE: secondary outcomes
195
9
only when the accelerometer was worn for at least 4 valid days. Using Matlab version 
R2011 (MathWorks, Natick, MA, USA), the vector magnitude of the three axes (x2 + y2 + 
z2) was calculated for valid measurements and used to calculate time in moderate-to-
vigorous-intensity physical activity (MVPA) and sedentary time. MVPA time was defined 
as time spent in activities with at least 672.5 counts per 15-second epoch (on the vector 
magnitude).33 Sedentary time was defined as time spent in activities with 37.5 or fewer 
counts per 15-second epoch.34 Steps per day were also captured by the accelerometer. 
To correct for differences in accelerometer wear time between patients, MVPA time and 
sedentary time were expressed as percentages of wear time and the number of steps as 
mean steps per minute of wear time.  
measurement occasions
All outcomes and mediating factors were measured at randomization (T0); at comple-
tion of standard CR (3 months after randomization [T3m]); at completion of after-care 
(12 months after randomization [T12m]); and 6 months after completion of after-care 
(18 months after randomization [T18m]) (Figure 9.1).
data analysis
Patients were only included in the data analysis if at least one measurement after 
baseline was available. We compared baseline characteristics of patients included and 
excluded from analysis using Student’s T-tests and chi-squared tests, to explore unin-
tentional bias.
Scores on the subdomain experienced restrictions in participation in society showed 
severe negative skewness. Therefore, dichotomized scores (no restrictions experienced 
or restrictions experienced) were used in the analysis. Data for other measures were 
normally distributed. 
Generalized estimating equations (GEEs) with exchangeable correlation structures were 
performed to determine intervention effects of the two novel interventions compared 
to CR-only. First, separate overall models were created for each outcome (aerobic capac-
ity, fatigue and participation in society); group allocation was included as a categorical 
predictor and baseline values for outcome measures were used as covariates to correct 
for baseline differences between subjects. Second, time-dependent models were cre-
ated by adding the variable time (measurement occasions) and an interaction variable 
of group allocation x time. By changing the order of the time variable, between-group 
differences (intervention effects) could be calculated for T3m, T12m, and T18m. In all 
models, CR-only served as a reference group, and age and gender were added as con-
founders. The regression coefficient B represented between-group differences over all 
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measurements for the overall model. In the time-dependent models, B represented the 
between-group difference at different time points. For dichotomous variables, between-
group differences are presented as odds ratios (OR). 
In case of missing baseline data, values were imputed five times (multiple imputations), 
using baseline characteristics and all available follow-up outcomes of the particular 
outcome as predictors. Because GEE models correct for missing data, other time points 
(endpoints) did not require data imputation.35 The GEEs were performed using the 
original dataset and all five datasets containing imputed baseline values. Pooled results 
are reported. 
In case significant intervention effects were found for any of the novel interventions 
compared to CR-only, additional analyses were performed to explore the mediating 
effects of MVPA time, sedentary time, and daily step count. Mediation was expressed as 
the percentage change in the intervention effect (regression coefficient, B) after adding 
the potential mediator to the overall model. We considered mediating effects to be clini-
cally relevant when the percentage change was 10% or higher.
We considered a P value smaller than .05 to be statistically significant. SPSS version 21.0 
(IBM Corp, Armonk, NY, USA) was used for all analyses.
Results
Participants
In total, 914 patients with ACS were enrolled between November 2011 and August 2014, 
of whom 141 patients quit CR prematurely due to reasons unrelated to the study. An 
additional 33 patients dropped out of the study before the second measurement due 
to logistic reasons or lack of motivation (Figure 9.2). The remaining 740 patients were 
included in the analysis. The mean patient age was 57 years and 81% were male (Table 
9.1). The excluded patients were, on average, two years younger (P = .017) and more 
likely to have a history of smoking (58% vs 40%, P < .001). Physical activity and sedentary 
behavior (potential mediating factors) were measured in a subsample consisting of 589 
of the 740 patients (80%) included in the analysis 
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table 9.1 Participant baseline characteristics (n = 740) 
Characteristic
CR+F
(n = 251)
CR+t
(n = 245)
CR-only
(n = 244)
Male, % 80.5 82.4 80.3
Age, mean (SD) 57.5 (8.8) 56.7 (9.2) 57.5 (9.2)
Therapeutic intervention at index event, %
    No revascularization 6.8 9.8 7.4
    Percutaneous coronary intervention 80.1 73.5 79.1
    Coronary artery bypass graft 13.1 16.7 13.5
Risk factors, %
    Diabetes 13.5 9.8 14.3
    Dyslipidemia 27.9 35.5 41.4
    Family history 53.4 52.2 55.7
    Smoking history 43.4 38.8 36.5
    Hypertension 43.4 39.2 40.2
    Overweight 77.6 75.9 76.6
Partnered, %a 80.5 84.0 83.4
Employed, %b 64.7 60.5 56.0
CR+F= cardiac rehabilitation plus face-to-face group counseling; CR+T= cardiac rehabilitation plus individual 
telephonic counseling; CR-only= standard cardiac rehabilitation.
a Data missing for n = 41 (CR+F), n = 45 (CR+T), and n = 39 (CR-only). 
b Data missing for n = 61 (CR+F), n = 60 (CR+T), and n = 53 (CR-only).
      
 
 
Included in analysis (n = 251)  
 
 
 
 
Lost to follow-up (n = 58) 
Prematurely quit CR (n = 40) 
Dropped out before T3m (n = 18) 
Lack of motivation (n = 5), lack of 
time (n = 2), medical complications 
(n = 1), unknown (n = 10) 
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Lost to follow-up (n = 54) 
Prematurely quit CR (n = 44) 
Dropped out before T3m (n = 10) 
Lack of motivation (n = 1), lack of 
time (n = 1), unknown (n = 8) 
 
Lost to follow-up (n = 62) 
Prematurely quit CR (n = 57) 
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Figure 9.2 Consort fl ow diagram
CR= cardiac rehabilitation; CR+F= cardiac rehabilitation plus face-to-face group counseling; CR+T= cardiac re-
habilitation plus individual telephonic counseling; CR-only= standard cardiac rehabilitation; m= months.
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intervention effects
Figure 9.3 shows the observed data for all outcomes measures. Outcomes of the GEE 
analyses are presented in Table 9.2.  
Aerobic capacity
Significant intervention effects were found at T12m for CR+F. On average, participants 
in the CR+F grouped walked 12.49 m more on the 6MWT than patients in the CR-only 
group (95% confidence interval [CI], 0.53 to 24.46; P =.041; Table 9.2). This difference was 
no longer present at T18m. No intervention effects were found for CR+T (Table 9.2). 
Fatigue
Patients randomized to CR+F had a greater improvement in FSS scores (3.29 at T0 to 
2.56 at T18m) compared to patients randomized to CR-only (3.33 at T0 to 2.87 at T18m; 
between-group difference at T18m, -0.24; 95% CI, -0.49 to 0.03; P = .053; Table 9.2). Fur-
thermore, prevalence of fatigue (including severe fatigue) decreased from 30.2% at T0 
to 11.9% at T18m in the CR+F group compared to an improvement from 37.3% at T0 to 
24.9% at T18m in the CR-only group (OR, 0.47; 95% CI, 0.26 to 0.84; P = .010). Prevalence 
of severe fatigue decreased from 13.8% at T0 to 4.2% at T18m for CR+F compared to an 
increase from 9.7% at T0 to 10.2% at T18m for CR-only (OR, 0.39; 95% CI, 0.17 to 0.95; P = 
.038; Table 9.2). No intervention effects were found for CR+T.
Participation in society
No interventions effects were found on any subdomain of participation in society for 
either novel intervention (Table 9.2).
mediating effects
Exploratory analysis revealed that the intervention effects for CR+F on aerobic capac-
ity were mediated by MVPA time (15.8%), sedentary time (5.3%), and daily step count 
(36.9%). None of the selected mediating variables explained the intervention effects 
observed for fatigue. 
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table 9.2 General estimating equation modelǂ intervention effects 
CR+F vs CR-only CR+t vs CR-only
B† Ci P B† Ci P
Aerobic capacity (n= 674)
  6MWT, meters overall 6.83 -3.45, 17.12 .192 3.82 -14.39, 6.74 .477
  ΔT0-T3m 6.84 -5.75, 19.43 .287 -0.14 -13.77, 13.48 .984
ΔT0-T12m 12.49 0.53, 24.46 .041 -9.20 -20.89, 2.48 .122
ΔT0-T18m 1.54 -11.86, 14.94 .822 -2.21 -15.66, 11.24 .747
Fatigue (n= 665)
  FSS score overall -0.16 -0.35, 0.03 .095 -0.05 -0.24, 0.14 .619
ΔT0-T3m -0.13 -0.35, 0.09 .235 -0.04 -0.26, 0.18 .708
ΔT0-T12m -0.13 -0.37, 0.11 .296 -0.02 -0.28, 0.23 .872
ΔT0-T18m -0.24 -0.49, 0.03 .053 -0.09 -0.34, 0.15 .453
  Prevalence of overall 0.62¥ 0.41, 0,94 .024 0.95¥ 0.63, 1.45 .832
  fatigue ΔT0-T3m 0.75¥ 0.45, 1.23 .260 1.07¥ 0.65, 1.77 .778
  (FSS > 4.0) ΔT0-T12m 0.63¥ 0.35, 1.13 .119 1.01¥ 0.57, 1.79 .969
ΔT0-T18m 0.47¥ 0.26, 0.84 .010 0.76¥ 0.43, 1.35 .356
  Prevalence of overall 0.55¥ 0.30, 1.01 .056 0.70¥ 0.38, 1.28 .250
  severe fatigue ΔT0-T3m 0.72¥ 0.31, 1.63 .428 0.83¥ 0.37, 1.84 .644
  (FSS > 5.2) ΔT0-T12m 0.57¥ 0.24, 1.35 .199 0.80¥ 0.34, 1.92 .623
ΔT0-T18m 0.39¥ 0.17, 0.95 .038 0.53¥ 0.24, 1.17 .117
Participation in society (n= 671)
  Frequency score overall -0.46 -1.92, 1.01 .540 0.73 -0.71, 2.16 .320
 ΔT0-T3m -0.18 -1.96, 1.60 .842 0.98 -0.79, 2.74 .277
ΔT0-T12m -1.06 -2.92, 0.80 .263 -0.03 -2.15, 2.08 .977
ΔT0-T18m -0.30 -2.26, 1.65 .760 1.10 -0.77, 2.98 .248
  Perceived overall 1.03¥ 0.73, 1.46 .858 0.93¥ 0.66, 1.32 .698
  restrictions scorea ΔT0-T3m 1.03¥ 0.68, 1.55 .903 1.09¥ 0.70, 1.67 .698
ΔT0-T12m 0.95¥ 0.60, 1.51 .824 0.82¥ 0.51, 1.30 .386
ΔT0-T18m 1.07¥ 0.67, 1.70 .777 0.86¥ 0.54, 1.36 .524
  Satisfaction score overall 0.32 -1.93, 2.57 .778 1.08 -1.24, 3.39 .361
  ΔT0-T3m 0.67 -1.96, 3.31 .618 1.50 -1.13, 4.12 .264
ΔT0-T12m -0.76 -3.59, 2.06 .596 -0.72 -3.68, 2.24 .632
ΔT0-T18m 1.40 -1.84, 3.65 .518 2.27 -0.49, 5.02 .107
6MWT= 6-minute walk test; CI= confidence interval; CR+F= cardiac rehabilitation plus face-to-face group coun-
seling; CR+T= cardiac rehabilitation plus individual telephonic counseling; CR-only= standard cardiac rehabili-
tation; m= months; FSS= Fatigue Severity Scale; n=number of patients that had at least 1 outcome post-baseline 
and were included in the GEE analysis.
ǂAll analyses were adjusted for baseline differences between patients and corrected for confounding effects of 
gender and age. The CR-only group is the reference group for all analyses.
†B, regression coefficient; represents the between-group difference and the intervention effect relative to CR-only 
at the specified time point.
¥Odds ratios are shown for dichotomous variables to indicate the odds (relative risk) relative to CR-only at the 
specified time point.
aScores violated normality assumption, dichotomized scores used for analysis.
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Figure 9.3 A) Aerobic capacity (meters walked on 6-minute walk test); B) FSS score, Fatigue severity scale 
score; C) Prevalence of fatigue (FSS > 4.0); d) Prevalence of severe fatigue (FSS > 5.2); e) Participation in 
society (frequency score of Utrecht Scale for Evaluation of Rehabilitation-Participation [USER-P] question-
naire); F) Participation in society (restrictions score of USER-P questionnaire); g) Participation in society 
(satisfaction score of USER-P questionnaire)
CR+F= cardiac rehabilitation plus face-to-face group counseling; CR+T= cardiac rehabilitation plus telephonic 
counseling; CR-only= standard cardiac rehabilitation; m= months; FSS= fatigue severity score. 
*intervention effect present for CR+F compared to CR-only.
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disCussiON
Extending CR with a face-to-face behavioral group intervention (CR+F) focused on 
permanent healthy lifestyle adoption resulted in improved maintenance of aerobic 
capacity gains up to 12 months and decreased prevalence of fatigue up to at least 18 
months, compared to CR alone. The improvements in aerobic capacity seemed to be 
mediated by improvements in physical activity. Extending CR with a telephonic behav-
ioral program (CR+T) did not lead to additional improvements in aerobic capacity or 
fatigue. Furthermore, neither the telephonic nor the face-to-face intervention improved 
participation in society compared to CR-only. 
All three groups improved aerobic capacity during the initial 3-month CR period. As in 
previous studies7,9, a decline in these benefits was seen after completion of CR (after 
T3m) in patients randomized to CR-only. The finding that CR+F prevented this decline is 
important, as aerobic capacity is associated with secondary cardiovascular events and 
mortality.10,11 Because CR+T did not prevent this decline in aerobic capacity, we hypoth-
esize that the stronger focus on physical activity during the face-to-face intervention 
was a crucial element in the successful maintenance. Indeed, an exploratory analysis 
showed that the CR+F intervention effects were mediated by both MVPA time (15.8%) 
and daily step count (36.9%). These mediating effects partly overlap, as some of the 
walking activities (step count) will be performed at a moderate-to-vigorous intensity. 
Another interesting finding is that the mediating effect of walking was twice as large 
as that of physical activity expressed as total MVPA time. This result is not completely 
surprising, as the 6MWT is a functional aerobic capacity test comprised of walking. A 
previous study showed a similar relationship between daily step count and functional 
aerobic capacity.36 An alternative explanation for the positive effects of the CR+F inter-
vention on maintenance of aerobic capacity gains is that the intervention included an 
exercise component during after-care. Although the frequency of this exercise program 
(three 1-hour sessions during a 9-month period) was insufficient to improve aerobic 
capacity, these sessions may have encouraged patients to pursue activities that improve 
aerobic capacity. 
Our results suggest that ongoing attention might be needed for permanent maintenance 
of gains in aerobic capacity. As soon as the after-care program ended, aerobic capacity 
also declined in the CR+F group. Our results suggest that this ongoing attention can be 
low-frequency, an after-care program with only three group meetings during a 9 month 
period was sufficient.
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To our knowledge, this is the first study to assess secondary effects of a lifestyle interven-
tion integrated into CR on fatigue. In addition to improving aerobic capacity, the CR+F 
intervention improved perceived fatigue (including severe fatigue). Patients who were 
randomized to CR+F reached fatigue levels even lower than those reported for healthy 
persons (11.9% vs 18%).30 In contrast, those randomized to standard CR continued to 
have a high prevalence of fatigue (24.9%). With regard to prevalence of severe fatigue, 
the prevalence among those randomized to CR+F (4.2%) approached that of healthy 
persons (3.5%) by study end.30 As with previous results7, the prevalence of severe fatigue 
in our study remained high following CR-only (10.2%). The improvements to fatigue are 
clinically important, as fatigue is known to influence quality of life.12 In contrast to our hy-
pothesis, additional improvements in fatigue were not mediated by changes in physical 
activity or sedentary behavior. Because the telephonic behavioral intervention (CR+T) 
did not confer additional benefits to fatigue, an element of the face-to-face group ses-
sions must have been essential for these benefits. Unfortunately, the study design was 
not appropriate to detect the specific factor for the program’s success. Perhaps the im-
provements in aerobic capacity seen in CR+F lowered the physical strain associated with 
activities of daily life, which consequently decreased feelings of fatigue.7 In addition, the 
face-to-face coaching method (as opposed to individual telephone coaching) may have 
contributed. Another possibility is the mediating effect of depression, which is known 
to be associated with perceived fatigue.37 However, a previous publication showed that 
neither novel intervention conferred benefits to depressed mood14, so we do not expect 
improvements in depression to have mediated the additional improvements in fatigue.  
Adding behavioral interventions to standard CR (using face-to-face group or individual 
telephonic coaching) did not affect participation in society. As participation in society 
is associated with quality of life6, future research should focus on finding effective inter-
ventions. A more individualized approach may be needed.
study limitations
Some study limitations deserve discussion. Firstly, patients who were lost to follow-up 
and excluded from analyses were, on average, younger and more likely to smoke. CR 
drop-out rates tend to be higher among younger patients and those with more risk 
factors.38,39 Therefore, our results are probably most valid among the more adherent 
patients. Secondly, the power analysis for this RCT was performed using the primary 
outcomes SCORE (Systematic COronary Risk Evaluation) risk function and physical activ-
ity.13 The study was not powered for the outcomes analyzed in this study; therefore, our 
results should be considered as exploratory. Lastly, we did not perform official media-
tion analyses. However, our exploratory analyses do offer insight into possible mediators 
of findings. 
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CONClusiONs
CR extended by a face-to-face behavioral group intervention focusing on permanent 
adoption of a healthy lifestyle was successful in maintaining aerobic capacity gains up 
to 12 months and improving perceived levels of fatigue up to 18 months. The benefits in 
aerobic capacity seemed to be mediated by improvements in physical activity. Extend-
ing CR with a telephonic behavioral program was not effective with respect to these 
outcome measures and none of the behavioral interventions improved participation in 
society. 
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In part I of this thesis we focused on changes in physical activity, sedentary behaviour, 
fatigue and participation in society during current standard cardiac rehabilitation (CR). 
In part II, we focused on the main objective of this thesis: the added value of behav-
ioural interventions integrated into CR on physical activity in patients with an acute 
coronary syndrome (ACS). Also, eff ects of the behavioural interventions on sedentary 
behaviour, cardiovascular health, aerobic capacity, fatigue and participation in society 
were studied. In the current chapter, the main fi ndings of part I and part II are inter-
preted and discussed in the context of published literature. After that, methodological 
considerations, clinical implications and future directions are described. 
PARt i: stANdARd CARdiAC ReHABilitAtiON 
main fi ndings
CR programs focus on the promotion of a healthy lifestyle and optimization of cardio-
vascular risk factors and psychosocial status.1-3 CR is essential for patients with coronary 
heart disease (CHD) and was shown to have substantial benefi ts on risk factors such as 
lipid profi le and blood pressure, quality of life, aerobic capacity, mortality, and hospital 
readmissions.4-7 Results of part I of this thesis showed that physical activity, sedentary 
behaviour, fatigue and participation in society also improved during CR in patients 
with CHD (see Figure 10.1). These benefi ts were maintained up till at least 12 months. 
Despite the favourable results, further improvements are warranted. Patients still spend 
relatively little time in physical activity and a long time sedentary post CR. Furthermore, 
prevalence of severe fatigue remained high and some restrictions and dissatisfaction 
with participation in society persisted. The results are discussed in more detail below. 
Mediating effect >10% 
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Figure 10.1 Schematic representation of the outcomes of part I of this thesis
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discussion
Improvements in physical activity and sedentary behaviour during CR are insufficient
An important goal of CR is to improve physical activity.1 However, results of the sys-
tematic review presented in chapter 2, revealed that standard CR seems insufficient to 
reach this goal in patients with ACS. The majority of randomized controlled trials (RCT’s) 
that were included in this systematic review used self-reported outcome measures for 
physical activity, which are known to have limited validity and reliability.8-11 Therefore, 
in chapter 3, we studied longitudinal changes in physical activity more in-depth using 
objective accelerometers in a cohort of 135 patients with ACS. During CR, improvements 
were found in moderate-to-vigorous intensity physical activity (MVPA; +5 min per day) 
and daily step count (+583 steps/day), which lasted up to at least 12 months. Magnitude 
of these improvements can be considered modest.12 Similar improvements in physical 
activity during CR have been reported in a previous study13 and a cross-sectional study 
showed comparable step counts and MVPA levels after CR.14 Although the improve-
ments reached during CR are encouraging, MVPA time remained low compared to 
healthy adults (7.0% of waking hours vs 10.2%).15 With regard to step count, only half 
of the patients achieved a daily step target of 6500 steps, which is recommended to 
prevent cardiovascular disease progression.16,17 In addition, we found that patients with 
ACS tend to break up physical activity into short bouts (<10 min), which is suggested to 
be detrimental for health.18-20 This distribution did not change during CR. Our findings 
suggest that optimization of CR with regard to physical activity is needed. The RCT’s 
selected for the systematic review (chapter 2) showed a variability in the investigated 
CR programmes. We performed an additional analysis to gain insight into the most suc-
cessful strategy to improve physical activity. No evidence was found that extending CR 
duration or increasing the volume of the exercise programme leads to larger improve-
ments. This is in line with outcomes of previous research that already suggested that 
aerobic interventions do not automatically translate into increases in physical activity.21 
Results did, however, suggest that home-based CR might be more successful compared 
to centre-based CR. Possibly, physical activity is better incorporated into the daily routine 
after home-based programmes. Furthermore, we found evidence for the effectiveness 
of interventions using self-monitoring of physical activity. This finding is supported by 
previous studies that confirmed the potential of interventions containing behavioural 
techniques to change physical activity such as self-monitoring, but also goal-setting 
and developing plans for relapse.22-25 Although behavioural programmes focussing on 
lifestyle changes such as healthy diet and stress management are usually offered dur-
ing CR, behavioural programmes focussing on physical activity are often lacking. There 
seems to exist a gap between the CR guidelines that recommend implementing physical 
activity counselling1-3 and daily practice.
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Independent of physical activity, increased sedentary time is also related to unfavour-
able health.26-29 Outcomes of chapter 3 revealed that patients had decreased sedentary 
time with nearly 22 min per day at the end of CR. In addition, sedentary time became 
more fragmented with more breaks and shorter sedentary periods, as is suggested to 
gain extra health benefits.30,31 The magnitude of the found improvements is comparable 
to improvements in sedentary time reported in a large meta-analysis for healthy adults 
after participation in a lifestyle intervention.32 Time in sedentary behaviour was mainly 
relocated to activities of light intensity. Although a previous study demonstrated that 
relocating time to MVPA yields greater reductions in risk factors, meaningful reductions 
in risk can also be achieved by relocating time in sedentary behaviour to light activity.33 
Regardless the promising improvements, sedentary time remained high at the end of 
CR with 62.8% of waking hours spent sedentary (approximately 9 hours), compared 
to 57.5% in healthy adults.15 Outcomes of previous studies also suggest that cardiac 
patients tend to be sedentary and inactive.34-36 Current CR programmes generally do 
not target sedentary behaviour. Our findings highlight the need to develop adjusted CR 
targets focusing not only on physical activity but also on sedentary behaviour. 
CR should focus on severe fatigue and dissatisfaction with participation in society
In chapters 4 and 5, we focused on fatigue and participation in society in a cohort of 121 
patients with CHD. Results of chapter 4 showed a high level of fatigue at the start of CR 
(21% experienced mild fatigue and 18% severe fatigue). The prevalence of mild fatigue 
decreased during CR and in the first year after CR to a level which is comparable to that 
of a healthy population.37 However, standard CR appeared inadequate for a subgroup 
of patients that experienced more severe fatigue. Post CR and at 12 months follow-up, 
respectively 11% and 8% of patients remained severely fatigued, which is high when 
compared to a prevalence of 3.5% reported for healthy adults.37 Patients with severe 
fatigue should probably be identified in an early stage of CR, so that additional interven-
tions to relieve fatigue can be offered. An exploratory mediation analysis suggested that 
improvements in fatigue are mainly mediated by improvements in depressive mood, 
and only for a small amount by improvements in aerobic capacity. This suggests that 
interventions targeting severe fatigue should probably focus more on the mental, rather 
than the physical, component of fatigue. An association between depressive mood and 
fatigue has been reported before.38
With regard to participation in society, the focus in CR is often on return to work. Since 
a large proportion of CR patients are retired or unemployed (in our sample 35%), the 
focus in chapter 5 was on domestic, occupational and recreational activities. Although 
our results did not show improvements in frequency of participation, considerable 
improvements were found in experienced restriction and satisfaction with participation 
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in society. In addition, results showed that satisfaction with participation and experi-
enced restrictions are related to quality of life, whereas frequency of participation is not. 
These results are in line with previous studies39,40 and confirm the relevance of the found 
improvements. Furthermore, these findings underline the importance of focussing on 
experienced restrictions and satisfaction, instead of focusing solely on frequency of 
participation. Despite the improvements, a large proportion of patients still reported 
experiencing restrictions (40%) and dissatisfaction (49%) at the end of CR in at least one 
activity of participation in society. A more individualized approach focusing on areas 
in which restrictions and dissatisfaction are experienced might help to optimize par-
ticipation and, as a consequence, quality of life. In our study cohort, lasting restrictions 
were mainly experienced during exercising and lasting dissatisfaction during going 
out, exercising, outdoor activities, housekeeping and contact with friends. To gain more 
insight how to target these lasting restrictions and dissatisfaction, we performed an ex-
ploratory mediation analysis. We found indications that improvements in restrictions in 
participation were mediated by aerobic capacity (9%) and improvements in satisfaction 
by depressive mood (20%). 
Additional interventions needed
Outcomes of Part I suggest that CR could be optimized with regard to physical activity, 
sedentary behaviour, fatigue and participation in society. Mainly for physical activity, 
there seems to be a large gap between guidelines and daily practice. In the OPTICARE 
trial, the additional effects of behavioural interventions added to standard CR were 
investigated (Part II). Primary aim was a further improvement in physical activity and 
cardiovascular health. Since the interventions had a broad focus on several aspects of 
behaviour and daily life, there could be an additional effect on sedentary behaviour, 
fatigue and participation in society.
PARt ii. BeHAviOuRAl iNteRveNtiONs Added tO CARdiAC 
ReHABilitAtiON 
main findings
Chapter 6 describes the design of the OPTICARE RCT. Patients were randomized to 
standard CR (CR-only) or one of the two novel behavioural interventions. The first novel 
intervention (CR+F) consisted of 3 months of standard CR with three pedometer-based, 
face-to-face physical activity group counselling sessions followed by 9 months of after-
care with three general lifestyle, face-to-face, group counselling sessions. The second 
novel intervention (CR+T) consisted of standard CR followed by 9 months of aftercare 
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with five to six general lifestyle, telephonic counselling sessions. Both novel behavioural 
interventions did not improve MVPA time as compared to CR-only. However, the physi-
cal activity counselling sessions offered in the CR+F intervention during the 3-month CR 
period were successful in increasing daily step count and increasing time spent in pro-
longed physical activity periods (>10 min). During the CR+F aftercare programme, im-
provements in step count partly diminished, while improvements in prolonged physical 
activity were maintained. Furthermore, the CR+F intervention resulted in an improved 
maintenance of aerobic capacity up to 12 months and in long-term improvements in 
fatigue. The CR+T intervention did not result in additional benefits. The outcomes are 
discussed in detail below. See also Figure 10.2. 
discussion
Pedometer-based behavioural group intervention increases physical activity 
Our main results (chapter 7) showed that the pedometer-based physical activity coun-
selling sessions that were integrated into the 3-month CR programme of the CR+F group 
resulted in an additional improvement of 513 steps/day as compared to CR-only. As a 
consequence, more patients were reaching a daily step target of 6500 (62% for CR+F 
vs 47% for CR-only), which is advised for prevention of cardiac disease progression. The 
magnitude of the improvements was similar to those reported in a large meta-analysis 
summarizing the effect of physical activity interventions among healthy subjects, which 
considered this a modest improvement.12 Regardless the promising improvements in 
step count, there were no additional improvements in MVPA time. This indicates that 
an increase in step count does not automatically translate into increased MVPA time. 
Possibly, part of the walking activities was classified as light intensity or the extra walk-
ing activities were compensated for by decreasing other MVPA activities such as biking. 
Future research is needed to determine whether increasing step count or increasing 
MVPA time is more important for health. Our finding that patients mainly increased 
the activity on which they received objective feedback (in our study provided by pe-
dometers) emphasizes the importance of self-monitoring for physical activity change, 
which is in line with results of other studies.23 Unfortunately, during participation in the 
face-to-face aftercare programme offered to the CR+F group after the end of the initial 
CR phase, the improvements in step count partly diminished. This aftercare programme 
focused on several lifestyle changes simultaneously (eg. diet, physical activity and 
psychosocial functioning). In line with literature, we postulate that for more successful 
maintenance, the aftercare programme probably should have focused exclusively on 
physical activity.12,41 
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In addition to the improvements in step count, distribution of physical activity over 
time also improved in the CR+F group. MVPA was more often accumulated in prolonged 
periods of at least 10 minutes, which is recommended for optimal health benefits.18-20 
These additional improvements were maintained up to at least 18 months.
The CR+T group experienced no additional benefits with regard to physical activity. 
Since the CR+T aftercare programme also focused on several lifestyle changes, this is in 
line with our hypothesis that an exclusive focus on physical activity might be needed. 
The lack of effects could also be due to the mode of delivery (by telephone). A previ-
ous meta-analysis suggested that face-to-face contact is more successful for physical 
activity improvements.42 In contrast to our findings, two previous studies investigating 
the effects of the COACH programme on which our telephonic aftercare programme 
(CR+T) was based, did show physical activity improvements.43,44 These outcomes were, 
however, self-reported, and therefore less valid8-11, which may explain the discrepancy 
with our results.
Both novel interventions did not lead to additional benefits with regard to sedentary 
behaviour (chapter 7). In the CR+F intervention, our primary aim was to improve 
physical activity. Only general advice was given about the health benefits of breaking up 
sedentary time. In the CR+T intervention, there was no specific attention for changing 
sedentary behaviour. Our results suggest that a focus on physical activity does not lead 
to changes in sedentary behaviour and that giving general information is insufficient. 
These results are in line with results of previous studies in healthy adults.24,32
Patients already achieve health outcome targets after standard CR
Results presented in chapter 8 show that the novel interventions did not lead to addi-
tional improvements in SCORE, a risk function that estimates the 10 years risk of cardio-
vascular death based on age, gender and the modifiable components total cholesterol, 
systolic blood pressure and smoking status. In addition, there were no between-group 
differences in number of (cardiovascular) events. Although the individual risk factor total 
cholesterol did show some additional improvements in the CR+F group, the magnitude of 
this improvement seemed clinically irrelevant and was probably mainly caused by more 
strict titration of medication in the CR+F group, rather than by the behavioural group 
intervention. Further improvements were also not found for the individual risk factors 
blood pressure and smoking status. Patients randomized to standard CR without any ad-
ditions (CR-only) were already successful; 75% of the patients were meeting guidelines 
for systolic blood pressure at 18 months, 64% for total cholesterol and 73% were not 
smoking. Since we did not include a control group that did not participate in CR, caution 
is required when attributing the success directly to CR. Since lipids and blood pressure 
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were already well-controlled at baseline, advances in medical treatment and cardio pro-
tective drugs seem to be at least partly responsible for the favourable results. With these 
well-controlled risk profiles, additional improvements with lifestyle modification will be 
more difficult to accomplish. An alternative explanation for the lack of additional health 
improvements is the poor adherence to the protocol. In an additional per-protocol 
analysis, we found that adherent patients participating in both novel interventions were 
more likely to permanently quit smoking compared to adherent patients participating 
in CR-only. Results of this per-protocol analysis should, however, be interpreted with 
caution. To be included in this analysis, patients needed to attend >75% of sessions. 
The CR-only group participated only in standard CR, whereas the extended groups had 
to attend additional sessions and therefore needed much greater engagement (and 
possibly motivation) over a much longer time period to be considered adherent, which 
could have caused a bias.
Studies that investigated CR aftercare  programmes  that differed in  frequency and 
content of sessions, presented more successful outcomes regarding cardiovascular 
health in patient samples comparable to ours.44-47 However, these studies all compared 
their interventions  to usual care, generally not including CR. This difference in study 
design might explain the inconsistency with our results. A recent RCT that compared 
extended behavioural CR to standard CR reported outcomes comparable to ours.48
The lack of further improvements in cardiovascular health could suggest that the ad-
ditional improvements in physical activity, found for the CR+F intervention, were insuffi-
cient to yield improvements in cardiovascular health. However, physical activity remains 
important. Physical activity can also influence mortality through other pathways (e.g. 
reducing chronic inflammation; improving coronary blood flow or augmenting cardiac 
function).49 There are some alternative explanations why the improvements in physical 
activity did not translate to additional improvements in cardiovascular health. First, the 
majority of patients were using medications which could have masked effects on for 
instance blood pressure and cholesterol. Second, changes in physical activity possibly 
should be larger and sustained for a longer period to affect cardiovascular health. Finally, 
a large variation in physical activity was observed. Probably, patients with a low level of 
physical activity at baseline can profit more compared to patients with a high baseline 
level.
Secondary outcomes
In addition to the improvements in physical activity, the CR+F intervention was success-
ful in preventing the commonly seen decline in aerobic capacity after ending CR.50,51 An 
exploratory mediation analysis suggested that these benefits could partly be explained 
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by improvements in physical activity. In addition, the improved maintenance of aerobic 
capacity gains could be the result of the exercise component that was offered during the 
CR+F aftercare programme. Although the frequency of this exercise programme (three 
1-hour sessions during a 9-month period) was insufficient to maintain aerobic capacity, 
these sessions may have encouraged patients to pursue activities that improve aerobic 
capacity. In line with previous studies51-53, aerobic capacity started to decline in the CR+F 
group as soon as the aftercare programme ended. This suggests that ongoing attention 
is needed for permanent maintenance of gains.
The CR+F intervention was also successful in further improving fatigue up till at least 18 
months. Prevalence of fatigue reached levels which are comparable or even lower than 
the prevalence reported for healthy people (11.9% vs 18% for mild-to-severe fatigue and 
4.2% vs 3.5% for severe fatigue). This finding is of clinical relevance since outcomes of 
chapter 3 revealed that prevalence of severe fatigue remained high after standard CR. 
Fatigue is known to influence quality of life.54 The additional improvements in fatigue 
seemed unrelated to improvements in physical activity. The study design was not ap-
propriate to detect what other factors could have caused the success. In chapter 3 we 
described an association between depressive symptoms and fatigue. Since CR+F did not 
improve depression (chapter 7), improvements in depression are not expected to have 
mediated the improvements in fatigue.     
No improvements in aerobic capacity and fatigue were seen for the CR+T group. Ad-
ditionally, both novel interventions did not have secondary effects on participation 
in society, quality of life, anxiety, and depression (chapter 7 & 8). Even though lower 
anxiety and higher quality of life were seen at 18 months in adherent patients random-
ized to CR+F (visiting at least 75% of sessions), these improvements were mainly caused 
by baseline differences, rather than by the intervention. Patients with higher anxiety 
and lower quality of life were more likely to drop-out during the extended programme.
metHOdOlOgiCAl CONsideRAtiONs 
study design
In Part I of this thesis we investigated changes in several understudied outcomes in a 
longitudinal cohort of patients with CHD participating in CR. Since no control group 
was included and the study was performed in a single centre, caution is required when 
attributing changes directly to CR. 
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Outcomes of part II of this thesis are based on the OPTICARE randomized controlled 
trial. The OPTICARE was set up as a pragmatic trial. The design of the novel interventions 
makes it impossible to specify which elements of the programme contributed to the 
improvements. Due to the nature of the study, blinding was not feasible. Due to our 
strict measurement protocol, we believe that this did not result in relevant bias. 
Although we did include the number of patients in the OPTICARE trial as intended 
after power calculation, the percentage of drop-outs was higher than expected. As a 
consequence, the number of patients in the main analysis for physical activity was lower 
than intended. However, since only one of the novel interventions showed significant 
benefits in physical activity as compared to CR-only, we decided to not directly compare 
the two novel interventions, thus no longer needing a Bonferroni correction. To be able 
to detect the hypothesized differences between each novel intervention and CR-only 
(p<0.05), only 57 patients in each arm were needed. So, we believe that we still had 
sufficient power to detect clinically meaningful differences. 
Although we did not perform formal mediator analyses, our exploratory analyses per-
formed in chapter 4, 5 and 9 do offer insight into possible mediators of results. 
generalizability
First, participants in our trial consisted of a relatively low-risk population. Included 
patients were young (on average 57 years) and had well-preserved cardiac function 
(left ventricular function >40%). The majority had no cardiac history. Our outcomes do 
not automatically generalize to a higher-risk population. In addition, our results do not 
generalize to women, who were underrepresented in our trial (19%). Second, Intention-
to-treat analysis with full datasets is preferred to avoid bias in RCTs.55 To answer our 
main question, patients had to visit the rehabilitation centre to have the accelerometer 
installed. Patients who dropped out before the second measurement and no longer 
visited the rehabilitation centre, as a consequence, had no follow-up physical activity 
measurement. Therefore, a full ITT analysis was not possible. We included only patients 
with at least 1 follow-up measurement in the analysis. The group that was excluded from 
analysis was on average older and had higher cardiovascular risk. Lastly, an additional 
bias could be caused by compliance to the intervention. Sensitivity analyses performed 
in chapter 7, showed that intervention effects were more pronounced for adherent 
patients who participated in at least 75% of interventions sessions. 
In conclusion, our results are probably mainly valid for more compliant, lower-risk, male 
patients.  
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Outcome measures
Physical behaviour was objectively measured using accelerometers. Objective mea-
surement is the method of choice, as it is more valid than self-reported measures.11 
In addition, accelerometers also estimate distribution and intensity of activities and 
not only volume of walking activities, which is a major strength when compared to 
pedometers. However, the use of accelerometers also has limitations. First, consensus 
in Actigraph accelerometer data processing is lacking. There is wide variability in the 
choices made for intensity cut-off points, which limits comparability between studies. 
Intensity cut-off points used in our study were originally developed for a healthy popu-
lation. As a consequence, physical activity intensity may be underestimated for patients 
with lower aerobic capacity. An additional limitation is that the accelerometer we used 
is not water-resistant and could therefore not be worn during swimming activities. 
Finally, participants were aware that their physical activity was being measured, which 
may have influenced their behaviour. Since the accelerometers were blinded and the 
measurement period lasted at least 4 days, we expect this last limitation to only have a 
minimal effect on our results. 
To estimate cardiovascular health, we used the SCORE risk function. We selected the 
SCORE risk function that was developed for primary prevention7 because there is 
currently no validated risk score available for secondary prevention. Absolute scores 
(percentages) are therefore inaccurately reflecting 10-year mortality risk. However, 
the between-group differences in SCORE do provide an estimate of the relative overall 
impact of the investigated interventions. 
Performing a maximal exercise stress test with measurement of oxygen consumption is 
preferred when measuring aerobic capacity. Unfortunately, this was not possible in the 
complex logistics of this study. Therefore we chose to use a 6-minute walk test (6MWT), 
which is an easy-to-administer and a frequently used test to measure functional aerobic 
capacity.56 The 6MWT was found to be a valid and reliable test and responsive to clini-
cally meaningful changes in a CR population.57 
CliNiCAl imPliCAtiONs
Based on our results, it is recommend to implement physical activity counselling into CR. 
The addition of three behavioural physical activity group counselling sessions (CR+F) 
was effective in improving step count and distribution of physical activity. Results sug-
gested that objective feedback (in our intervention provided by pedometers) might be 
essential for behaviour change. During the CR+F aftercare programme, the benefits in 
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physical activity partly worn off. Long-lasting improvements were found in prevalence 
of mild and severe fatigue. Furthermore, the common decline in aerobic capacity after 
CR was prevented. These secondary outcomes increase the clinical relevance of the CR+F 
intervention. The intervention in its current form leaves room for further improvements, 
mainly with regard to MVPA time, long-term maintenance of physical activity benefits, 
and sedentary behaviour. Ideally, the interventions should first be optimized and then 
implemented into CR. Results of this thesis give several suggestions for optimization, 
which are discussed below in the ‘future directions’. Since the CR+F intervention was 
imbedded in existing and reimbursed CR and consisted of a small number of additional 
group sessions, costs of the intervention are estimated to be relatively low. However, 
for successful implementation and reimbursement, a detailed economic evaluation is 
needed. 
Telephonic aftercare (CR+T) did not result in additional benefits. Although this interven-
tion requested a smaller effort (phone calls at home or at work), compliance was not 
higher than for the CR+F intervention. Since the phone calls were on individual basis, 
costs are not estimated to be much lower than for the CR+F group intervention. Imple-
mentation of the CR+T intervention is not recommended.
Usually, there is a great emphasis on cardiovascular risk profile and (cardiovascular) 
events when evaluating the success of CR. Our results showed very low event rates 
and well-controlled blood pressures and lipid profiles already at the start of CR. These 
favourable outcomes suggest that, both in clinical practice and when conducting re-
search, there should be more emphasis on other goals and outcomes of CR that are less 
well-controlled by medication, such as directly measuring lifestyle behaviours.58 Results 
of this thesis stress the importance of focussing on further improvements in physical 
activity habits. In addition, there is a need to develop additional CR targets for sedentary 
behaviour. Other important targets are experienced fatigue and participation in society. 
With regard to fatigue, main focus should be on patients that enter CR with severe fa-
tigue complaints. Improving participation in society is already specified as a goal of CR. 
However, usually, the focus is on frequency of participation, while our results highlight 
the importance of focusing on areas of participation in society in which patients report 
to experience restrictions and dissatisfaction, such as going out, exercising, outdoor 
activities, housekeeping and contact with friends. 
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FutuRe diReCtiONs
Further optimization of physical activity counselling
The CR+F intervention showed encouraging outcomes. For further improvements, a 
more in-depth understanding of barriers and facilitators for CR participants to become 
physically active is needed. Knowledge about common barriers and facilitators will 
help identify feasible and potentially more effective interventions to improve physical 
activity. Results of this thesis also provided several directions for optimization of the 
intervention with regard to physical activity. First, patients were most responsive to 
change the outcome on which they received objective feedback; in our case step count. 
A previous review also underlined the importance of objective self-monitoring.23 The 
physical activity counselling sessions could possibly be improved by not only providing 
feedback on walking activities but also on total MVPA, which is possible with new tech-
nologies. Second, both aftercare programmes (CR+F and CR+T) had a focus on multiple 
lifestyle behaviours and were not successful with regard to physical activity, as opposed 
to physical activity counselling integrated into the initial phase of the CR+F intervention. 
An exclusive focus on physical activity might be needed also during aftercare. A meta-
analysis in a general population confirmed that interventions focusing solely on physi-
cal activity were more successful than interventions addressing multiple behaviours.42 
Finally, to reach lasting changes, patients probably need ongoing attention, which could 
be feasible using E-health interventions.59 Compliance might also be higher for home-
based sessions, although results in this thesis indicated that compliance was not higher 
for a telephonic aftercare programme. Furthermore, results of a meta-analysis also show 
the importance of, at least partly, face-to-face contact.42
Physical activity counselling could additionally be improved by adding a focus on sed-
entary behaviour, preferably including objective feedback. In line with previous stud-
ies24,32, our results suggest that interventions with a main focus on physical activity do 
not automatically improve sedentary behaviour. Although more research into this area 
is needed, both for physical activity and sedentary behaviour it has been suggested that 
an exclusive focus on one of the behaviours is more successful than focussing on both 
components simultaneously.24,32,42 Future studies should find a way to target sedentary 
behaviour, without replacing or diminishing the focus and effects on physical activity. 
Probably the focus could be divided over the day, for instance emphasize increasing 
physical activity during leisure time and reducing sedentary behaviour during working 
hours. The choice in focus could also be based on the motivation and baseline values of 
the patient. Future research should also investigate whether changing physical activity 
or sedentary behaviour yields larger health benefit. Most evidence on the association 
between physical behaviour (physical activity and sedentary behaviour) and health in 
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patients with CHD is based on outcomes of cross-sectional research. In addition, evi-
dence is often based on self-reported outcomes, which are known to be less valid.8-11 The 
exact magnitude of changes in objectively measured physical activity and sedentary 
behaviour required to gain health benefits are unclear. The longitudinal association 
between physical behaviour and health should be studied more extensively. 
which patients benefit most?
Probably not all patients need to prolong standard CR. Participation in aftercare pro-
grammes should perhaps be restricted to some specific groups who do not accomplish 
the target values for lifestyle recommendation or cardiovascular health after standard 
CR. Future studies should focus on selecting those patients that will benefit most from 
additional interventions.  
Collaboration in the Netherlands 
Over the last years, several large trials have been conducted in the Netherlands focus-
sing on improving lifestyle habits in CR populations.45,48,60,61 All trials strived to improve 
secondary prevention, but differed in content and in focus. Combining the outcomes 
of these trials, and discussing them in a multidisciplinary team, would give a unique 
opportunity to learn important lessons about secondary prevention in the Netherlands. 
This could lead to optimization of guidelines as well as opportunities for further research.
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Cardiac Rehabilitation (CR) focusses on the adoption of a healthy lifestyle (including 
regular physical activity) and the optimization of cardiovascular risk factors and psycho-
social status. Standard CR programs last 6-12 weeks. The core of CR exists of an exercise 
program. In addition, educational sessions and counselling programs on cardiovascular 
risk factors and a heart-healthy lifestyle are offered. Previous studies have demonstrated 
that CR successfully improves health (e.g. blood pressure and lipid profile), aerobic ca-
pacity, quality of life, and risk of mortality in patients with coronary heart disease (CHD). 
Notwithstanding these benefits, it has been suggested that standard CR is insufficient 
for physical activity improvements. Regular physical activity is important since it is as-
sociated with substantial health benefits, such as an improved cardiac risk profile and a 
lower risk of (recurrent) cardiovascular events.
In part I (chapters 2-5) of this thesis we focused on the effects of current standard CR on 
physical activity and on the secondary outcomes sedentary behaviour, fatigue and par-
ticipation in society. In part II (chapters 6-9), we focused on the main objective of this 
thesis: the effect of extra behavioural lifestyle interventions integrated into standard CR 
on physical activity. Furthermore, effects of the behavioural interventions on sedentary 
behaviour, cardiovascular health, aerobic capacity, fatigue, and participation in society 
were studied.
Chapter 1 of this thesis contains the general introduction which gives background 
information on CHD (including acute coronary syndromes, ACS), on CR, on the primary 
outcome physical activity, and on the secondary outcomes. Additionally, the theoreti-
cal background of the investigated behavioural lifestyle interventions is described. The 
chapter concludes with the aims and outline of this thesis. 
In chapter 2 (part I), we systematically reviewed the literature regarding the effects 
of standard CR on physical activity in patients with ACS. We included 26 randomized 
controlled trials (RCT’s). Results suggest that centre-based CR is insufficient to improve 
and maintain physical activity. Home-based programs seemed more successful, but 
the literature is limited. There was no clear evidence that increasing training volume 
or extending the duration of CR is more effective with regard to physical activity. The 
majority of the RCT’s used self-reported outcome measures for physical activity, which 
are less valid and reliable. Therefore, in chapter 3, we studied longitudinal changes in 
physical activity during standard CR more in-depth using objective accelerometers. We 
additionally focussed on sedentary behaviour, which is known to be an independent risk 
factor for health. The standard CR program lasted 6-12 weeks. The core of the program 
consisted of an exercise program (twice a week). In addition, educational sessions on 
cardiovascular risk factors and a heart-healthy lifestyle were offered. Upon indication 
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and motivation, patients could also participate in a stress management program, a di-
etary program, a smoking cessation program and/or an individualized psychologic pro-
gram. During this CR program, patients achieved a small improvement in moderate-to-
vigorous intensity physical activity (MVPA; +5min/day). More substantial improvements 
occurred for sedentary behaviour (-22 min/day). Regardless these improvements, by the 
end of CR, patients still spent relatively little time in MVPA and a long time sedentary. 
We concluded that standard CR is insufficient and additional resources are needed to 
further improve physical activity and sedentary behaviour. 
In chapter 4, we focused on longitudinal changes in fatigue in patients with CHD. Fatigue 
decreased during and after standard CR. However, the prevalence of severely fatigued 
patients remained high one year after CR (8%) as compared to a healthy population 
(3.5%). Aerobic capacity was weakly associated with fatigue, while depressive symptoms 
were more strongly associated. Our results indicate that for patients with severe fatigue 
additional interventions seem necessary. These interventions should probably focus 
mainly on the mental components of fatigue, instead of the physical components. 
In chapter 5, we describe longitudinal changes during standard CR in participation in 
society (domestic, occupational and recreational activities) in patients with CHD. The 
frequency of participation did not change during CR. However, the proportion of pa-
tients experiencing restrictions in participation decreased from 69% pre-CR to 29% at 
one-year follow-up. Dissatisfaction with participation decreased from 71% to 53%. Re-
gardless these considerable improvements, the proportion of patients that experienced 
restrictions and dissatisfaction remained high at follow-up. Since we additionally found 
that experienced restrictions and dissatisfaction are associated with quality of life, we 
suggest that a more individualized approach during CR, focusing on activities in which 
restrictions and dissatisfaction are experienced, is needed.
In chapter 6 (part II), the design of the OPTICARE study is described. In this RCT, we 
investigated the added value of two novel behavioural lifestyle interventions on top of 
standard CR. The first novel CR+F (CR + Face-to-face counselling) intervention consisted 
of 3 months of standard CR with the addition of three pedometer-based, face-to-face 
physical activity group counselling sessions. This initial phase was followed by 9 months 
of aftercare with three face-to-face group counselling sessions focusing on several 
lifestyle components (e.g. healthy diet, physical activity, and psychosocial functioning). 
The second novel intervention, the CR+T (CR+Telephonic counselling) intervention 
consisted of 3 months of standard CR without additions in the initial phase. After the 
initial phase, patients participated in 9 months of aftercare with five to six telephonic 
counselling sessions which also focused on several lifestyle components. In the chapters 
230
Summary
7-9, we describe the outcomes of the novel interventions as compared to standard CR 
only (as described for chapter 3 and with no aftercare) in patients with ACS. 
Chapter 7 focuses on the additional benefits with regard to physical activity (primary 
outcome). Compared to standard CR, adding three pedometer-based physical activity 
counselling sessions (initial phase CR+F) improved daily step count with an additional 
500 steps/day. Furthermore, time spent in prolonged MVPA periods (>10min, which is 
suggested for health benefits) increased. There were no changes in total MVPA time 
or sedentary behaviour. At completion of the CR+F aftercare program, improvements 
in step count partly diminished. However, the additional improvements in prolonged 
MVPA were maintained. No additional benefits were found for the CR+T intervention 
with regard to physical activity or sedentary behaviour. Based on the results, we recom-
mend that face-to-face physical activity group counselling sessions including objective 
feedback (CR+F) be added to standard CR, although aftercare optimization is needed. 
Our results give several directions for optimization, which are further discussed in chap-
ter 7.
The aim of chapter 8 was to investigate the additional effect on SCORE, a risk function 
that estimates the 10 years risk of cardiovascular death based on total cholesterol, 
systolic blood pressure, and smoking status. None of the novel interventions did lead 
to additional benefits with respect to SCORE or any of its individual components.  Pa-
tients largely reached target levels for modifiable risk factors already following standard 
CR. These outcomes suggest that with regard to cardiovascular risk factors, no additional 
resources are needed. 
In chapter 9, we describe secondary outcomes. The CR+F intervention was successful 
in sustaining aerobic capacity gains up to 12 months and reaching long-term improve-
ments in fatigue. No additional improvements were seen for participation in society. 
No additional benefits were found for the CR+T intervention. The additional benefits 
in aerobic capacity and fatigue increase the clinical relevance of the CR+F intervention. 
Chapter 10 contains the general discussion. In this chapter, the main findings of this 
thesis are described and interpreted, and methodological considerations are discussed. 
Furthermore, we address the clinical implications of our outcomes and give future direc-
tions for optimization of cardiac rehabilitation and for further research into this area.
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Hartrevalidatie (HR) richt zich op het ontwikkelen van een gezonde leefstijl (inclusief het 
doen van regelmatige lichamelijk activiteit) en op het verbeteren van cardiovasculaire 
risicofactoren en de psychosociale status. Standaard HR duurt 6 tot 12 weken. De kern 
van HR bestaat uit een trainingsprogramma en daarnaast kunnen patiënten diverse 
voorlichtingen en behandelprogramma’s over cardiovasculaire risicofactoren en een 
gezonde leefstijl volgen. Wetenschappelijk onderzoek heeft aangetoond dat deelname 
aan HR leidt tot een verbetering in de cardiovasculaire gezondheid (bijv. bloeddruk en 
lipidenprofiel), lichamelijke fitheid, kwaliteit van leven, en mortaliteit bij patiënten met 
een coronaire hartziekte (CHZ). Ondanks deze gunstige effecten wordt vaak gesug-
gereerd dat de huidige HR-programma’s onvoldoende zijn voor het ontwikkelen van 
een lichamelijk actieve leefstijl. Mogelijk zijn aanvullende leefstijlinterventies nodig. 
Regelmatige lichamelijke activiteit is belangrijk voor de gezondheid en is bijvoorbeeld 
gerelateerd aan een verbetering van cardiovasculaire risicofactoren en een reductie in 
het aantal (her)opnamen ten gevolge van nieuwe hartproblemen.
In deel I (hoofdstuk 2-5) van dit proefschrift worden de effecten van standaard HR op 
lichamelijk activiteit en op de secundaire uitkomstmaten sedentair gedrag, vermoeid-
heid en maatschappelijke participatie beschreven. In deel II (hoofdstuk 6-9) richten we 
ons op de primaire doelstelling van dit proefschrift: het bepalen van de toegevoegde 
waarde van twee verschillende leefstijlinterventies, als aanvulling op standaard HR, 
op lichamelijke activiteit. Daarnaast beschrijven we de effecten van deze leefstijlinter-
venties op sedentair gedrag, cardiovasculaire risicofactoren, fitheid, vermoeidheid en 
maatschappelijke participatie.
In het inleidende hoofdstuk 1 wordt achtergrondinformatie gegeven over CHZ (inclusief 
acute coronaire syndromen, ACS), over HR, over de primaire uitkomstmaat lichamelijke 
activiteit en over de secundaire uitkomstmaten. Daarnaast wordt de theoretische ach-
tergrond van de onderzochte leefstijlinterventies beschreven. Het hoofdstuk sluit af met 
een overzicht van  de doelstellingen van dit proefschrift.
In hoofdstuk 2 (deel 1) worden de uitkomsten van een systematische review besproken, 
waarin we de resultaten van eerder wetenschappelijke onderzoek samenvatten die de 
effecten van standaard HR op lichamelijk activiteit in hartpatiënten met ACS hebben on-
derzocht. Er werden 26 gerandomiseerde studies (RCT’s) geïncludeerd. Resultaten tonen 
aan dat standaard HR onvoldoende is voor het verbeteren van lichamelijke activiteit. Er 
werden aanwijzingen gevonden dat revalideren in de thuissituatie betere resultaten op-
levert dan revalideren in een centrum. De literatuur op dit gebied is overigens beperkt. Er 
werd geen bewijs gevonden dat het verlengen van de duur van revalidatieprogramma’s 
of het verhogen van trainingsvolume leidt tot betere effecten. De meerderheid van de 
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geïncludeerde RCT’s baseerden hun conclusies op zelf-gerapporteerde lichamelijke 
activiteit, waarvan bekend is dat dit een uitkomstmaat is met beperkte validiteit en 
betrouwbaarheid. Om deze reden hebben we in hoofdstuk 3 objectieve accelerometers 
gebruikt om lichamelijk activiteit meer gedetailleerd te kunnen meten tijdens standaard 
HR bij hartpatiënten met ACS. Aanvullend hebben we ook gekeken naar veranderingen 
in sedentair gedrag, waarvan bekend is dat dit een onafhankelijke risicofactor is voor de 
gezondheid. Het standaard HR-programma duurde 6 tot 12 weken. De kern bestond uit 
een trainingsprogramma (2 maal per week). Daarnaast konden patiënten diverse voor-
lichtingen over cardiovasculaire risicofactoren en een gezonde leefstijl volgen, en mee-
doen aan groepsbehandelprogramma’s waarin begeleiding werd geboden bij stoppen 
met roken, gezond afvallen, en omgaan met stress. Indien noodzakelijk kon de patiënt 
individuele begeleiding krijgen van een diëtist, maatschappelijk werker, psycholoog, of 
psychiater. Tijdens deelname aan dit HR programma steeg het aantal minuten dat werd 
besteed aan matig tot intensieve lichamelijke activiteit gemiddeld met 5 minuten per 
dag en verminderde sedentair gedrag gemiddeld met 22 minuten per dag. Ondanks 
deze verbeteringen, besteedden patiënten na afloop van HR nog steeds relatief weinig 
tijd aan lichamelijke activiteit en waren zij relatief veel tijd sedentair. De resultaten sug-
gereren dat standaard HR onvoldoende is en aanvullende interventies nodig zijn om 
lichamelijke activiteit en sedentair gedrag verder te verbeteren.
In hoofdstuk 4 hebben we ons geconcentreerd op veranderingen in vermoeidheid bij 
hartpatiënten met CHZ. Resultaten laten zien dat vermoeidheidsklachten significant 
dalen tijdens en na deelname aan standaard HR. Echter, de prevalentie van patiënten 
met ernstige vermoeidheidsklachten was een jaar na HR nog steeds relatief hoog (8%) 
in vergelijking met een gezonde populatie (3.5%). Verbeteringen in vermoeidheids-
klachten waren slechts zwak geassocieerd met verbeteringen in lichamelijke fitheid. De 
associatie was sterker met verbeteringen in depressieve symptomen. Onze resultaten 
impliceren dat patiënten met ernstige vermoeidheidsklachten aanvullende interventies 
nodig hebben. Deze interventies zullen zich waarschijnlijk vooral moeten concentreren 
op de mentale componenten van vermoeidheid, in plaats van op de lichamelijke com-
ponenten.
In hoofdstuk 5 beschrijven we veranderingen tijdens standaard HR in maatschappelijke 
participatie (huishoudelijke-, werk gerelateerde-, en vrijetijdsactiviteiten) bij hartpa-
tiënten met CHZ. Frequentie van participatie veranderde niet. Echter, het percentage 
patiënten dat beperkingen ervaart in de maatschappelijke participatie daalde van 89% 
voor HR tot 29% een jaar na HR. Het aantal patiënten dat ontevreden was met de eigen 
participatie daalde van 71% naar 53%. Ondanks deze aanzienlijke verbeteringen, was 
het percentage patiënten dat beperkingen ervaarde of ontevreden was nog steeds 
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hoog één jaar na HR. Aanvullende analyses lieten zien dat deze ervaren beperkingen 
en ontevredenheid gerelateerd zijn aan de kwaliteit van leven. Deze bevindingen bena-
drukken het belang van meer geïndividualiseerde aandacht tijdens HR voor activiteiten 
waarin beperkingen en ontevredenheid worden ervaren. 
In hoofdstuk 6 (deel 2) wordt de aanleiding en opzet van het OPTICARE onderzoek 
beschreven. In deze gerandomiseerde trial (RCT) hebben we de toegevoegde waarde 
van twee leefstijlinterventies bovenop standaard HR onderzocht. De CR+F (CR+Face-to-
face counselling) interventie bestond uit 3 maanden standaard HR met de toevoeging 
van een beweegstimuleringsprogramma bestaande uit 3 groepssessies waarin gewerkt 
werd met stappentellers. Na afloop van deze eerste drie maanden (initiële fase) werden 
patiënten uitgenodigd voor een nazorgprogramma van 9 maanden bestaande uit drie 
groepssessies die zich richtten op blijvende leefstijlveranderingen op het gebied van 
gezonde voeding, lichamelijke activiteit, maar ook op het gebied van psychosociaal her-
stel. De tweede nieuwe leefstijlinterventie (CR+T; CR+Telefonische counselling) bestond 
alleen uit standaard HR in de eerste 3 maanden. Na afloop van de initiële fase, werden 
patiënten uitgenodigd voor 9 maanden nazorg bestaande uit vijf tot zes individuele 
telefonische counselling sessies, die zich net als het CR+F nazorgprogramma richtten 
op blijvende leefstijlaanpassingen en pychosociaal herstel. In de hoofdstukken 7-9 ver-
gelijken we de uitkomsten van de twee nieuwe interventies met standaard HR (zonder 
toevoegingen) bij hartpatiënten met ACS.
In hoofdstuk 7 beschrijven we de toegevoegde waarde van de nieuwe interventies met 
betrekking tot lichamelijke activiteit (primaire vraagstelling). De toevoeging van het 
beweegstimuleringprogramma (groepssessies) aan standaard HR (initiële fase CR+F) 
leidde tot een extra verbetering van 500 stappen per dag. Tevens leidden deze extra 
counselling sessies tot een verdere verbetering van de verdeling van lichamelijke activi-
teit over de dag: lichamelijke activiteit werd vaker uitgevoerd in blokken van minimaal 
10 minuten. Het CR+F beweegstimuleringsprogramma resulteerde niet in extra verbe-
teringen in totale tijd in matig-tot-intensieve lichamelijke activiteit en sedentair gedrag. 
Aan het einde van het CR+F nazorgprogramma waren de extra verbeteringen in stappen 
per dag afgenomen. De aanvullende verbetering in verdeling van lichamelijk activiteit 
over de dag bleef behouden. De CR+T interventie was niet succesvol met betrekking 
tot de genoemde uitkomstmaten. Gebaseerd op de uitkomsten adviseren wij om het 
beweegstimuleringprogramma (groepssessies als onderdeel van CR+F) toe te voegen 
aan standaard HR, alhoewel optimalisatie van het nazorgprogramma noodzakelijk is. 
Onze resultaten geven diverse richtingen voor verbeteringen, welke verder worden 
besproken in hoofdstuk 7. 
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In hoofdstuk 8 beschrijven we het aanvullende effect van de nieuwe interventies op 
SCORE, een formule die het 10-jarig risico op sterfte door hart- en vaatziekten inschat 
op basis van totaal cholesterol, systolische bloeddruk en rookstatus. Beide nieuwe inter-
venties leidden niet tot extra verberingen in de SCORE-uitkomst of in de afzonderlijke 
componenten van de SCORE. Onze resultaten laten zien dat patiënten de streefwaarden 
voor cardiovasculaire risicofactoren grotendeels al behaalden na afloop van standaard 
HR. Hieruit concluderen we dat er geen extra interventies nodig zijn voor verdere verbe-
tering van cardiovasculaire risicofactoren zoals bloeddruk en cholesterol. 
In hoofdstuk 9 beschrijven we secundaire uitkomsten. De CR+F interventie was succes-
vol in het op peil houden van de lichamelijke fitheid tot 12 maanden en het langdurig 
verbeteren van vermoeidheid. Er werden geen extra verbeteringen gevonden in de 
maatschappelijke participatie. De CR+T interventie verbeterde geen van de secun-
daire uitkomsten ten opzichte van standaard HR. De gunstige effecten gevonden voor 
lichamelijke fitheid en vermoeidheid verhogen de klinische relevantie van de CR+F 
interventie. 
Hoofdstuk 10 bevat de algemene discussie waarin de belangrijkste bevindingen van 
dit proefschrift worden beschreven en geïnterpreteerd. Tevens worden de sterke en 
zwakke punten van de gebruikte methodologie besproken. Daarnaast bespreken we 
in dit hoofdstuk de klinische implicaties van onze uitkomsten en geven aanbevelingen 
voor optimalisatie van hartrevalidatie en ideeën voor verder onderzoek op dit gebied.
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onderzoek, het schrijven van artikelen en nog veel meer. Onze studieverpleegkundigen 
Els, Verena en Saskia wil ik bedanken voor het bijhouden van al die mappen vol SAE’s 
en data, ontelbare telefoontjes over bloeduitslagen, het informeren van patiënten en 
het uitvoeren van metingen. Ik ben blij dat jullie altijd vrolijk de moed erin hebben 
gehouden! Ook heel veel dank natuurlijk voor Eric Boersma en Marcel Geleijnse. Jullie 
kritische blik en bijsturing was zeer waardevol. Ken, bedankt voor je hulp bij de kosten-
effectiviteit berekeningen. Als laatste wil ik graag de CEC (Mattie Lenzen en Arend 
Schinkel) bedanken voor hun tijd.
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leden van de kleine en grote commissie
Naast mijn promotoren en copromotoren wil ik ook graag de overige leden van de 
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dit vertrouwen en jouw bijdrage hadden wij het onderzoek bij Capri nooit op kunnen 
zetten. Bedankt ook voor je geduld, ideeën, enthousiasme en interesse. 
mijn collega’s bij Capri 
Jullie hebben allemaal wel een steentje (of zeg maar gerust kei) bijgedragen aan dit 
proefschrift. Bijvoorbeeld door het geven van terugkombijeenkomsten, door deelne-
mers te stimuleren, wandeltesten uit te voeren, telefoontjes aan te nemen, metingen 
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collega’s bedanken. Egbert, Nathalie & Ronald: bedankt voor alle middagen en avonden 
die jullie hebben opgegeven om de actieve leefstijl bijeenkomsten & terugkomsessies 
tot een succes te maken. Tanja, jij bent denk ik de meeste avonden van iedereen aanwe-
zig geweest (hoeveel liter karnemelk was het?). Bedankt voor je flexibiliteit, kundigheid 
en gezelligheid! Iris, ik ben blij dat jij het onderzoeksteam van Capri ondertussen hebt 
aangevuld en het onderzoek voortgang geeft. Bedankt voor de support tijdens het laat-
ste deel van mijn promotie en veel succes en plezier tijdens je eigen promotie traject.
Het Hartcoach team
Bedankt voor de fijne overleggen en de tijd en het enthousiasme die jullie in de telefo-
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ten als je er zelf even niet uit komt. Alle gezelligheid (wielrentochtjes, taartjes, feestjes, 
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blijft om te gaan werken! Herwin, Hans en Malou: bedankt voor jullie hulp bij het ver-
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studenten van het  erasmus mC
Dit onderzoek was niet mogelijk geweest zonder alle hulp die ik heb gehad van het 
studententeam van het Erasmus MC (honderden wandeltesten, invoeren van data, con-
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mijn co-auteurs
Bedankt voor het (mee) schrijven en jullie kritische commentaar. Jullie bijdrage vormt 
een belangrijk onderdeel van mijn proefschrift.
mijn paranimfen
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de ontwerper(s) van mijn omslag
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mijn vrienden en familie
Ik sta er eigenlijk niet vaak genoeg bij stil hoe ontzettend gelukkig ik ben met zoveel 
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Bernardo, sem esta tese nunca nos teríamos conhecido. Muito obrigada pela tua infinita 
paciênca e por todas as outras coisas. Tu fazes-me muito feliz! Preparemo-nos para a 
próxima festa ☺.
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Research school: NIHES
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supervisors: Dr. H.J.G. van den Berg-Emons & Dr. R.T. van 
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1. Phd training year hours (eCts)
general Academic skills
- CPO mini Course 2011 8 (0,3)
- Biomedical English Writing and Communication 2012 112 (4)
- BROK course 2012 30 (1)
- Research Integrity 2014 8 (0,3)
- BROK course update 2016 8 (0,3)
Research skills
- Biostatistics for clinicians (NIHES EWP22) 2012 20 (0,7)
-  Hands on performing exercise intervention trials in cardiovascular prevention 
and rehabilitation (EACPR workshop)
2015 14 (0,5)
- Stepping stones for funding and grant writing 2015 4 (0,2)
- Regression analysis (NIHES ESP09) 2015 53 (1,9)
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- Puls evenement Hartstichting 2013 8 (0,3)
- PhD day Erasmus MC 2015 6 (0,2)
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- Puls evenement Hartstichting 2015 8 (0,3)
- NVVC congress hartrevalidatie 2015 6 (0,2)
- VVBN symposium 2017 8 (0,3)
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2012 10 (0,4)
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-  Oral presentation: Current cardiac rehabilitation programmes are not sufficient 
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2014 8 (0,3)
-  Poster presentation: Improvements in physical fitness and depression are related 
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EuroPrevent, Amsterdam.
2014 8 (0,3)
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habits? A systematic review. ICBM, Groningen.
2014 28 (1)
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2015 28 (1)
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international conferences
- EuroPrevent (Dublin) 2012 28 (1)
- ESC congress (Amsterdam) 2013 28 (1)
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- Co-supervising PhD student 2016-2017 40 (1,4)
total 1387 (49,8)

